Clinical Epidemiology and Ageing

Our publications

All our original articles and reviews published in international peer-reviewed journals.


  1. Mebarki S, Pamoukdjian F, Pierro M, Poisson J, Baldini C, Taieb J, Fabre E, Canoui-Poitrine F, Oudard S, Paillaud E. Safety and efficacy of immunotherapy according to the age threshold of 80 years. Bull Cancer. 2023;110(5):570-580.
  2. Vergnenègre A, Monnet I, Ricordel C, Bizieux A, Curcio H, Bernardi M, Corre R, Guisier F, Hominal S, Le Garff G, Bylicki O, Locher C, Geier M, Chouaid C, Robinet G. Safety and efficacy of second-line metronomic oral vinorelbine-atezolizumab combination in stage IV non-small-cell lung cancer: An open-label phase II trial (VinMetAtezo). Lung Cancer. 2023;178:191-197.
  3. Secretan P-H, Vieillard V, Thirion O, Annereau M, Yayé HSadou, Astier A, Paul M, Damy T, Do B. 3D-Printed, Liquid-Filled Capsules of Concentrated and Stabilized Polyphenol Epigallocatechin Gallate, Developed in a Clinical Trial. Antioxidants (Basel). 2023;12(2).
  4. Logeart D, Damy T, Doublet M, Salvat M, Tribouilloy C, Bauer F, Eicher J-C, Picard F, Roul G, Trochu J-N, De Groote P, Bihry N, Berthelot E, Jondeau G, Seronde M-F, Roubille F, Isnard R. Feasibility and accuracy of linking a heart failure registry to the national claims database using indirect identifiers. Arch Cardiovasc Dis. 2023;116(1):18-24.
  5. Lund LH, Zeymer U, Clark AL, Barrios V, Damy T, Drożdż J, Fonseca C, Kalus S, Ferber PC, Koch C, Maggioni AP. Association between sacubitril/valsartan initiation and changes in left ventricular ejection fraction: Insights from ARIADNE registry. Int J Cardiol. 2023;370:279-286.
  6. Kharoubi M, Bezard M, Broussier A, Galat A, Gounot R, Poullot E, Molinier-Frenkel V, Fanen P, Funalot B, Itti E, Lemonnier F, Chadha GDeep Sing, Guendouz S, Mallet S, Zaroui A, Audard V, Audureau E, Le Corvoisier P, Hittinger L, Bordeneuve VPlanté, Lefaucheur J-P, Amiot A, Béquignon E, Bartier S, Leroy V, Teiger E, Oghina S, Damy T. Amylo-AFFECT-QOL, a self-reported questionnaire to assess health-related quality of life and to determine the prognosis in cardiac amyloidosis. Front Cardiovasc Med. 2023;10:1124660.
  7. Girerd N, Leclercq C, Hanon O, Bayes-Génis A, Januzzi JL, Damy T, Lequeux B, Meune C, Sabouret P, Roubille F. Optimisation of treatments for heart failure with reduced ejection fraction in routine practice: a position statement from a panel of experts. Rev Esp Cardiol (Engl Ed). 2023.
  8. Grambow-Velilla J, Seban R-D, Chouahnia K, Assié J-B, Champion L, Girard N, Bonardel G, Matton L, Soussan M, Chouaid C, Duchemann B. Total Metabolic Tumor Volume on 18F-FDG PET/CT Is a Useful Prognostic Biomarker for Patients with Extensive Small-Cell Lung Cancer Undergoing First-Line Chemo-Immunotherapy. Cancers (Basel). 2023;15(8).
  9. Girard N, Bar J, Garrido P, Garassino MC, McDonald F, Mornex F, Filippi AR, Smit HJM, Peters S, Field JK, Christoph DC, Sibille A, Fietkau R, Haakensen VD, Chouaid C, Markman B, T Hiltermann JN, Taus A, Sawyer W, Allen A, Chander P, Licour M, Solomon B. Treatment Characteristics and Real-World Progression-Free Survival in Patients With Unresectable Stage III NSCLC Who Received Durvalumab After Chemoradiotherapy: Findings From the PACIFIC-R Study. J Thorac Oncol. 2023;18(2):181-193.
  10. Fauvel C, Bonnet G, Mullens W, Giraldo CInes Salda, Mežnar AZupan, Barasa A, Tokmakova M, Shchendrygina A, Costa FMoscoso, Mapelli M, Zemrak F, Tops LF, Jakus N, Sultan A, Bahouth F, Hadjseyd C-E, Salvat M, Anselmino M, Messroghli D, Weberndörfer V, Giverts I, Bochaton T, Courand PYves, Berthelot E, Legallois D, Beauvais F, Bauer F, Lamblin N, Damy T, Girerd N, Sebbag L, Pezel T, Cohen-Solal A, Rosano G, Roubille F, Mewton N. Sequencing and titrating approach of therapy in heart failure with reduced ejection fraction following the 2021 European Society of Cardiology guidelines: an international cardiology survey. Eur J Heart Fail. 2023;25(2):213-222.
  11. Dang J, Ferlicot S, Misrahi M, Mussini C, Kounis I, Remy P, Samuel D, Planté-Bordeneuve V, Adams D, Funalot B, Snanoudj R, Damy T, Moktefi A, Audard V, Zaidan M. Pathological spectrum of hereditary transthyretin renal amyloidosis and clinicopathologic correlation: a French observational study. Nephrol Dial Transplant. 2023;38(9):2019-2030.
  12. Descourt R, Greillier L, Perol M, Ricordel C, Auliac J-B, Falchero L, Gervais R, Veillon R, Vieillot S, Guisier F, Marcq M, Justeau G, Bigay-Gamé L, Bernardi M, Fournel P, Doubre H, Pinsolle J, Amrane K, Chouaid C, Decroisette C. First-line single-agent pembrolizumab for PD-L1-positive (tumor proportion score ≥ 50%) advanced non-small cell lung cancer in the real world: impact in brain metastasis: a national French multicentric cohort (ESCKEYP GFPC study). Cancer Immunol Immunother. 2023;72(1):91-99.
  13. Bylicki O, Tomasini P, Radj G, Guisier F, Monnet I, Ricordel C, Bigay-Gamé L, Geier M, Chouaid C, Daniel C, Swalduz A, Toffart A-C, Doubre H, Peloni J-M, Moreau D, Subtil F, Grellard J-M, Castera M, Clarisse B, Martins-Lavinas P-H, Decroisette C, Greillier L. Atezolizumab with or without bevacizumab and platinum-pemetrexed in patients with stage IIIB/IV non-squamous non-small cell lung cancer with EGFR mutation, ALK rearrangement or ROS1 fusion progressing after targeted therapies: A multicentre phase II open-. Eur J Cancer. 2023;183:38-48.
  14. Bezard M, Kharoubi M, Galat A, Le Bras F, Poullot E, Molinier-Frenkel V, Fanen P, Funalot B, Moktefi A, Abulizi M, Deux J-F, Lemonnier F, Guendouz S, Chalard C, Zaroui A, Itti E, Hittinger L, Teiger E, Oghina S, Damy T. Real-Life Evaluation of an Algorithm for the Diagnosis of Cardiac Amyloidosis. Mayo Clin Proc. 2023;98(1):48-59.
  15. Soubeyran P, Bellera C, Paillaud E. Achieving harmony in oncological geriatric assessment - Should we agree on a best set of tools?. J Geriatr Oncol. 2023;14(7):101482.
  16. Aparicio T, Layese R, Hemery F, Tournigand C, Paillaud E, de Angelis N, Quero L, Ganne N, Prat F, Pachev A, Galula G, Benderra M-A, Canoui-Poitrine F. The 10-month mortality rate among older patients treated for digestive system cancer during the first wave of the COVID-19 pandemic: The CADIGCOVAGE multicentre cohort study. J Geriatr Oncol. 2023;14(2):101443.
  17. Gendarme S, Zebachi S, Corre R, Greillier L, Justeau G, Bylicki O, Decroisette C, Auliac J-B, Guisier F, Geier M, Ricordel C, Frelaut M, Paillaud E, Chouaid C, Canoui-Poitrine F. Predictors of three-month mortality and severe chemotherapy-related adverse events in patients aged 70 years and older with metastatic non-small-cell lung cancer: A secondary analysis of ESOGIA-GFPC-GECP 08-02 study. J Geriatr Oncol. 2023:101506.
  18. Labbe V, Contou D, Heming N, Megarbane B, Razazi K, Boissier F, Ait-Oufella H, Turpin M, Carreira S, Robert A, Monchi M, Souweine B, Préau S, Doyen D, Vivier E, Zucman N, Dres M, Fejjal M, Noel-Savina E, Bachir M, Jaffal K, Timsit J-F, Picos SAlberto, Mariotte E, Martis N, Juguet W, Melica G, Rondeau P, Audureau E, Dessap AMekontso. Effects of Standard-Dose Prophylactic, High-Dose Prophylactic, and Therapeutic Anticoagulation in Patients With Hypoxemic COVID-19 Pneumonia: The ANTICOVID Randomized Clinical Trial. JAMA Intern Med. 2023;183(6):520-531.
  19. Halimi F, Sabouret P, Huberman JP, Ouazana L, Guedj D, Djouadi K, Dhanjal TS, Goette A, Lafont C, Lellouche N. Atrial fibrillation detection with long-term continuous Holter ECG recording in patients with high cardiovascular risk and clinical palpitations: the prospective after study. Clin Res Cardiol. 2023;112(6):807-814.
  20. Guillet S, Loustau V, Boutin E, Zarour A, Comont T, Souchaud-Debouverie O, Chalumeau NCostedoat, Pan-Petesch B, Gobert D, Cheze S, Viallard JFrancois, Morin A-S, Sauvetre G, Cliquennois M, Royer B, Masseau A, Terriou L, Fieschi C, Lambotte O, Girault S, Lioger B, Audia S, Sacre K, Lega JChristophe, Langlois V, Benachi A, Orvain C, Devidas A, Humbert S, Gambier N, Ruivard M, Zarrouk V, Ebbo M, Willems L, Segaux L, Mahévas M, Haddad B, Michel M, Canoui-Poitrine F, Godeau B. Immune thrombocytopenia and pregnancy: an exposed/nonexposed cohort study. Blood. 2023;141(1):11-21.
  21. Lopinto J, Arrestier R, Peiffer B, Gaillet A, Voiriot G, Urbina T, Luyt C-E, Bellaïche R, Pham T, Ait-Hamou Z, Roux D, Clere-Jehl R, Azoulay E, Gaudry S, Mayaux J, Dessap AMekontso, Canoui-Poitrine F, de Prost N. High-Dose Steroids for Nonresolving Acute Respiratory Distress Syndrome in Critically Ill COVID-19 Patients Treated With Dexamethasone: A Multicenter Cohort Study. Crit Care Med. 2023;51(10):1306-1317.
  22. Schlemmer F, Valentin S, Boyer L, Guillaumot A, Chabot F, Dupin C, Le Guen P, Lorillon G, Bergeron A, Basille D, Delomez J, Andrejak C, Bonnefoy V, Goussault H, Assié J-B, Choinier P, Ruppert A-M, Cadranel J, Mennitti MChiara, Roumila M, Colin C, Günther S, Sanchez O, Gille T, Sésé L, Uzunhan Y, Faure M, Patout M, Morelot-Panzini C, Laveneziana P, Zysman M, Blanchard E, Raherison-Semjen C, Giraud V, Giroux-Leprieur E, Habib S, Roche N, Dinh-Xuan ATuan, Sifaoui I, Brillet P-Y, Jung C, Boutin E, Layese R, Canoui-Poitrine F, Maitre B. Respiratory recovery trajectories after severe-to-critical COVID-19: a 1-year prospective multicentre study. Eur Respir J. 2023;61(4).
  23. Dreyfus J, Bohbot Y, Coisne A, Lavie-Badie Y, Flagiello M, Bazire B, Eggenspieler F, Viau F, Riant E, Mbaki Y, Eyharts D, Senage T, Modine T, Nicol M, Doguet F, Le Tourneau T, Tribouilloy C, Donal E, Tomasi J, Habib G, Selton-Suty C, Radu C, Lim P, Raffoul R, Iung B, Obadia J-F, Audureau E, Messika-Zeitoun D. Predictive value of the TRI-SCORE for in-hospital mortality after redo isolated tricuspid valve surgery. Heart. 2023;109(12):951-958.
  24. Hild S, Teigné D, Ferrat E, Banaszuk A-S, Berquet K, Lebon A, Bataille E, Nanin F, Gaultier A, Rat C. Breast cancer: a randomized controlled trial assessing the effect of a decision aid on mammography screening uptake: study protocol. Front Oncol. 2023;13:1128467.
  25. Ramond-Roquin A, Gautier S, Le Breton J, Bourgueil Y, Bouchez T. French General Practitioners' Adaptations for Patients with Suspected COVID-19 in May 2020. Int J Environ Res Public Health. 2023;20(3).
  26. Depotte L, Caroux M, Gligorov J, Canoui-Poitrine F, Belkacemi Y, de la Taille A, Tournigand C, Kempf E. Association between overweight, obesity, and quality of life of patients receiving an anticancer treatment for prostate cancer: a systematic literature review. Health Qual Life Outcomes. 2023;21(1):11.
  27. Couderc A-L, Liuu E, Boudou-Rouquette P, Poisson J, Frelaut M, Montégut C, Mebarki S, Geiss R, Thomas ZAp, Noret A, Pierro M, Baldini C, Paillaud E, Pamoukdjian F. Pre-Therapeutic Sarcopenia among Cancer Patients: An Up-to-Date Meta-Analysis of Prevalence and Predictive Value during Cancer Treatment. Nutrients. 2023;15(5).
  28. Guittet L, Quipourt V, Aparicio T, Carola E, Seitz J-F, Paillaud E, Lièvre A, Boulahssass R, Vitellius C, Bengrine L, Canoui-Poitrine F, Manfredi S. Should we screen for colorectal cancer in people aged 75 and over? A systematic review - collaborative work of the French geriatric oncology society (SOFOG) and the French federation of digestive oncology (FFCD). BMC Cancer. 2023;23(1):17.
  29. Pezel T, Dreyfus J, Mouhat B, Thébaut C, Audureau E, Bernard A, Badie YLavie, Bohbot Y, Fard D, Nguyen LS, Monteil C, Bière L, Le Ven F, Canu M, Ribeyrolles S, Mion B, Bazire B, Fauvel C, Cautela J, Cambet T, Le Tourneau T, Donal E, Lafitte S, Magne J, Mansencal N, Coisne A. Effectiveness of Simulation-Based Training on Transesophageal Echocardiography Learning: The SIMULATOR Randomized Clinical Trial. JAMA Cardiol. 2023;8(3):248-256.
  30. Serrano AGonzález, Laurent M, Barnay T, Martinez-Tapia C, Audureau E, Boudou-Rouquette P, Aparicio T, Rollot-Trad F, Soubeyran P, Bellera C, Caillet P, Paillaud E, Canoui-Poitrine F. A Two-Step Frailty Assessment Strategy in Older Patients With Solid Tumors: A Decision Curve Analysis. J Clin Oncol. 2023;41(4):826-834.
  31. Torres MJ, Coste J, Canoui-Poitrine F, Pouchot J, Rachas A, Carcaillon-Bentata L. Impact of the First COVID-19 Pandemic Wave on Hospitalizations and Deaths Caused by Geriatric Syndromes in France: A Nationwide Study. J Gerontol A Biol Sci Med Sci. 2023;78(9):1612-1626.
  32. Guillet S, Crickx E, Azzaoui I, Chappert P, Boutin E, Viallard J-F, Rivière E, Gobert D, Galicier L, Malphettes M, Cheze S, Lefrère F, Audia S, Bonnotte B, Lambotte O, Noel N, Fain O, Moulis G, Hamidou M, Gerfaud-Valentin M, Marolleau J-P, Terriou L, Martis N, Morin A-S, Perlat A, Le Gallou T, Roy-Peaud F, Robbins A, Lega J-C, Puyade M, Comont T, Limal N, Languille L, Zarrour A, Luka M, Menager M, Belmondo T, Hue S, Canoui-Poitrine F, Michel M, Godeau B, Mahévas M. Prolonged response after TPO-RA discontinuation in primary ITP: results of a prospective multicenter study. Blood. 2023;141(23):2867-2877.
  33. Le Goff E, Blanc-Durand P, Roulin L, Lafont C, Loyaux R, MBoumbae D-L, Benmaad I, Claudel A, Poullot E, Robe C, Gricourt G, Aissat A, Copie-Bergman C, Lemonnier F, Gaulard P, Itti E, Haioun C, Delfau-Larue M-H. Baseline circulating tumour DNA and total metabolic tumour volume as early outcome predictors in aggressive large B-cell lymphoma. A real-world 112-patient cohort. Br J Haematol. 2023;202(1):54-64.
  34. Feredj E, Audureau E, Boueilh A, Fihman V, Fourati S, Lelièvre J-D, Gallien S, Grimbert P, Matignon M, Melica G. Impact of a Dedicated Pretransplant Infectious Disease Consultation on Respiratory Tract Infections in Kidney Allograft Recipients: A Retrospective Study of 516 Recipients. Pathogens. 2023;12(1).
  35. Celante H, Oubaya N, Fourati S, Beaune S, Khellaf M, Casalino E, Ricard J-D, Vieillard-Baron A, Heming N, Dessap AMekontso, de Montmollin E, Benghanem S, Epaillard N, Layese R, de Prost N. Prognosis of hospitalised adult patients with respiratory syncytial virus infection: a multicentre retrospective cohort study. Clin Microbiol Infect. 2023;29(7):943.e1-943.e8.
  36. Jenvrin A, Galletto-Pregliasco A, Audureau E, Pujals A, Favre L, Luciani A, Calderaro J, Sommacale D, Chatellier G, Tournigand C, Laurent A, Kempf E. Intentional R1 resection of liver metastases: A new treatment paradigm for patients with advanced colorectal cancer based on a propensity score-Matched case-control analysis. Clin Res Hepatol Gastroenterol. 2023;47(4):102097.
  37. Melica G, Bartolucci P, Audureau E, Le Corvoisier P, Habibi A, Gellen J, Selmane D, Michel M, Lacabaratz C, Levy Y. Immunological Efficacy of Pneumococcal Vaccination Including the 13-Valent Pneumococcal Conjugate Vaccine in Adult Patients With Sickle Cell Disease: Results of the Randomized DREVAC Controlled Trial. Clin Infect Dis. 2023;76(11):1949-1958.
  38. Dang J, Segaux L, Moktefi A, Stehlé T, Kharoubi M, Karoui KEl, Remy P, Grimbert P, Planté-Bordeneuve V, Guendouz S, Galat A, Mallet S, Oghina S, Chadha GDeep Singh, Zaroui A, Fanen P, Canoui-Poitrine F, Damy T, Audard V. Natural course and determinants of short-term kidney function decline in hereditary transthyretin amyloidosis: a French observational study. Amyloid. 2023;30(1):38-48.
  39. Bastuji-Garin S, Brouard L, Bourgeon-Ghittori I, Zebachi S, Boutin E, Hemery F, Fourreau F, Oubaya N, De Roux Q, Mongardon N, Fourati S, Decousser J-W. The Relative Contributions of Occupational and Community Risk Factors for COVID-19 among Hospital Workers: The HOP-COVID Cohort Study. J Clin Med. 2023;12(3).
  40. Assié J-B, Chouaid C, Nunes H, Reynaud D, Gaudin A-F, Grumberg V, Jolivel R, Jouaneton B, Cotté F-E, Duchemann B. Outcome following nivolumab treatment in patients with advanced non-small cell lung cancer and comorbid interstitial lung disease in a real-world setting. Ther Adv Med Oncol. 2023;15:17588359231152847.
  41. Berthelot E, Broussier A, Hittinger L, Donadio C, Rovani X, Salengro E, Megbemado R, Godreuil C, Belmin J, David JPhilippe, Genet B, Damy T. Patients with cardiac amyloidosis are at a greater risk of mortality and hospital readmission after acute heart failure. ESC Heart Fail. 2023;10(3):2042-2050.
  42. Chouaid C, Bosquet L, Girard N, Kron A, Scheffler M, Griesinger F, Sebastian M, Trigo J, Viteri S, Knott C, Rodrigues B, Rahhali N, Cabrieto J, Diels J, Perualila NJ, Schioppa CA, Sermon J, Toueg R, Erdmann N, Mielke J, Nematian-Samani M, Martin-Fernandez C, Pfaira I, Li T, Mahadevia P, Wolf J. An Adjusted Treatment Comparison Comparing Amivantamab Versus Real-World Clinical Practice in Europe and the United States for Patients with Advanced Non-Small Cell Lung Cancer with Activating Epidermal Growth Factor Receptor Exon 20 Insertion Mutations. Adv Ther. 2023;40(3):1187-1203.
  43. Martinez-Tapia C, Rougette K, Fossey-Diaz V, Cudennec T, Taleb C, Balardy L, Mertens C, Mitha N, Bringuier M, Maley K, Estivin S, Quipourt V, Canoui-Poitrine F, Baldini C, Poisson J, Paillaud E. Prevalence of Four Sarcopenia Criteria in Older Patients with Cancer, and Their Predictive Value for 6-Month Mortality: The NutriAgeCancer National Prospective Cohort Study. Nutrients. 2023;15(6).


  1. Paillaud E, Caillet P, Conti C, Mebarki S. [Specificities of supportive care in geriatric oncology]. Bull Cancer. 2022;109(5):568-578.
  2. Gendarme S, Bylicki O, Chouaid C, Guisier F. Fusions in Non-Small-Cell Lung Cancer: Evidence to Date. Curr Oncol. 2022;29(2):641-658.
  3. Hacil A, Genet B, Assayag P, Jourdain P, Motiejunaite J, David JPhilippe, Verny C, Hanon O, Berthelot E. Management and prognosis of older patients with acute heart failure hospitalized in geriatrics and cardiology departments: The GERDICA study. J Am Geriatr Soc. 2022;70(4):1282-1284.
  4. Odouard S, Abulizi M, Kharoubi M, Oghina S, Guendouz S, Zaroui A, Teiger E, Itti E, Damy T, Galat A. Tafamidis Decreases Cardiac Uptake of Tc-HMDP in Transthyretin Cardiac Amyloidosis. JACC Cardiovasc Imaging. 2022;15(12):2149-2151.
  5. Zeymer U, Clark AL, Barrios V, Damy T, Drożdż J, Fonseca C, Lund LH, Kalus S, Ferber PC, Hussain RI, Koch C, Maggioni AP. Utilization of sacubitril/valsartan in patients with heart failure with reduced ejection fraction: real-world data from the ARIADNE registry. Eur Heart J Qual Care Clin Outcomes. 2022;8(4):469-477.
  6. Touboul O, Algalarrondo V, Oghina S, Elbaz N, Rouffiac S, Hamon D, Extramiana F, Gandjbakhch E, d'Humières T, Marijon E, Dhanjal TS, Teiger E, Damy T, Lellouche N. Electrical cardioversion of atrial arrhythmias with cardiac amyloidosis in the era of direct oral anticogulants. ESC Heart Fail. 2022;9(5):3556-3564.
  7. Van Sanden S, Murton M, Bobrowska A, Rahhali N, Sermon J, Rodrigues B, Goff-Leggett D, Chouaid C, Sebastian M, Greystoke A. Prevalence of Epidermal Growth Factor Receptor Exon 20 Insertion Mutations in Non-small-Cell Lung Cancer in Europe: A Pragmatic Literature Review and Meta-analysis. Target Oncol. 2022;17(2):153-166.
  8. Paleiron N, Gervais R, Rousseau-Bussac G, Game LBigay, Chiappa AMarie, Lamy R, Guisier F, Le Caer H, Robinet G, Bizieux A, Chouaid C. Management of patients with synchronous head-and-neck and lung cancers: SYNCHRON GFPC 15-01 study. J Cancer Res Ther. 2022;18(Supplement):S160-S164.
  9. Pasteur-Rousseau A, Odouard S, Souibri K, Sebag FA, Deux J-F, Damy T. [Cardiac imaging in infiltrative cardiomyopathies. What cardiovascular imaging modalities to propose in hypertrophic cardiomyopathies ?]. Ann Cardiol Angeiol (Paris). 2022;71(2):63-74.
  10. Moulin T, Hamon D, Djouadi K, d'Humières T, Elbaz N, Boukantar M, Zerbib C, Rouffiac S, Dhanjal TS, Ernande L, Derumeaux G, Teiger E, Damy T, Lellouche N. Impact of cardiac resynchronization therapy optimization inside a heart failure programme: a real-world experience. ESC Heart Fail. 2022;9(5):3101-3112.
  11. Nguyen-Michel V-H, Houot M, Delorme C, Sangaré A, Gales A, Frazzini V, Hanin A, Aissani D, Trân T, Oquendo B, Ketz F, Lafuente-Lafuente C, Oasi C, Kinugawa K, Ouvrard G, Ursu R, Degos B, Rohaut B, Demeret S, Lambrecq V, Navarro V, Fournier E, Corvol J-C, Borden A. Older patients with COVID-19 and neuropsychiatric conditions: A study of risk factors for mortality. Brain Behav. 2022;12(12):e2787.
  12. Maggioni AP, Clark AL, Barrios V, Damy T, Drożdż J, Fonseca C, Lund LH, Kalus S, Ferber PC, Hussain RI, Koch C, Zeymer U. Outcomes with sacubitril/valsartan in outpatients with heart failure and reduced ejection fraction: The ARIADNE registry. ESC Heart Fail. 2022;9(6):4209-4218.
  13. Hourqueig M, Bouzille G, Mirabel M, Huttin O, Damy T, Labombarda F, Eicher J-C, Charron P, Habib G, Réant P, Hagège A, Donal E. Hypertrophic cardiomyopathies requiring more monitoring for less atrial fibrillation-related complications: a clustering analysis based on the French registry on hypertrophic cardiomyopathy (REMY). Clin Res Cardiol. 2022;111(2):163-174.
  14. Jobbé-Duval A, Bezard M, Moutereau S, Kharoubi M, Oghina S, Zaroui A, Galat A, Chalard C, Hugon-Vallet E, Lemonnier F, Eyharts D, Poulot E, Fanen P, Funalot B, Molinier-Frenkel V, Audard V, Hittinger L, Delbarre MAntoine, Teiger E, Damy T. Prevalence and determinants of iron deficiency in cardiac amyloidosis. ESC Heart Fail. 2022;9(2):1314-1327.
  15. Justeau G, Huchot E, Simonneau Y, Roa M, Le Treut J, Le Garff G, Bylicki O, Schott R, Bravard A-S, Tiercin M, Lamy R, De Chabot G, Marty A, Moreau D, Locher C, Bernier C, Chouaid C, Descourt R. Impact of KRAS G12C mutation in patients with advanced non-squamous non-small cell lung cancer treated with first-line pembrolizumab monotherapy. Lung Cancer. 2022;174:45-49.
  16. Kharoubi M, Bodez D, Bezard M, Zaroui A, Galat A, Guendouz S, Gendre T, Hittinger L, Attias D, Mohty D, Bergoend E, Itti E, Lebras F, Hamon D, Poullot E, Molinier-Frenkel V, Lellouche N, Deux J-F, Funalot B, Fannen P, Oghina S, Arrouasse R, Lecorvoisier P, Souvannanorath S, Amiot A, Teiger E, Bougouin W, Damy T. Describing mode of death in three major cardiac amyloidosis subtypes to improve management and survival. Amyloid. 2022;29(2):79-91.
  17. Landre T, Justeau G, Assié J-B, Chouahnia K, Davoine C, Taleb C, Chouaid C, Duchemann B. Anti-PD-(L)1 for KRAS-mutant advanced non-small-cell lung cancers: a meta-analysis of randomized-controlled trials. Cancer Immunol Immunother. 2022;71(3):719-726.
  18. Law S, Bezard M, Petrie A, Chacko L, Cohen OC, Ravichandran S, Ogunbiyi O, Kharoubi M, Ganeshananthan S, Ganeshananthan S, Gilbertson JA, Rowczenio D, Wechalekar A, Martinez-Naharro A, Lachmann HJ, Whelan CJ, Hutt DF, Hawkins PN, Damy T, Fontana M, Gillmore JD. Characteristics and natural history of early-stage cardiac transthyretin amyloidosis. Eur Heart J. 2022;43(27):2622-2632.
  19. Gonzalez-Lopez E, Escobar-Lopez L, Obici L, Saturi G, Bezard M, Saith SE, AbouEzzeddine OF, Mussinelli R, Gagliardi C, Kharoubi M, Griffin JM, Dispenzieri A, Vilches S, Perlini S, Longhi S, Oghina S, Rivas A, Grogan M, Maurer MS, Damy T, Palladini G, Rapezzi C, García-Pavía P. Prognosis of Transthyretin Cardiac Amyloidosis Without Heart Failure Symptoms. JACC CardioOncol. 2022;4(4):442-454.
  20. Goussault H, Gendarme S, Assié J-B, Jung C, Epaud S, Algans C, Salaün-Penquer N, Rousseau M, Lazatti A, Chouaid C. Risk factors for early mortality of lung cancer patients in France: A nationwide analysis. Cancer Med. 2022;11(24):5025-5034.
  21. Gendarme S, Pairon J-C, Andujar P, Laurent F, Brochard P, Delva F, Clin B, Gislard A, Paris C, Thaon I, Goussault H, Canoui-Poitrine F, Chouaid C. Cost-Effectiveness of an Organized Lung Cancer Screening Program for Asbestos-Exposed Subjects. Cancers (Basel). 2022;14(17).
  22. Edelman MJ, Dvorkin M, Laktionov K, Navarro A, Juan-Vidal O, Kozlov V, Golden G, Jordan O, Deng CQ, Bentsion D, Chouaid C, Dechev H, Dowlati A, Núñez NFernández, Ivashchuk O, Kiladze I, Kortua T, Leighl N, Luft A, Makharadze T, Min YJ, Quantin X. Randomized phase 3 study of the anti-disialoganglioside antibody dinutuximab and irinotecan vs irinotecan or topotecan for second-line treatment of small cell lung cancer. Lung Cancer. 2022;166:135-142.
  23. Fischer K, Lellouche N, Damy T, Martins R, Clementy N, Bisson A, Lesaffre F, Espinosa M, Garcia R, Degand B, Serzian G, Jourda F, Huttin O, Guichard J-B, Devilliers H, Eicher J-C, Laurent G, Guenancia C. Cardiovascular outcomes after cardiac resynchronization therapy in cardiac amyloidosis. ESC Heart Fail. 2022;9(1):740-750.
  24. Damy T, Adams D, Bridoux F, Grateau G, Planté-Bordeneuve V, Ghiron Y, Farrugia A, Pelcot F, Taieb C, Labeyrie C, Jaccard A, Georgin-Lavialle S. Amyloidosis from the patient perspective: the French daily impact of amyloidosis study. Amyloid. 2022;29(3):165-174.
  25. Garassino MC, Mazières J, Reck M, Chouaid C, Bischoff H, Reinmuth N, Cove-Smith L, Mansy T, Cortinovis D, Migliorino MR, Delmonte A, Sánchez JGarcia, Velarde LEnrique Ch, Bernabe R, Paz-Ares L, Perez IDiaz, Trunova N, Foroutanpour K, Faivre-Finn C. Durvalumab After Sequential Chemoradiotherapy in Stage III, Unresectable NSCLC: The Phase 2 PACIFIC-6 Trial. J Thorac Oncol. 2022;17(12):1415-1427.
  26. Descourt R, Perol M, Rousseau-Bussac G, Planchard D, Mennecier B, Wislez M, Cadranel J, Cortot ABenjamin, Guisier F, Galland L, Do P, Schott R, Dansin E, Arrondeau J, Auliac J-B, Geier M, Chouaid C. Brigatinib for Pretreated, ALK-Positive, Advanced Non-Small-Cell Lung Cancers: Long-Term Follow-Up and Focus on Post-Brigatinib Lorlatinib Efficacy in the Multicenter, Real-World BrigALK2 Study. Cancers (Basel). 2022;14(7).
  27. Colombat M, Gaspard M, Camus M, Dalloux-Chioccioli J, Delas A, Poullot E, Moktefi A, François A, Moreau A, Gibier J-B, Raynaud P, Huart A, Piedrafita A, Gilhodes J, Lairez O, Grateau G, Georgin-Lavialle S, Maisonneuve H, Moreau P, Jaccard A, Bridoux F, Planté-Bordeneuve V, Damy T, Mal H, Brousset P, Valleix S, Burlet-Schiltz O. Mass spectrometry-based proteomics in clinical practice amyloid typing: state-of-the-art from a French nationwide cohort. Haematologica. 2022;107(12):2983-2987.
  28. Boureau A-S, Annweiler C, Belmin J, Bouleti C, Chacornac M, Chuzeville M, David J-P, Jourdain P, Krolak-Salmon P, Lamblin N, Paccalin M, Sebbag L, Hanon O. Practical management of frailty in older patients with heart failure: Statement from a panel of multidisciplinary experts on behalf the Heart Failure Working Group of the French Society of Cardiology and on behalf French Society of Geriatrics and Gerontol. ESC Heart Fail. 2022;9(6):4053-4063.
  29. Benson MD, Berk JL, Dispenzieri A, Damy T, Gillmore JD, Hazenberg BP, Lavatelli F, Picken MM, Röcken C, Schönland S, Ueda M, Westermark P. Tissue biopsy for the diagnosis of amyloidosis: experience from some centres. Amyloid. 2022;29(1):8-13.
  30. Assié J-B, Crépin F, Grolleau E, Canellas A, Geier M, Grébert-Manuardi A, Akkache N, Renault A, Hauss P-A, Sabatini M, Bonnefoy V, Cortot A, Wislez M, Gauvain C, Chouaid C, Scherpereel A, Monnet I. Immune-Checkpoint Inhibitors for Malignant Pleural Mesothelioma: A French, Multicenter, Retrospective Real-World Study. Cancers (Basel). 2022;14(6).
  31. Abroud H, Beldi-Ferchiou A, Audard V, Lemonnier F, Le Bras F, Belhadj K, Moktefi A, Poullot E, Karoui KEl, Dupuis J, Maarek A, Roulin L, Delfau-Larue M-H, Oghina S, Kharoubi M, Bezard M, Zaroui A, Damy T, Molinier-Frenkel V. Evaluation of a new ELISA assay for monoclonal free-light chain detection in patients with cardiac amyloidosis. EJHaem. 2022;3(3):828-837.
  32. Ladner J, Alshurafa S, Madi F, Nofal A, Jayasundera R, Saba J, Audureau E. Factors impacting self-management ability in patients with chronic diseases in the United Arab Emirates, 2019. J Comp Eff Res. 2022;11(3):179-192.
  33. Paillaud E, Poisson J, Granier C, Ginguay A, Plonquet A, Conti C, Broussier A, Raynaud-Simon A, Bastuji-Garin S. Serum Leptin Levels, Nutritional Status, and the Risk of Healthcare-Associated Infections in Hospitalized Older Adults. Nutrients. 2022;14(1).
  34. Aparicio T, Layese R, Hemery F, Tournigand C, Paillaud E, de Angelis N, Quero L, Ganne N, Prat F, Pachev A, Galula G, Benderra M-A, Canoui-Poitrine F. Effect of lockdown on digestive system cancer care amongst older patients during the first wave of COVID-19: The CADIGCOVAGE multicentre cohort study. Dig Liver Dis. 2022;54(1):10-18.
  35. Boudou-Rouquette P, de Moura A, Martinez-Tapia C, Serrano AGonzalez, Chahwakilian A, Jouinot A, Ulmann G, Orvoën G, Chambraud C, Durand J-P, Caillet P, Goldwasser F, Paillaud E, Canoui-Poitrine F. Energy expenditure profiles and the risk of early limiting toxicity in older patients with cancer: The ELCAPA-25 prospective cohort survey. Clin Nutr. 2022;41(5):1073-1082.
  36. Jung C, Excoffier J-B, Raphaël-Rousseau M, Salaün-Penquer N, Ortala M, Chouaid C. Evolution of hospitalized patient characteristics through the first three COVID-19 waves in Paris area using machine learning analysis. PLoS One. 2022;17(2):e0263266.
  37. Damy T, Benedyga V, Pezel T, Berthelot E, Gauthier J, Habib G, Iliou M-C, Aupetit J-F, Baudry G, De Groote P, Logeart D, Chaufourier L, Ciobotaru V, Pousset F, Beauvais F, Bauer F, Zores F, Lairez O, Richard K, Hittinger L, Teiger E, Taieb C, Audureau E. Prescription, Compliance, and Burden Associated with Salt-Restricted Diets in Heart Failure Patients: Results from the French National OFICSel Observatory. Nutrients. 2022;14(2).
  38. Esser R, Oufkir M, Tall F, David J-P. [Screening and management of peripheral arterial obstructive disease in the lower limb wounds amongst diabetic elderly patients]. Geriatr Psychol Neuropsychiatr Vieil. 2022;20(4):473-480.
  39. Paillaud E, Brugel L, Bertolus C, Baron M, Béquignon E, Caillet P, Schouman T, Guily JLacau Sain, Périé S, Bouvard E, Laurent M, Salvan D, Chaumette L, de Decker L, Piot B, Barry B, Raynaud-Simon A, Sauvaget E, Bach C, Bizard A, Bounar A, Minard A, Aziz B, Chevalier E, Chevalier D, Gaxatte C, Malard O, Liuu E, Lacour S, Gregoire L, Lafont C, Canoui-Poitrine F. Effectiveness of Geriatric Assessment-Driven Interventions on Survival and Functional and Nutritional Status in Older Patients with Head and Neck Cancer: A Randomized Controlled Trial (EGeSOR). Cancers (Basel). 2022;14(13).
  40. Moreno ASuarez, Nguyen J-P, Calmelet A, Le Saout E, Damier P, de Decker L, Malineau C, Nizard J, Canoui-Poitrine F, Lefaucheur J-P. Multi-site rTMS with cognitive training improves apathy in the long term in Alzheimer's disease: A 4-year chart review. Clin Neurophysiol. 2022;137:75-83.
  41. Belmin J, Lafuente-Lafuente C. [Not Available]. Geriatr Psychol Neuropsychiatr Vieil. 2022;20(1):5-7.
  42. Tuppin P, Lesuffleur T, Constantinou P, Atramont A, Coatsaliou C, Ferrat E, Canoui-Poitrine F, Debeugny G, Rachas A. Underuse of primary healthcare in France during the COVID-19 epidemic in 2020 according to individual characteristics: a national observational study. BMC Prim Care. 2022;23(1):200.
  43. Bencheikh L, Nguyen K-A, Chadebech P, Kiger L, Bodivit G, Jouard A, Pakdaman S, Adypagavane S, Audureau E, Tebbakha K, Bocquet T, Mignen B, Hebert N, Seguin M, Pirenne F, Sowemimo-Coker S, Dunham A, Bartolucci P. Preclinical evaluation of the preservation of red blood cell concentrates by hypoxic storage technology for transfusion in sickle cell disease. Haematologica. 2022;107(8):1944-1949.
  44. Boisteau E, Francois E, Aparicio T, Le Malicot K, Boulahssass R, Lecomte T, Laurent-Puig P, Guiu B, Paillaud E, Galais M-P, Ataz DLopez-Trab, Tougeron D, Dourthe L-M, Guimbaud R, Samalin E, Moreau M, Louvet C, Lepage C, Lièvre A. SOCRATE-PRODIGE 55 trial: A randomized phase II study to evaluate second-line ramucirumab alone or with paclitaxel in older patients with advanced gastric cancer. Dig Liver Dis. 2022;54(6):747-754.
  45. Labbe V, Contou D, Heming N, Megarbane B, Ait-Oufella H, Boissier F, Carreira S, Robert A, Vivier E, Fejjal M, Doyen D, Monchi M, Préau S, Noel-Savina E, Souweine B, Zucman N, Picos SAlberto, Dres M, Juguet W, Mariotte E, Timsit J-F, Turpin M, Razazi K, Gendreau S, Baloul S, Voiriot G, Fartoukh M, Audureau E, Dessap AMekontso. Comparison of standard prophylactic, intermediate prophylactic and therapeutic anticoagulation in patients with severe COVID-19: protocol for the ANTICOVID multicentre, parallel-group, open-label, randomised controlled trial. BMJ Open. 2022;12(4):e059383.
  46. Vincent Y-M, Frachon A, Allaire A, Boussageon R, Pouchain D, Ferrat E, Rat C. Development of a patient decision aid for COVID-19 vaccination with the Comirnaty vaccine. Fam Pract. 2022;39(3):486-492.
  47. Amélie A-E, Ruelle Y, Frèche B, Houllemare M, Bonillo A, Bouaziz L, Rat C, Gocko X, Cerisey C, Aubin-Auger I, Ferrat E. What do women and healthcare professionals expect of decision aids for breast cancer screening? A qualitative study in France. BMJ Open. 2022;12(3):e058879.
  48. Oghina S, Delbarre MA, Poullot E, Belhadj K, Fanen P, Damy T. [Cardiac amyloidosis: State of art in 2022]. Rev Med Interne. 2022;43(9):537-544.
  49. C Quarta C, Fontana M, Damy T, Catini J, Simoneau D, Mercuri M, García-Pavía P, Maurer MS, Palladini G. Changing paradigm in the treatment of amyloidosis: From disease-modifying drugs to anti-fibril therapy. Front Cardiovasc Med. 2022;9:1073503.
  50. Sabouret P, Attias D, Beauvais C, Berthelot E, Bouleti C, G Genty G, Galat A, Hanon O, Hulot JS, Isnard R, Jourdain P, Lamblin N, Lebreton G, Lellouche N, Logeart D, Meune C, Pezel T, Damy T. Diagnosis and management of heart failure from hospital admission to discharge: A practical expert guidance. Ann Cardiol Angeiol (Paris). 2022;71(1):41-52.
  51. Bourdon E, Havreng-Théry C, Lafuente C, Belmin J. Effect of the Physical Environment on Health and Well-Being of Nursing Homes Residents: A Scoping Review. J Am Med Dir Assoc. 2022;23(11):1826.e1-1826.e20.
  52. Hagege M, Ali-Hamadi A, Oddou S, Serhal R, Isocarma T, Klass M, Khettab M. Health, illness and cancer in Mayotte: Multicultural experiences in a medically underserved French Territory. Bull Cancer. 2022;109(2):241-245.
  53. Miller EJ, Campisi R, Shah NR, McMahon S, Cuddy S, Gallegos-Kattan C, Maurer MS, Damy T, Slart RHJA, Bhatia K, Einstein AJ. Radiopharmaceutical supply disruptions and the use of Tc-hydroxymethylene diphosphonate as an alternative to Tc-pyrophosphate for the diagnosis of transthyretin cardiac amyloidosis: An ASNC Information Statement. J Nucl Cardiol. 2022;29(5):2748-2760.
  54. Girerd N, Mewton N, Tartiere J-M, Guijarro D, Jourdain P, Damy T, Lamblin N, Bayes-Génis A, Pellicori P, Januzzi JL, Rossignol P, Roubille F. Practical outpatient management of worsening chronic heart failure. Eur J Heart Fail. 2022;24(5):750-761.
  55. Bauër P, Leemans M, Audureau E, Gilbert C, Armal C, Fromantin I. Remote Medical Scent Detection of Cancer and Infectious Diseases With Dogs and Rats: A Systematic Review. Integr Cancer Ther. 2022;21:15347354221140516.
  56. Greillier L, Gauvrit M, Paillaud E, Girard N, Montégut C, Boulahssass R, Wislez M, Pamoukdjian F, Corre R, Cabart M, Caillet P, Belaroussi Y, Frasca M, Noize P, Wang P, Mebarki S, Mathoulin-Pelissier S, Couderc A-L. Targeted Therapy for Older Patients with Non-Small Cell Lung Cancer: Systematic Review and Guidelines from the French Society of Geriatric Oncology (SoFOG) and the French-Language Society of Pulmonology (SPLF)/French-Language Oncology Group (GOLF). Cancers (Basel). 2022;14(3).
  57. Hanna M, Damy T, Grogan M, Stewart M, Gundapaneni B, Sultan MB, Maurer MS. Tafamidis and quality of life in people with transthyretin amyloid cardiomyopathy in the study ATTR-ACT: A plain language summary. Future Cardiol. 2022;18(3):165-172.
  58. Griesinger F, Perol M, Girard N, Durand-Zaleski I, Zacharias S, Bosquet L, Jänicke M, Quantin X, Groth A, Fleitz A, Calleja A, Patel S, Lacoin L, Daumont MJ, Penrod JR, Carroll R, Waldenberger D, Reynaud D, Thomas M, Chouaid C. Impact of immune checkpoint inhibitors on the management of locally advanced or metastatic non-small cell lung cancer in real-life practice in patients initiating treatment between 2015 and 2018 in France and Germany. Lung Cancer. 2022;172:65-74.
  59. Grumberg V, Chouaid C, Cotté F-E, Jouaneton B, Jolivel R, Gaudin A-F, Reynaud D, Assié J-B, Borget I. Long-term hospital resource utilization and associated costs of care for patients initiating nivolumab in advanced non-small cell lung cancer in France. J Med Econ. 2022;25(1):691-699.
  60. Guendouz S, Grimbert P, Radu C, Cherqui D, Salloum C, Mongardon N, Maghrebi S, Belhadj K, Le Bras F, Teiger E, Couetil J-P, Balan A, Kharoubi M, Bezard M, Oghina S, Bodez D, Hittinger L, Audard V, Planté-Bordeneuve V, de la Taille A, Bergoend E, Frenkel V, Fanen P, Leroy V, Duvoux C, Carmagnat M, Folliguet T, Damy T. Heart Transplantation, Either Alone or Combined With Liver and Kidney, a Viable Treatment Option for Selected Patients With Severe Cardiac Amyloidosis. Transplant Direct. 2022;8(7):e1323.
  61. Minssen L, Dao THa, Quang AVo, Martin L, Andureau E, Luciani A, Meyblum E, Derumeaux G, Deux J-F. Breast arterial calcifications on mammography: a new marker of cardiovascular risk in asymptomatic middle age women?. Eur Radiol. 2022;32(7):4889-4897.
  62. Touma J, Couture T, Davaine J-M, de Boissieu P, Oubaya N, Michel C, Cochennec F, Chiche L, Desgranges P. Mycotic/Infective Native Aortic Aneurysms: Results After Preferential Use of Open Surgery and Arterial Allografts. Eur J Vasc Endovasc Surg. 2022;63(3):475-483.
  63. Lemercier P, de Langavant LCleret, Bagnou JHamet, Youssov K, Lemoine L, Audureau E, Massart R, Bachoud-Lévi A-C. Self-Reported Social Relationship Capacities Predict Motor, Functional and Cognitive Decline in Huntington's Disease. J Pers Med. 2022;12(2).
  64. Grimaldi D, Legriel S, Pichon N, Colardelle P, Leblanc S, Canoui-Poitrine F, O Salem BHadj, Muller G, de Prost N, Herrmann S, Marque S, Baron A, Sauneuf B, Messika J, Dior M, Creteur J, Bedos JP, Boutin E, Cariou A. Ischemic injury of the upper gastrointestinal tract after out-of-hospital cardiac arrest: a prospective, multicenter study. Crit Care. 2022;26(1):59.
  65. Beaudart C, Bonnefoy M, Gilbert T, Paillaud E, Raynaud-Simon A, Guerin O, Jeandel C, Le Sourd B, Haine M, Ferry M, Rolland Y, Berrut G, Reginster J-Y, Bruyère O. Quality of life and sarcopenic patients. Geriatr Psychol Neuropsychiatr Vieil. 2022.
  66. Morel A, Ouamri Y, Canoui-Poitrine F, Mulé S, Champy CMaud, Ingels A, Audard V, Luciani A, Grimbert P, Matignon M, Pigneur F, Stehlé T. Myosteatosis as an independent risk factor for mortality after kidney allograft transplantation: a retrospective cohort study. J Cachexia Sarcopenia Muscle. 2022;13(1):386-396.
  67. Sebti M, Petit-Hoang C, Chami B, Audureau E, Cordonnier-Jourdin C, Paul M, Pourcine F, Grimbert P, Ourghanlian C, Matignon M. ATG-Fresenius increases the risk of red blood cell transfusion after kidney transplantation. Front Immunol. 2022;13:1045580.
  68. Dreyfus J, Audureau E, Bohbot Y, Coisne A, Lavie-Badie Y, Bouchery M, Flagiello M, Bazire B, Eggenspieler F, Viau F, Riant E, Mbaki Y, Eyharts D, Senage T, Modine T, Nicol M, Doguet F, Nguyen V, Le Tourneau T, Tribouilloy C, Donal E, Tomasi J, Habib G, Selton-Suty C, Raffoul R, Iung B, Obadia J-F, Messika-Zeitoun D. TRI-SCORE: a new risk score for in-hospital mortality prediction after isolated tricuspid valve surgery. Eur Heart J. 2022;43(7):654-662.
  69. Youssov K, Audureau E, Vandendriessche H, Morgado G, Layese R, Goizet C, Verny C, Bourhis M-L, Bachoud-Lévi A-C. The burden of Huntington's disease: A prospective longitudinal study of patient/caregiver pairs. Parkinsonism Relat Disord. 2022;103:77-84.
  70. Hanon O, Vidal J-S, Lehmann S, Bombois S, Allinquant B, Baret-Rose C, Tréluyer J-M, Abdoul H, Gelé P, Delmaire C, Blanc F, Mangin J-F, Buée L, Touchon J, Hugon J, Vellas B, Galbrun E, Benetos A, Berrut G, Paillaud E, Wallon D, Castelnovo G, Volpe-Gillot L, Paccalin M, Robert P, Godefroy O, Camus V, Belmin J, Vandel P, Novella J-L, Duron E, Rigaud A-S, Schraen-Maschke S, Gabelle A. Plasma amyloid beta predicts conversion to dementia in subjects with mild cognitive impairment: The BALTAZAR study. Alzheimers Dement. 2022;18(12):2537-2550.
  71. Baptista BRibeiro, d'Humières T, Schlemmer F, Bendib I, Justeau G, Al-Assaad L, Hachem M, Codiat R, Bardel B, Chakra LAbou, Belmondo T, Audureau E, Hue S, Mekontso-Dessap A, Derumeaux G, Boyer L. Identification of factors impairing exercise capacity after severe COVID-19 pulmonary infection: a 3-month follow-up of prospective COVulnerability cohort. Respir Res. 2022;23(1):68.
  72. Lidou-Renault V, Baudouin É, Courtois-Amiot P, Bianco C, Esnault H, Rouet A, Baque M, Toméo C, Rainone A, Thietart S, Veber R, Ayache C, Pépin M, Lafuente-Lafuente C, Duron E, Cailleaux P-E, Haguenauer D, Lemarié N, Paillaud E, Raynaud-Simon A, Thomas C, Boddaert J, Zerah L, Vallet H. Corticosteroid Therapy in COVID-19 Associated With In-hospital Mortality in Geriatric Patients: A Propensity Matched Cohort Study. J Gerontol A Biol Sci Med Sci. 2022;77(7):1352-1360.
  73. Oubaya N, Pombet T, Delestrain C, Remus N, Douvry B, Grenet D, Corvol H, Thouvenin G, Prulière-Escabasse V, Mounir H, Argoud D, Fretigne C, Costes L, Mackiewicz M-P, Jung C, Ahamada L, Lanone S, Maitre B, Bégot A-C, Epaud R. Impact of the COVID-19 pandemic and associated lockdown measures on the management, health, and behavior of the cystic fibrosis population in France during 2020 (MUCONFIN). Front Public Health. 2022;10:978627.
  74. Excoffier J-B, Salaün-Penquer N, Ortala M, Raphaël-Rousseau M, Chouaid C, Jung C. Analysis of COVID-19 inpatients in France during first lockdown of 2020 using explainability methods. Med Biol Eng Comput. 2022;60(6):1647-1658.
  75. Jakubowicz D, Dariane C, Correas J-M, Audenet F, Caillet P, Méjean A, Timsit M-O. Disease Progression in Older Patients With Renal Tumor Assigned to an Active Surveillance Protocol. Clin Genitourin Cancer. 2022;20(1):e53-e60.
  76. Poucineau J, Delory T, Lapidus N, Hejblum G, Chouaid C, Le Cœur S, Khlat M. Hospital admissions and mortality for acute exacerbations of COPD during the COVID-19 pandemic: A nationwide study in France. Front Med (Lausanne). 2022;9:995016.
  77. Conti C, Pamoukdjian F, Aparicio T, Mebarki S, Poisson J, Manceau G, Taieb J, Rance B, Katsahian S, Charles-Nelson A, Paillaud E. Overall Survival and Prognostic Factors among Older Patients with Metastatic Pancreatic Cancer: A Retrospective Analysis Using a Hospital Database. Cancers (Basel). 2022;14(5).
  78. Chouaid C, Grumberg V, Batisse A, Corre R, Levra MGiaj, Gaudin A-F, Prodel M, Lortet-Tieulent J, Assié J-B, Cotté F-E. Machine Learning-Based Analysis of Treatment Sequences Typology in Advanced Non-Small-Cell Lung Cancer Long-Term Survivors Treated With Nivolumab. JCO Clin Cancer Inform. 2022;6:e2100108.
  79. Chouaid C, Thomas M, Debieuvre D, Durand-Zaleski I, Zacharias S, Bosquet L, Groth A, Fleitz A, Calleja A, Patel S, Lacoin L, Daumont MJ, Penrod JR, Carroll R, Waldenberger D, Cotté F-E, Audigier-Valette C, Griesinger F. Effectiveness of Nivolumab in Second-Line and Later in Patients with Advanced Non-Small Cell Lung Cancer in Real-Life Practice in France and Germany: Analysis of the ESME-AMLC and CRISP Cohorts. Cancers (Basel). 2022;14(24).
  80. Lafuente-Lafuente C, Rainone A, Guerin O, Drunat O, Jeandel C, Hanon O, Belmin J. COVID-19 Outbreaks in Nursing Homes Despite Full Vaccination with BNT162b2 of a Majority of Residents. Gerontology. 2022;68(12):1384-1392.
  81. Seknazi L, Jamelot M, Canoui-Poitrine F, Gligorov J, Benderra M-A. COVID-19 mortality: are comorbidities, socio-economic status and ethnicity more important than cancer?. Ann Transl Med. 2022;10(24):1302.


  1. Garcia-Pavia P, Rapezzi C, Adler Y, Arad M, Basso C, Brucato A, Burazor I, Caforio ALP, Damy T, Eriksson U, Fontana M, Gillmore JD, Gonzalez-Lopez E, Grogan M, Heymans S, Imazio M, Kindermann I, Kristen AV, Maurer MS, Merlini G, Pantazis A, Pankuweit S, Rigopoulos AG, Linhart A. Diagnosis and treatment of cardiac amyloidosis. A position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur J Heart FailEur J Heart FailEur J Heart Fail. 2021;23:512-526.
  2. Garcia-Pavia P, Rapezzi C, Adler Y, Arad M, Basso C, Brucato A, Burazor I, Caforio ALP, Damy T, Eriksson U, Fontana M, Gillmore JD, Gonzalez-Lopez E, Grogan M, Heymans S, Imazio M, Kindermann I, Kristen AV, Maurer MS, Merlini G, Pantazis A, Pankuweit S, Rigopoulos AG, Linhart A. Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC Working Group on Myocardial and Pericardial Diseases. Eur Heart JEur Heart JEur Heart J. 2021;42:1554-1568.
  3. Abdellatif A, Bouaud J, Lafuente-Lafuente C, Belmin J, Séroussi B. Computerized Decision Support Systems for Nursing Homes: A Scoping Review. J Am Med Dir Assoc. 2021;22(5):984-994.
  4. Gounot R, Le Bras F, Dupuis J, Oghina S, Bodez D, Roulin L, Maarek A, Ladaique A, Beldi-Ferchiou A, Poullot E, Molinier-Frenkel V, Haioun C, Damy T, Belhadj K, Lemonnier F. Daratumumab is safe and induces a rapid hematological response in light-chain amyloidosis with severe cardiac impairment. Leuk Lymphoma. 2021;62(4):979-983.
  5. Pasquer H, Belhadj K, Dupuis J, Oghina S, Galat A, Ladaique A, Maarek A, Roulin L, Gounot R, Poulot E, Beldi-Ferchiou A, Molinier-Frenkel V, Haioun C, Damy T, Le Bras F, Lemonnier F. Venetoclax induces profound and sustained responses in patients with relapsed/refractory light-chain amyloidosis. Br J Haematol. 2021;193(3):674-677.
  6. Moulin T, Landes R, Ouazana V, Abehsira G, Lim P, Huguet R, Damy T, Teiger E, Lellouche N, Hamon D. Severe Heart Failure Associated With Tachycardia-Induced Cardiomyopathy Due to Incessant Atrioventricular Re-Entrant Tachycardia. JACC Case Rep. 2021;3(3):479-483.
  7. Lebreton C, Cantarel C, Toulza E, Desgrippes R, Bozec L, Saada E, Ducoulombier A, Tardy M, Paillaud E, Lalet C, Bellera C, Italiano A. Incidence and prognostic factors of clinically meaningful toxicities of kinase inhibitors in older patients with cancer: The PreToxE study. J Geriatr Oncol. 2021;12(4):668-671.
  8. Poullot E, Oghina S, Kalsoum S, Damy T. [Cardiac amyloidosis]. Ann Pathol. 2021;41(1):25-37.
  9. Rapezzi C, Elliott P, Damy T, Nativi-Nicolau J, Berk JL, Velazquez EJ, Boman K, Gundapaneni B, Patterson TA, Schwartz JH, Sultan MB, Maurer MS. Efficacy of Tafamidis in Patients With Hereditary and Wild-Type Transthyretin Amyloid Cardiomyopathy: Further Analyses From ATTR-ACT. JACC Heart Fail. 2021;9(2):115-123.
  10. Roncalli J, Roubille F, Lamblin N, Girerd N, Mouquet F, Chapet N, Roubille C, Berthelot E, Galois K, Battistella P, Jondeau G, Tartiere J-M, Aguilhon S, Gueffet J-P, Salvat M, Damy T, Galinier M. Coronavirus disease vaccination in heart failure: No time to waste. Arch Cardiovasc Dis. 2021;114(5):434-438.
  11. Scotte F, Simon H, Laplaige P, Antoine E-C, Spasojevic C, Texier N, Gouhier K, Chouaid C. Febrile neutropenia prophylaxis, G-CSF physician preferences: discrete-choice experiment. BMJ Support Palliat Care. 2021.
  12. Oghina S, Bougouin W, Kharoubi M, Bonnefous L, Galat A, Guendouz S, Bezard M, Le Bras F, Deux J-F, Itti E, Moktefi A, Fanen P, Teiger E, Mohty D, Damy T, Bodez D. Echocardiographic Patterns of Left Ventricular Diastolic Function in Cardiac Amyloidosis: An Updated Evaluation. J Clin Med. 2021;10(21).
  13. Oghina S, Josse C, Bezard M, Kharoubi M, Delbarre M-A, Eyharts D, Zaroui A, Guendouz S, Galat A, Hittinger L, Fanen P, Teiger E, Mouri N, Montestruc F, Damy T. Prognostic Value of N-Terminal Pro-Brain Natriuretic Peptide and High-Sensitivity Troponin T Levels in the Natural History of Transthyretin Amyloid Cardiomyopathy and Their Evolution after Tafamidis Treatment. J Clin Med. 2021;10(21).
  14. Nicol M, Deney A, Lairez O, Vergaro G, Emdin M, Carecci A, Inamo J, Montfort A, Neviere R, Damy T, Harel S, Royer B, Baudet M, Cohen-Solal A, Arnulf B, Logeart D. Prognostic value of cardiopulmonary exercise testing in cardiac amyloidosis. Eur J Heart Fail. 2021;23(2):231-239.
  15. Martel-Lafay I, Monnet I, Lardy-Cleaud A, Danhier S, Salem N, Gallocher O, Fournel P, Chouaid C, Bylicki O. Feasibility of Stereotactic Body Radiation Therapy on Unresectable Stage III NSCLC with Peripheral Primary Tumor: A Prospective Study (GFPC 01-14). Curr Oncol. 2021;28(5):3804-3811.
  16. Matrat M, Gain M, Haioun C, Le Bras F, Nisse C, Morschhauser F, Clin B, Baldi I, Verdun-Esquer C, Garnier R, Laborde-Castérot H, Hérin F, Esquirol Y, Andujar P, Belacel M, Chouaid C, Chauvet C, Lasfargues G, Pairon J-C. Development of a Questionnaire for the Search for Occupational Causes in Patients with Non-Hodgkin Lymphoma: The RHELYPRO Study. Int J Environ Res Public Health. 2021;18(8).
  17. Michalon A, Hagenbuch A, Huy C, Varela E, Combaluzier B, Damy T, Suhr OB, Saraiva MJ, Hock C, Nitsch RM. A human antibody selective for transthyretin amyloid removes cardiac amyloid through phagocytic immune cells. Nat Commun. 2021;12(1):3142.
  18. Monnet I, Vergnenègre A, Robinet G, Bérard H, Lamy R, Falchero L, Vieillot S, Schott R, Ricordel C, Chouabe S, Thomas P, Gervais R, Madroszyk A, Abdiche S, Chiappa AMarie, Greillier L, Decroisette C, Auliac JBernard, Chouaid C. Phase III randomized study of carboplatin pemetrexed with or without bevacizumab with initial "at progression" cerebral radiotherapy in advanced non squamous non-small cell lung cancer with asymptomatic brain metastasis. Ther Adv Med Oncol. 2021;13:17588359211006983.
  19. Kharoubi M, Bezard M, Galat A, Le Bras F, Poullot E, Molinier-Frenkel V, Fanen P, Funalot B, Moktefi A, Lefaucheur J-P, Abulizi M, Deux J-F, Lemonnier F, Guendouz S, Chalard C, Zaroui A, Audard V, Béquignon E, Bodez D, Itti E, Hittinger L, Audureau E, Teiger E, Oghina S, Damy T. History of extracardiac/cardiac events in cardiac amyloidosis: prevalence and time from initial onset to diagnosis. ESC Heart Fail. 2021;8(6):5501-5512.
  20. Lamy T, Cabarrou B, Planchard D, Quantin X, Schneider S, Bringuier M, Besse B, Girard N, Chouaid C, Filleron T, Simon G, Baldini C. Biomarker Testing in Older Patients Treated for an Advanced or Metastatic Non-Squamous Non-Small-Cell Lung Cancer: The French ESME Real-Life Multicenter Cohort Experience. Cancers (Basel). 2021;14(1).
  21. Gounant V, Duruisseaux M, Soussi G, Van Hulst S, Bylicki O, Cadranel J, Wislez M, Trédaniel J, Spano J-P, Helissey C, Chouaid C, Molinier O, Dhalluin X, Doucet L, Hureaux J, Cazes A, Zalcman G. Does Very Poor Performance Status Systematically Preclude Single Agent Anti-PD-1 Immunotherapy? A Multicenter Study of 35 Consecutive Patients. Cancers (Basel). 2021;13(5).
  22. Girard N, Perol M, Simon G, Valette CAudigier, Gervais R, Debieuvre D, Schott R, Quantin X, Coudert B, Lena H, Carton M, Robain M, Filleron T, Chouaid C. Treatment strategies for unresectable locally advanced non-small cell lung cancer in the real-life ESME cohort. Lung Cancer. 2021;162:119-127.
  23. Damy T, García-Pavía P, Hanna M, Judge DP, Merlini G, Gundapaneni B, Patterson TA, Riley S, Schwartz JH, Sultan MB, Witteles R. Efficacy and safety of tafamidis doses in the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial (ATTR-ACT) and long-term extension study. Eur J Heart Fail. 2021;23(2):277-285.
  24. Bezard M, Oghina S, Vitiello D, Kharoubi M, Kordeli E, Galat A, Zaroui A, Guendouz S, Gilles F, Shourick J, Hamon D, Audard V, Teiger E, Poullot E, Molinier-Frenkel V, Lemonnier F, Agbulut O, Le Bras F, Damy T. Dexamethasone is associated with early deaths in light chain amyloidosis patients with severe cardiac involvement. PLoS One. 2021;16(9):e0257189.
  25. Brannagan TH, Auer-Grumbach M, Berk JL, Briani C, Bril V, Coelho T, Damy T, Dispenzieri A, Drachman BM, Fine N, Gaggin HK, Gertz M, Gillmore JD, Gonzalez E, Hanna M, Hurwitz DR, Khella SL, Maurer MS, Nativi-Nicolau J, Olugemo K, Quintana LF, Rosen AM, Schmidt HH, Shehata J, Waddington-Cruz M, Whelan C, Ruberg FL. ATTR amyloidosis during the COVID-19 pandemic: insights from a global medical roundtable. Orphanet J Rare Dis. 2021;16(1):204.
  26. Berthelot E, Flécher E, Roubille F, Damy T, Lamblin N. [Impact de la pandémie de COVID-19 sur la charge des patients atteints d'insuffisance cardiaque chronique en France]. Ann Cardiol Angeiol (Paris). 2021;70(4):191-195.
  27. Auliac J-B, Monnet I, Bizieux A, Greillier L, Geier M, Falchero L, Le Garff G, Lamy R, Guisier F, Ricordel C, Chouaid C, Vergnenègre A. Multicenter phase II trial of nintedanib plus docetaxel in second-line treatment in advanced non-squamous non-small cell lung cancer patients refractory to first-line platin-based chemotherapy (REFRACT GFPC 02-15 study). Lung Cancer. 2021;161:122-127.
  28. Beauvais F, Tartière L, Pezel T, Motet C, Aumont M-C, Baudry G, Eicher J-C, Galinier M, Gellen B, Guihaire J, Legallois D, Lequeux B, Mika D, Mouquet F, Salvat M, Taieb C, Zores F, Berthelot E, Damy T. First symptoms and health care pathways in hospitalized patients with acute heart failure: ICPS2 survey. A report from the Heart Failure Working Group (GICC) of the French Society of Cardiology. Clin Cardiol. 2021;44(8):1144-1150.
  29. Belmin J, Georges S, Franke F, Daniau C, Cochet A, Durand C, Noury U, Santo MEugênia G, Fonteneau L, Pariel S, Lafuente-Lafuente C, Danis K. Coronavirus Disease 2019 in French Residential Care Facilities: A Nationwide Study. J Am Med Dir Assoc. 2021;22(6):1142-1145.
  30. Abulizi M, Sifaoui I, Wuliya-Gariepy M, Kharoubi M, Israël J-M, Emsen B, Bodez D, Monnet A, Didierlaurent D, Tacher V, Luciani A, Damy T, Deux J-F, Itti E. F-sodium fluoride PET/MRI myocardial imaging in patients with suspected cardiac amyloidosis. J Nucl Cardiol. 2021;28(4):1586-1595.
  31. Bonnefous L, Kharoubi M, Bezard M, Oghina S, Le Bras F, Poullot E, Molinier-Frenkel V, Fanen P, Deux J-F, Audard V, Itti E, Damy T, Audureau E. Assessing Cardiac Amyloidosis Subtypes by Unsupervised Phenotype Clustering Analysis. J Am Coll Cardiol. 2021;78(22):2177-2192.
  32. Hanon O, Vidal J-S, Pisica-Donose G, Orvoën G, David J-P, Chaussade E, Caillard L, de Jong LW, Boulloche N, Vinsonneau U, Bouée S, Krolak-Salmon P, Fauchier L, Jouanny P, Sacco G, Bellarbre F, Belmin J, Puisieux F, Lilamand M, Paillaud E, Boureau ASophie. Bleeding risk with rivaroxaban compared with vitamin K antagonists in patients aged 80 years or older with atrial fibrillation. Heart. 2021;107(17):1376-1382.
  33. Belmin J, Din NUm, Pariel S, Lafuente-Lafuente C. [How staff members of 17 French nursing homes protected their residents from Covid-19]. Geriatr Psychol Neuropsychiatr Vieil. 2021;19(3):243-244.
  34. Serrano AGonzález, Tapia CMartínez, de la Taille A, Mongiat-Artus P, Irani J, Bex A, Paillaud E, Audureau E, Barnay T, Laurent M, Canoui-Poitrine F. Adherence to Treatment Guidelines and Associated Survival in Older Patients with Prostate Cancer: A Prospective Multicentre Cohort Study. Cancers (Basel). 2021;13(18).
  35. Ganne-Carrié N, Nahon P, Chaffaut C, N'Kontchou G, Layese R, Audureau E, Chevret S. Impact of cirrhosis aetiology on incidence and prognosis of hepatocellular carcinoma diagnosed during surveillance. JHEP Rep. 2021;3(3):100285.
  36. Oghina S, Bougouin W, Bezard M, Kharoubi M, Komajda M, Cohen-Solal A, Mebazaa A, Damy T, Bodez D. The Impact of Patients With Cardiac Amyloidosis in HFpEF Trials. JACC Heart Fail. 2021;9(3):169-178.
  37. Khettab M, Hagege M, Ah-Pine F, Zunic P, Kassir R, Bay J-O. [Oncology in French overseas territories]. Bull Cancer. 2021;108(12):1067-1068.
  38. Girerd N, Chapet N, Roubille C, Roncalli J, Salvat M, Mouquet F, Lamblin N, Gueffet J-P, Damy T, Galinier M, Tartiere J-M, Janssen C, Berthelot E, Aguilhon S, Escamilla R, Roubille F. Vaccination for Respiratory Infections in Patients with Heart Failure. J Clin Med. 2021;10(19).
  39. Goussault H, Gendarme S, Assié JBaptiste, Bylicki O, Chouaid C. Factors associated with early lung cancer mortality: a systematic review. Expert Rev Anticancer Ther. 2021;21(10):1125-1133.
  40. Vergnenègre A, Chouaid C. Economic analyses of immune-checkpoint inhibitors to treat lung cancer. Expert Rev Pharmacoecon Outcomes Res. 2021;21(3):365-371.
  41. Adam RDaniel, Coriu D, Jercan A, Bădeliţă S, Popescu BA, Damy T, Jurcuţ R. Progress and challenges in the treatment of cardiac amyloidosis: a review of the literature. ESC Heart Fail. 2021;8(4):2380-2396.
  42. Damy T, Chouihed T, Delarche N, Berrut G, Cacoub P, Henry P, Lamblin N, Andrès E, Hanon O. Diagnosis and Management of Heart Failure in Elderly Patients from Hospital Admission to Discharge: Position Paper. J Clin Med. 2021;10(16).
  43. Damy T, Conceição I, García-Pavía P, Gillmore J, Jandhyala R, Sabbat J, Wixner J, Coelho T. A simple core dataset and disease severity score for hereditary transthyretin (ATTRv) amyloidosis. Amyloid. 2021;28(3):189-198.
  44. García-Pavía P, Bengel F, Brito D, Damy T, Duca F, Dorbala S, Nativi-Nicolau J, Obici L, Rapezzi C, Sekijima Y, Elliott PM. Expert consensus on the monitoring of transthyretin amyloid cardiomyopathy. Eur J Heart Fail. 2021;23(6):895-905.
  45. Granier C, Gey A, Roncelin S, Weiss L, Paillaud E, Tartour E. Immunotherapy in older patients with cancer. Biomed J. 2021;44(3):260-271.
  46. Hanna M, Damy T, Grogan M, Stewart M, Gundapaneni B, Patterson TA, Schwartz JH, Sultan MB, Maurer MS. Impact of Tafamidis on Health-Related Quality of Life in Patients With Transthyretin Amyloid Cardiomyopathy (from the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial). Am J Cardiol. 2021;141:98-105.
  47. Geiss R, Sebaste L, Valter R, Poisson J, Mebarki S, Conti C, Vordos D, Bringuier M, Méjean A, Mongiat-Artus P, Cudennec T, Canoui-Poitrine F, Caillet P, Paillaud E. Complications and Discharge after Radical Cystectomy for Older Patients with Muscle-Invasive Bladder Cancer: The ELCAPA-27 Cohort Study. Cancers (Basel). 2021;13(23).
  48. Wind P, Thomas ZAp, Laurent M, Aparicio T, Siebert M, Audureau E, Paillaud E, Bousquet G, Pamoukdjian F. The Pre-Operative GRADE Score Is Associated with 5-Year Survival among Older Patients with Cancer Undergoing Surgery. Cancers (Basel). 2021;14(1).
  49. Gamé X, Piollet-Calmette I, Descazeaud A, Hermieu J-F, Fatton B, Paillaud E, Bellessort A, Coloby P. [Mirror survey of patients with urge urinary incontinence and healthcare professionals]. Prog Urol. 2021;31(12):747-754.
  50. Beaudart C, Bonnefoy M, Gilbert T, Paillaud E, Raynaud-Simon A, Guerin O, Jeandel C, Le Sourd B, Haine M, Ferry M, Rolland Y, Berrut G, Reginster J-Y, Bruyère O. [Which quality of life for the sarcopenic patient?]. Geriatr Psychol Neuropsychiatr Vieil. 2021;19(3):245-252.
  51. Burgassi F, Paillaud E, Poisson J, Bousquet G, Pamoukdjian F. Prognostic Value of Prospective Longitudinal CRP to Albumin Ratio among Older Outpatients with Cancer. Cancers (Basel). 2021;13(22).
  52. Benderra M-A, Aparicio A, Leblanc J, Wassermann D, Kempf E, Galula G, Bernaux M, Canellas A, Moreau T, Bellamine A, Spano J-P, Daniel C, Champ J, Canoui-Poitrine F, Gligorov J. Clinical Characteristics, Care Trajectories and Mortality Rate of SARS-CoV-2 Infected Cancer Patients: A Multicenter Cohort Study. Cancers (Basel). 2021;13(19).
  53. Oubaya N, Soubeyran P, Reinald N, Fonck M, Allain M, Zebachi S, Heitz D, Laurent M, Delattre C, Caillet P, Dauba J, Bastuji-Garin S, Albrand G, Bringuier M, Rainfray M, Brain E, Grellety T, Paillaud E, Mathoulin-Pelissier S, Bellera C, Canoui-Poitrine F. Prognostic Value of Routinely Measured Inflammatory Biomarkers in Older Cancer Patients: Pooled Analysis of Three Cohorts. Cancers (Basel). 2021;13(24).
  54. Seban R-D, Assié J-B, Giroux-Leprieur E, Massiani M-A, Bonardel G, Chouaid C, Deleval N, Richard C, Mezquita L, Girard N, Champion L. Prognostic value of inflammatory response biomarkers using peripheral blood and [18F]-FDG PET/CT in advanced NSCLC patients treated with first-line chemo- or immunotherapy. Lung Cancer. 2021;159:45-55.
  55. Burugorri-Pierre C, Lafuente-Lafuente C, Oasi C, Lecorche E, Pariel S, Donadio C, Belmin J. Investigation of an Outbreak of COVID-19 in a French Nursing Home With Most Residents Vaccinated. JAMA Netw Open. 2021;4(9):e2125294.
  56. Descourt R, Chouaid C, Perol M, Besse B, Greillier L, Bylicki O, Ricordel C, Guisier F, Gervais R, Schott R, Auliac J-B, Robinet G, Decroisette C. First-line pembrolizumab with or without platinum doublet chemotherapy in non-small-cell lung cancer patients with PD-L1 expression ≥50. Future Oncol. 2021;17(23):3007-3016.
  57. de Climens FRoborel, Chouaid C, Poulet C, Leroy V, Stoven L, Cortot ABenjamin, Dhalluin X, Gauvain C. Salvage Immunotherapy With Pembrolizumab in Patients Hospitalized for Life-Threatening Complications of NSCLC. JTO Clin Res Rep. 2021;2(5):100147.
  58. Chouaid C, Filleron T, Debieuvre D, Perol M, Girard N, Dansin E, Lena H, Gervais R, Cousin S, Otto J, Schott R, Planchard D, Madroszyk A, Kaderbhai C, Dubray-Longeras P, Hiret S, Pichon E, Clément-Duchêne C, Chenuc G, Simon G, Bosquet L, Quantin X. A Real-World Study of Patients with Advanced Non-squamous Non-small Cell Lung Cancer with EGFR Exon 20 Insertion: Clinical Characteristics and Outcomes. Target Oncol. 2021;16(6):801-811.
  59. Lafuente-Lafuente C, Nghiem QDuy, Keravec H, Oukbir-Ferrag S, Magri M, Oquendo B, Donadio C, Rainone A, Belmin J. Chronology of COVID-19 Symptoms in Very Old Patients: Study of a Hospital Outbreak. J Clin Med. 2021;10(13).
  60. Rollot-Trad F, Chéron M, Bonhomme S, Fromantin I, Engels C. [Needs and feelings of caregivers in oncogeriatrics, usefulness of a serious game]. Soins Gerontol. 2021;26(152):31-36.
  61. Teiger E, Thambo J-B, Defaye P, Hermida J-S, Abbey S, Klug D, Juliard J-M, Spaulding C, Armero S, Champagnac D, Bhugaloo H, Ternacle J, Lellouche N, Audureau E, Le Corvoisier P. Left atrial appendage closure for stroke prevention in atrial fibrillation: Final report from the French left atrial appendage closure registry. Catheter Cardiovasc Interv. 2021;98(4):788-799.
  62. Nahon P, Layese R, Cagnot C, Asselah T, Guyader D, Pol S, Pageaux G-P, De Lédinghen V, Ouzan D, Zoulim F, Audureau E. HCV Eradication in Primary or Secondary Prevention Optimizes Hepatocellular Carcinoma Curative Management. Cancer Prev Res (Phila). 2021;14(5):581-592.
  63. Salmon-Céron D, Slama D, De Broucker T, Karmochkine M, Pavie J, Sorbets E, Etienne N, Batisse D, Spiridon G, Le Baut V, Meritet J-F, Pichard E, Canoui-Poitrine F. Clinical, virological and imaging profile in patients with prolonged forms of COVID-19: A cross-sectional study. J Infect. 2021;82(2):e1-e4.
  64. Elkrief L, Lazareth M, Chevret S, Paradis V, Magaz M, Blaise L, Rubbia-Brandt L, Moga L, Durand F, Payancé A, Plessier A, Chaffaut C, Valla D, Malphettes M, Diaz A, Nault J-C, Nahon P, Audureau E, Ratziu V, Castera L, Pagan J-CGarcia, Ganne-Carrié N, Rautou P-E. Liver Stiffness by Transient Elastography to Detect Porto-Sinusoidal Vascular Liver Disease With Portal Hypertension. Hepatology. 2021;74(1):364-378.
  65. Benjdir M, Audureau E, Beresniak A, Coll P, Epaud R, Fiedler K, Jacquemin B, Niddam L, Pandis SN, Pohlmann G, Sandanger TM, Simmons K, Sørensen M, Wagner P, Lanone S. Assessing the impact of exposome on the course of chronic obstructive pulmonary disease and cystc fibrosis: The REMEDIA European Project Approach. Environ Epidemiol. 2021;5(4):e165.
  66. Pezel T, Audureau E, Mansourati J, Baudry G, Ben Driss A, Durup F, Fertin M, Godreuil C, Jeanneteau J, Kloeckner M, Koukoui F, Kesri-Tartière L, Laperche T, Roubille F, Cohen-Solal A, Damy T. Diagnosis and Treatment of Iron Deficiency in Heart Failure: OFICSel study by the French Heart Failure Working Group. ESC Heart Fail. 2021;8(2):1509-1521.
  67. Fourati S, Langendorf C, Audureau E, Challine D, Michel J, Soulier A, Ahnou N, Désveaux I, Picard O, Ortonne V, Gourgeon A, Mills C, Hemery F, Rieux C, Pawlotsky J-M, Malou N, Chevaliez S. Performance of six rapid diagnostic tests for SARS-CoV-2 antigen detection and implications for practical use. J Clin Virol. 2021;142:104930.
  68. Runyo F, Matignon M, Audureau E, Vindrios W, Boueilh A, Gomart C, Grimbert P, Gallien S, Melica G. Infectious disease consultation is effective in boosting vaccine coverage in patients awaiting kidney transplantation: A French prospective study. Transpl Infect Dis. 2021;23(4):e13607.
  69. Schlemmer F, Zysman M, Baptista BRibeiro, Audureau E, Noroc ACovali, Ridoux A, Derumeaux G, Adnot S, Maitre B, Le Corvoisier P, Lanone S, Boczkowski J, Boyer L. Beclin-1 increases with obstructive sleep apnea severity. Sleep Med. 2021;81:474-476.
  70. Verliere A, Clariot S, Pascual-Jouani C, Audureau E, Langeron O, Levesque E. Outcome of asymptomatic patients with positive SARS-CoV-2 viral RNA reverse transcriptase-PCR undergoing surgery: A matched cohort study. Eur J Anaesthesiol. 2021;38(4):442-444.
  71. Ghosn M, Derbel H, Kharrat R, Oubaya N, Mulé S, Chalaye J, Regnault H, Amaddeo G, Itti E, Luciani A, Kobeiter H, Tacher V. Prediction of overall survival in patients with hepatocellular carcinoma treated with Y-90 radioembolization by imaging response criteria. Diagn Interv Imaging. 2021;102(1):35-44.
  72. Pezel T, Bernard A, Badie YLavie, Dreyfus J, Audureau E, Bohbot Y, Fard D, Hubert A, Nguyen LS, Monteil C, Bière L, Le Ven F, Canu M, Ribeyrolles S, Mion B, Mouhat B, Bazire B, Fauvel C, Ternacle J, Cautela J, Cambet T, Le Tourneau T, Donal E, Lafitte S, Mansencal N, Coisne A. Rational and Design of the SIMULATOR Study: A Multicentre Randomized Study to Assess the Impact of SIMULation-bAsed Training on Transoesophageal echocardiOgraphy leaRning for Cardiology Residents. Front Cardiovasc Med. 2021;8:661355.
  73. Lunven M, Bagnou JHamet, Youssov K, Gabadinho A, Fliss R, Montillot J, Audureau E, Bapst B, Morgado G, Reilmann R, Schubert R, Busse M, Craufurd D, Massart R, Rosser A, Bachoud-Lévi A-C. Cognitive decline in Huntington's disease in the Digitalized Arithmetic Task (DAT). PLoS One. 2021;16(8):e0253064.
  74. d'Humières T, Savale L, Inamo J, Deux J-F, Deswarte S, Lionnet F, Loko G, Chantalat C, Damy T, Guillet H, d'Orengiani ALaure Pham, Galactéros F, Audureau E, Maitre B, Humbert M, Derumeaux G, Bartolucci P. Cardiovascular phenotypes predict clinical outcomes in sickle cell disease: An echocardiography-based cluster analysis. Am J Hematol. 2021;96(9):1166-1175.
  75. Deux J-F, Nouri R, Tacher V, Zaroui A, Derbel H, Sifaoui I, Chevance V, Ridouani F, Galat A, Kharoubi M, Oghina S, Guendouz S, Audureau E, Teiger E, Kobeiter H, Damy T. Diagnostic Value of Extracellular Volume Quantification and Myocardial Perfusion Analysis at CT in Cardiac Amyloidosis. Radiology. 2021;300(2):326-335.
  76. Kempf E, Lamé G, Layese R, Priou S, Chatellier G, Chaieb H, Benderra M-A, Bellamine A, Bey R, Bréant S, Galula G, Taright N, Tannier X, Guyet T, Salamanca E, Audureau E, Daniel C, Tournigand C. New cancer cases at the time of SARS-Cov2 pandemic and related public health policies: A persistent and concerning decrease long after the end of the national lockdown. Eur J Cancer. 2021;150:260-267.
  77. Schlemmer F, Hamzaoui A, Zebachi S, Le Thuaut A, Mangiapan G, Monnet I, Boudjema A, Jabot L, Housset B, Bastuji-Garin S, Bassinet L, Maitre B. Etiological Work-Up for Adults with Bronchiectasis: A Predictive Diagnostic Score for Primary Ciliary Dyskinesia and Cystic Fibrosis. J Clin Med. 2021;10(16).
  78. Nicodème M, Chéron M, Labedade É, Fromantin I, Lefort H. [Management of patients with haemorrhage malignant wounds]. Rev Infirm. 2021;70(273):27-30.
  79. Nicodème M, Dureau S, Chéron M, Kriegel I, Trenchand M, Bauër P, Fromantin I. Frequency and Management of Hemorrhagic Malignant Wounds: A Retrospective, Single-Center, Observational Study. J Pain Symptom Manage. 2021;62(1):134-140.
  80. Rodriguez C, de Prost N, Fourati S, Lamoureux C, Gricourt G, N'debi M, Canoui-Poitrine F, Désveaux I, Picard O, Demontant V, Trawinski E, Lepeule R, Surgers L, Vindrios W, Lelièvre J-D, Mongardon N, Langeron O, Cohen JL, Mekontso-Dessap A, Woerther P-L, Pawlotsky J-M. Viral genomic, metagenomic and human transcriptomic characterization and prediction of the clinical forms of COVID-19. PLoS Pathog. 2021;17(3):e1009416.
  81. de'Angelis N, Baldini C, Brustia R, Pessaux P, Sommacale D, Laurent A, Le Roy B, Tacher V, Kobeiter H, Luciani A, Paillaud E, Aparicio T, Canoui-Poitrine F, Liuu E. Correction: Surgical and regional treatments for colorectal cancer metastases in older patients: A systematic review and meta-analysis. PLoS One. 2021;16(4):e0251005.
  82. Contou D, Colin G, Travert B, Jochmans S, Conrad M, Lascarrou J-B, Painvin B, Ferré A, Schnell D, La Combe B, Coudroy R, Ehrmann S, Rambaud J, Wiedemann A, Asfar P, Kalfon P, Guérot E, Préau S, Argaud L, Daviet F, Dellamonica J, Dupont A, Fartoukh M, Kamel T, Béduneau G, Canoui-Poitrine F, Boutin E, Lina G, Dessap AMekontso, Tristant A, de Prost N. Menstrual toxic shock syndrome: a French nationwide multicenter retrospective study. Clin Infect Dis. 2021.
  83. Boudhabhay I, Boutin E, Bartolucci P, Bornes M-I, Habibi A, Lionnet F, Hertig A, Grimbert P, Stehlé T, Karoui KEl, Sahali D, Fois E, Remy P, Galactéros F, Haddad B, Canoui-Poitrine F, Lecarpentier E, Audard V. Impact of pre-eclampsia on renal outcome in sickle cell disease patients. Br J Haematol. 2021;194(6):1053-1062.
  84. Urbina T, Canoui-Poitrine F, Hua C, Layese R, Alves A, Ouedraogo R, Bosc R, Sbidian E, Chosidow O, Dessap AMekontso, de Prost N. Long-term quality of life in necrotizing soft-tissue infection survivors: a monocentric prospective cohort study. Ann Intensive Care. 2021;11(1):102.
  85. Poisson J, Martinez-Tapia C, Heitz D, Geiss R, Albrand G, Falandry C, Gisselbrecht M, Couderc A-L, Boulahssass R, Liuu E, Boudou-Rouquette P, Wakilian AChah, Gaxatte C, Pamoukdjian F, de Decker L, Antoine V, Cattenoz C, Solem-Laviec H, Guillem O, Medjenah H, Natella PAndré, Canoui-Poitrine F, Laurent M, Paillaud E. Prevalence and prognostic impact of cachexia among older patients with cancer: a nationwide cross-sectional survey (NutriAgeCancer). J Cachexia Sarcopenia Muscle. 2021;12(6):1477-1488.
  86. Kharoubi M, Roche F, Bezard M, Hupin D, Silva S, Oghina S, Chalard C, Zaroui A, Galat A, Guendouz S, Canoui-Poitrine F, Hittinger L, Teiger E, Lefaucheur J-P, Damy T. Prevalence and prognostic value of autonomic neuropathy assessed by Sudoscan® in transthyretin wild-type cardiac amyloidosis. ESC Heart Fail. 2021;8(2):1656-1665.
  87. Mézière A, Oubaya N, Michel-Pellegrino V, Boudin B, Neau M, Robert H, Cara I, Sanchez LSalgado, Baloul S, Piette F, Pautas É, Picou Y, Curtis V, Schonheit C, Canoui-Poitrine F, Moreau C. Exercise Interventions With Trained Home Helpers for Preventing Loss of Autonomy and Falls in Community-Dwelling Older Adults Receiving Home Heath Physical Therapy T4H: A Randomized Controlled Pilot Study. J Geriatr Phys Ther. 2021;44(3):E138-E149.
  88. Lafont C, Wakilian AChah, Lemogne C, Gouraud C, Fossey-Diaz V, Orvoën G, Lhuillier N, Paillaud E, Bastuji-Garin S, Zebachi S, Hanon O, Goldwasser F, Boudou-Rouquette P, Canoui-Poitrine F. Diagnostic Performance of the 4-Item Geriatric Depression Scale for Depression Screening in Older Patients with Cancer: The ELCAPA Cohort Study. Oncologist. 2021;26(6):e983-e991.
  89. Zerah L, Baudouin É, Pépin M, Mary M, Krypciak S, Bianco C, Roux S, Gross A, Toméo C, Lemarié N, Dureau A, Bastiani S, Ketz F, Boully C, de Villelongue C, Romdhani M, Desoutter M-A, Duron E, David J-P, Thomas C, Paillaud E, de Malglaive P, Bouvard E, Lacrampe M, Mercadier E, Monti A, Hanon O, Fossey-Diaz V, Bourdonnec L, Riou B, Vallet H, Boddaert J. Clinical Characteristics and Outcomes of 821 Older Patients With SARS-Cov-2 Infection Admitted to Acute Care Geriatric Wards. J Gerontol A Biol Sci Med Sci. 2021;76(3):e4-e12.
  90. Berthelot E, Broussier A, Damy T, Donadio C, Cosson S, Rovani X, Salengro E, Billebeau G, Megbemado R, Rekik N, Godreuil C, Richard K, Shourick J, Assayag P, Belmin J, David JPhilippe, Hittinger L. Good performance in the management of acute heart failure in cardiogeriatric departments: the ICREX-94 experience. BMC Geriatr. 2021;21(1):288.
  91. Bezard M, Kharoubi M, Galat A, Poullot E, Guendouz S, Fanen P, Funalot B, Moktefi A, Lefaucheur J-P, Abulizi M, Deux J-F, Gendre T, Audard V, Karoui KEl, Canoui-Poitrine F, Zaroui A, Itti E, Teiger E, Planté-Bordeneuve V, Oghina S, Damy T. Natural history and impact of treatment with tafamidis on major cardiovascular outcome-free survival time in a cohort of patients with transthyretin amyloidosis. Eur J Heart Fail. 2021;23(2):264-274.
  92. Mahévas M, Azzaoui I, Crickx E, Canoui-Poitrine F, Gobert D, Languille L, Limal N, Guillaud C, Croisille L, Jeljeli M, Batteux F, Baloul S, Fain O, Pirenne F, Weill J-C, Reynaud C-A, Godeau B, Michel M. Efficacy, safety and immunological profile of combining rituximab with belimumab for adults with persistent or chronic immune thrombocytopenia: results from a prospective phase 2b trial. Haematologica. 2021;106(9):2449-2457.
  93. Bylicki O, Rivière F, Tournier C, Canoui-Poitrine F, Grassin F, Margery J, Prodel M, Vainchtock A, Assié J-B, Chouaid C. Factors Associated With Aggressiveness of End-of-Life Care for Lung Cancer Patients and Associated Costs of Care. Clin Lung Cancer. 2021;22(3):e320-e328.
  94. Oniszczuk J, Beldi-Ferchiou A, Audureau E, Azzaoui I, Molinier-Frenkel V, Frontera V, Karras A, Moktefi A, Pillebout E, Zaidan M, Karoui KEl, Delfau-Larue M-H, Hénique C, Ollero M, Sahali D, Mahévas M, Audard V. Circulating plasmablasts and high level of BAFF are hallmarks of minimal change nephrotic syndrome in adults. Nephrol Dial Transplant. 2021;36(4):609-617.
  95. Hamon D, Courty B, Leenhardt A, Lim P, Elbaz N, Rouffiac S, Varlet E, Algalarrondo V, Messali A, Audureau E, Extramiana F, Lellouche N. Predictive value of premature atrial complex characteristics in pulmonary vein isolation for patients with paroxysmal atrial fibrillation. Arch Cardiovasc Dis. 2021;114(2):122-131.
  96. Pezel T, Berthelot E, Gauthier J, Chong-Nguyen C, Iliou MC, Juillière Y, Galinier MC, De Groote P, Beauvais F, Bauer F, Vergeylen U, Gellen B, Raphael P, Bezard M, Ricci J-E, Boiteux M-C, Bonnefous L, Bodez D, Audureau E, Damy T. Epidemiological characteristics and therapeutic management of patients with chronic heart failure who use smartphones: Potential impact of a dedicated smartphone application (report from the OFICSel study). Arch Cardiovasc Dis. 2021;114(1):51-58.
  97. Jourdi G, Lobies S, Kosmider O, Duchemin J, Audureau E, Conard J, Mazoyer E, Horellou M-H, Gouin-Thibault I, Flaujac C, Fontenay M. Coagulation Characterization of Prothrombin 20209C > T Variant: About 27 New Cases. Thromb Haemost. 2021;121(2):246-249.
  98. Derbez B, Z Haffaf E, Galactéros F, de Montgolfier S. [Prevention of genetic diseases : the return of the family practitioner ?]. Rev Epidemiol Sante Publique. 2021;69(1):30-38.


  1. Gertz M, Adams D, Ando Y, Beirão JM, Bokhari S, Coelho T, Comenzo RL, Damy T, Dorbala S, Drachman BM, Fontana M, Gillmore JD, Grogan M, Hawkins PN, Lousada I, Kristen AV, Ruberg FL, Suhr OB, Maurer MS, Nativi-Nicolau J, Quarta CC, Rapezzi C, Witteles R, Merlini G. Avoiding misdiagnosis: expert consensus recommendations for the suspicion and diagnosis of transthyretin amyloidosis for the general practitioner. BMC Fam PractBMC Fam PractBMC Fam Pract. 2020;21:198.
  2. Heliö T, Elliott P, Koskenvuo JW, Gimeno JR, Tavazzi L, Tendera M, Kaski JP, Mansencal N, Bilińska Z, Carr-White G, Damy T, Frustaci A, Kindermann I, Ripoll-Vera T, Čelutkienė J, Axelsson A, Lorenzini M, Saad A, Maggioni AP, Laroche C, Caforio ALP, Charron P. ESC EORP Cardiomyopathy Registry: real-life practice of genetic counselling and testing in adult cardiomyopathy patients. ESC Heart FailESC Heart FailESC Heart Fail. 2020;7:3013-3021.
  3. Mottet N, Ribal MJ, Boyle H, De Santis M, Caillet P, Choudhury A, Garg T, Nielsen M, Wüthrich P, Gust KM, Shariat SF, Gakis G. Management of bladder cancer in older patients: Position paper of a SIOG Task Force. J Geriatr OncolJ Geriatr OncolJ Geriatr Oncol. 2020;11:1043-1053.
  4. Abdellatif A, Bouaud J, Nghiem D, Lafuente-Lafuente C, Belmin J, Séroussi B. Clinical Decision Support Systems in Nursing Homes: A Scoping Review. Stud Health Technol Inform. 2020;270:542-546.
  5. de'Angelis N, Baldini C, Brustia R, Pessaux P, Sommacale D, Laurent A, Le Roy B, Tacher V, Kobeiter H, Luciani A, Paillaud E, Aparicio T, Canuï-Poitrine F, Liuu E. Surgical and regional treatments for colorectal cancer metastases in older patients: A systematic review and meta-analysis. PLoS One. 2020;15(4):e0230914.
  6. Mourey L, Falandry C, de Decker L, Boulahssass R, Carola E, Lefevre LBengrine, Cudennec T, Brain E, Paillaud E, Soubeyran P. Taking care of older patients with cancer in the context of COVID-19 pandemic. Lancet Oncol. 2020;21(5):e236.
  7. Zeymer U, Clark AL, Barrios V, Damy T, Drożdż J, Fonseca C, Lund LH, Di Comite G, Hupfer S, Maggioni AP. Management of heart failure with reduced ejection fraction in Europe: design of the ARIADNE registry. ESC Heart Fail. 2020;7(2):727-736.
  8. Tamisier R, Damy T, Davy J-M, Verbraecken JA, Bailly S, Lavergne F, Palot A, Goutorbe F, Pépin J-L, d'Ortho M-P. Cohort profile: FACE, prospective follow-up of chronic heart failure patients with sleep-disordered breathing indicated for adaptive servo ventilation. BMJ Open. 2020;10(7):e038403.
  9. Sanchis-Borja M, Ricordel C, Chiappa AMarie, Hureaux J, Odier L, Jeannin G, Descourt R, Gervais R, Monnet I, Auliac J-B, Chouaid C. Encephalitis related to immunotherapy for lung cancer: Analysis of a multicenter cohort. Lung Cancer. 2020;143:36-39.
  10. Seban R-D, Assié J-B, Giroux-Leprieur E, Massiani M-A, Soussan M, Bonardel G, Chouaid C, Playe M, Goldfarb L, Duchemann B, Girard N, Champion L. FDG-PET biomarkers associated with long-term benefit from first-line immunotherapy in patients with advanced non-small cell lung cancer. Ann Nucl Med. 2020;34(12):968-974.
  11. Seban R-D, Assié J-B, Giroux-Leprieur E, Massiani M-A, Soussan M, Bonardel G, Chouaid C, Playe M, Goldfarb L, Duchemann B, Mezquita L, Girard N, Champion L. Association of the Metabolic Score Using Baseline FDG-PET/CT and dNLR with Immunotherapy Outcomes in Advanced NSCLC Patients Treated with First-Line Pembrolizumab. Cancers (Basel). 2020;12(8).
  12. Owonikoko TK, Niu H, Nackaerts K, Csoszi T, Ostoros G, Mark Z, Baik C, Joy AAbraham, Chouaid C, Jaime JCorral, Kolek V, Majem M, Roubec J, Santos ES, Chiang AC, Speranza G, Belani CP, Chiappori A, Patel MR, Czebe K, Byers L, Bahamon B, Li C, Sheldon-Waniga E, Kong EF, Williams M, Badola S, Shin H, Bedford L, Ecsedy JA, Bryant M, Jones S, Simmons J, E Leonard J, Ullmann CDansky, Spigel DR. Randomized Phase II Study of Paclitaxel plus Alisertib versus Paclitaxel plus Placebo as Second-Line Therapy for SCLC: Primary and Correlative Biomarker Analyses. J Thorac Oncol. 2020;15(2):274-287.
  13. Malka N, Abulizi M, Kharoubi M, Oghina S, Galat A, Le Bras F, Moktefi A, Guendouz S, Molinier-Frenkel V, Fanen P, Funalot B, Lefaucheur J-P, Blanc-Durand P, Deux J-F, Audard V, Bodez D, Itti E, Damy T. Extracardiac soft tissue uptake, evidenced on early Tc-HMDP SPECT/CT, helps typing cardiac amyloidosis and demonstrates high prognostic value. Eur J Nucl Med Mol Imaging. 2020;47(10):2396-2406.
  14. Mayenga M, Assié J-B, Monnet I, Massiani M-A, Tabeze L, Friard S, Fraboulet S, Métivier A-C, Chouaid C, Zemoura L, Longchampt E, Callens C, Melaabi S, Couderc L-J, Doubre H. Durable responses to immunotherapy of non-small cell lung cancers harboring MET exon-14-skipping mutation: A series of 6 cases. Lung Cancer. 2020;150:21-25.
  15. Levra MGiaj, Cotté F-E, Corre R, Calvet C, Gaudin A-F, Penrod JR, Grumberg V, Jouaneton B, Jolivel R, Assié J-B, Chouaid C. Immunotherapy rechallenge after nivolumab treatment in advanced non-small cell lung cancer in the real-world setting: A national data base analysis. Lung Cancer. 2020;140:99-106.
  16. Gibiot Q, Monnet I, Levy P, Brun A-L, Antoine M, Chouaid C, Cadranel J, Naccache J-M. Interstitial Lung Disease Associated with Lung Cancer: A Case-Control Study. J Clin Med. 2020;9(3).
  17. Perot JGiner, Jarzebowski W, Lafuente-Lafuente C, Crozet C, Belmin J. Aging-simulation experience: impact on health professionals' social representations. BMC Geriatr. 2020;20(1):14.
  18. Girard N, Moro-Sibilot D, Bouée S, Emery C, Torreton E, Le Lay K, Luciani L, Maritaz C, Chouaid C. Treatment sequence of first and second generation tyrosine kinase inhibitor followed by osimertinib in -mutated non-small-cell lung cancer: a real life study. Future Oncol. 2020;16(16):1115-1124.
  19. Geier M, Descourt R, Corre R, Léveiller G, Lamy R, Goarant E, Bizec J-L, Bernier C, Quere G, Amrane K, Gaye E, Lucia F, Burte E, Chouaid C, Robinet G. Duration of nivolumab for pretreated, advanced non-small-cell lung cancer. Cancer Med. 2020;9(19):6923-6932.
  20. Gadby F, Descourt R, Robinet G, Quere G, Gouva S, Roge C, Couturaud F, Chouaid C. [Evolution of the costs and management of lung cancer between 2004 and 2014]. Rev Mal Respir. 2020;37(1):1-7.
  21. Garassino MChiara, Cho B-C, Kim J-H, Mazières J, Vansteenkiste J, Lena H, Jaime JCorral, Gray JE, Powderly J, Chouaid C, Bidoli P, Wheatley-Price P, Park K, Soo RA, Poole L, Wadsworth C, Dennis PA, Rizvi NA. Final overall survival and safety update for durvalumab in third- or later-line advanced NSCLC: The phase II ATLANTIC study. Lung Cancer. 2020;147:137-142.
  22. Bocciarelli C, Cohen J, Pelletier R, Van Nhieu JTran, Derman J, Favre L, Bourgogne A, Monnet I, Chouaid C, Pujals A. Evaluation of the Idylla system to detect the EGFR mutation using extracted DNA. Pathol Res Pract. 2020;216(1):152773.
  23. Breton M, Costemale-Lacoste J-F, Li Z, Lafuente-Lafuente C, Belmin J, Mericskay M. Blood NAD levels are reduced in very old patients hospitalized for heart failure. Exp Gerontol. 2020;139:111051.
  24. Belmin J, Khellaf L, Pariel S, Jarzebowski W, Valembois L, Zeisel J, Lafuente-Lafuente C. Validation of the French version of the Vulnerable Elders Survey-13 (VES-13). BMC Med Res Methodol. 2020;20(1):21.
  25. Belmin J, Um-Din N, Donadio C, Magri M, Nghiem QDuy, Oquendo B, Pariel S, Lafuente-Lafuente C. Coronavirus Disease 2019 Outcomes in French Nursing Homes That Implemented Staff Confinement With Residents. JAMA Netw Open. 2020;3(8):e2017533.
  26. Bennouna J, Girard N, Audigier-Valette C, Le Thuaut A, Gervais R, Masson P, Marcq M, Molinier O, Cortot A, Debieuvre D, Cadranel J, Lena H, Moro-Sibilot D, Chouaid C, Mennecier B, Urban T, Sagan C, Perrier L, Barlesi F, Denis MG. Phase II Study Evaluating the Mechanisms of Resistance on Tumor Tissue and Liquid Biopsy in Patients With EGFR-mutated Non-pretreated Advanced Lung Cancer Receiving Osimertinib Until and Beyond Radiologic Progression: The MELROSE Trial. Clin Lung Cancer. 2020;21(1):e10-e14.
  27. Auliac J-B, Bayle S, Do P, Le Garff G, Roa M, Falchero L, Huchot E, Quere G, Jeannin G, Métivier A-C, Hobeika J, Guisier F, Chouaid C. Efficacy of Dabrafenib Plus Trametinib Combination in Patients with V600E-Mutant NSCLC in Real-World Setting: GFPC 01-2019. Cancers (Basel). 2020;12(12).
  28. Baize N, Monnet I, Greillier L, Geier M, Lena H, Janicot H, Vergnenègre A, Crequit J, Lamy R, Auliac J-B, Letreut J, Le Caer H, Gervais R, Dansin E, Madroszyk A, Renault P-A, Le Garff G, Falchero L, Bérard H, Schott R, Saulnier P, Chouaid C. Carboplatin plus etoposide versus topotecan as second-line treatment for patients with sensitive relapsed small-cell lung cancer: an open-label, multicentre, randomised, phase 3 trial. Lancet Oncol. 2020;21(9):1224-1233.
  29. Akinboboye O, Shah K, Warner AL, Damy T, Taylor HA, Gollob J, Powell C, Karsten V, Vest J, Maurer MS. DISCOVERY: prevalence of transthyretin () mutations in a US-centric patient population suspected of having cardiac amyloidosis. Amyloid. 2020;27(4):223-230.
  30. Amrane K, Geier M, Corre R, Lena H, Léveiller G, Gadby F, Lamy R, Bizec J-L, Goarant E, Robinet G, Gouva S, Quere G, Abgral R, Schick U, Bernier C, Chouaid C, Descourt R. First-line pembrolizumab for non-small cell lung cancer patients with PD-L1 ≥50% in a multicenter real-life cohort: The PEMBREIZH study. Cancer Med. 2020;9(7):2309-2316.
  31. Arpin D, Charpentier M-C, Bernardi M, Monnet I, Boni A, Watkin E, Goubin-Versini I, Lamy R, Gérinière L, Geier M, Forest F, Gervais R, Madrosyk A, Guisier F, Serrand C, Locher C, Decroisette C, Fournel P, Auliac J-B, Jeanfaivre T, Letreut J, Doubre H, François G, Piton N, Chouaid C, Damotte D. PD-L1-expression patterns in large-cell neuroendocrine carcinoma of the lung: potential implications for use of immunotherapy in these patients: the GFPC 03-2017 "EPNEC" study. Ther Adv Med Oncol. 2020;12:1758835920937972.
  32. Assié J-B, Corre R, Levra MGiaj, Calvet CYannick, Gaudin A-F, Grumberg V, Jouaneton B, Cotté F-E, Chouaid C. Nivolumab treatment in advanced non-small cell lung cancer: real-world long-term outcomes within overall and special populations (the UNIVOC study). Ther Adv Med Oncol. 2020;12:1758835920967237.
  33. Lièvre A, Turpin A, Ray-Coquard I, Le Malicot K, Thariat J, Ahle G, Neuzillet C, Paoletti X, Bouché O, Aldabbagh K, Michel P, Debieuvre D, Canellas A, Wislez M, Laurent L, Mabro M, Colle R, Hardy-Bessard A-C, Mansi L, Colomba E, Bourhis J, Gorphe P, Pointreau Y, Idbaih A, Ursu R, Di Stefano ALuisa, Zalcman G, Aparicio T. Risk factors for Coronavirus Disease 2019 (COVID-19) severity and mortality among solid cancer patients and impact of the disease on anticancer treatment: A French nationwide cohort study (GCO-002 CACOVID-19). Eur J Cancer. 2020;141:62-81.
  34. Landre T, Chouahnia K, Guetz GDes, Duchemann B, Assié J-B, Chouaid C. First-line immune-checkpoint inhibitor plus chemotherapy chemotherapy alone for extensive-stage small-cell lung cancer: a meta-analysis. Ther Adv Med Oncol. 2020;12:1758835920977137.
  35. Landre T, Guetz GDes, Chouahnia K, Duchemann B, Assié J-B, Chouaid C. First-line angiogenesis inhibitor plus erlotinib versus erlotinib alone for advanced non-small-cell lung cancer harboring an EGFR mutation. J Cancer Res Clin Oncol. 2020;146(12):3333-3339.
  36. Landre T, Guetz GDes, Chouahnia K, Taleb C, Vergnenègre A, Chouaid C. First-line PD-1/PD-L1 inhibitor plus chemotherapy vs chemotherapy alone for negative or < 1% PD-L1-expressing metastatic non-small-cell lung cancers.. J Cancer Res Clin Oncol. 2020;146(2):441-448.
  37. Belmin J, Donadio C, Jarzebowski W, Genranmayeh K, Valembois L, Lafuente-Lafuente C. The value of B-type natriuretic peptide plasma concentrations in very old people with chronic peripheral oedema. Arch Cardiovasc Dis. 2020;113(5):332-340.
  38. Belmin J, Din NUm, Pariel S, Lafuente-Lafuente C. [Confinement of staff with residents in nursing homes: a solution against COVID-19?]. Geriatr Psychol Neuropsychiatr Vieil. 2020;18(3):238-240.
  39. Saint-Lary O, Gautier S, Le Breton J, Gilberg S, Frappé P, Schuers M, Bourgueil Y, Renard V. How GPs adapted their practices and organisations at the beginning of COVID-19 outbreak: a French national observational survey. BMJ Open. 2020;10(12):e042119.
  40. Bylicki O, Paleiron N, Assié J-B, Chouaid C. Targeting the MET-Signaling Pathway in Non-Small-Cell Lung Cancer: Evidence to Date. Onco Targets Ther. 2020;13:5691-5706.
  41. Hauchecorne M, Pierro M, Brain E, Bringuier M, Soubeyran P, Chakiba C, Mathoulin-Pelissier S, Paillaud E, Geiss R, Besse B, Mourey L, Vincent H, Baldini C. Perspectives on cancer care in older patients in France. Ecancermedicalscience. 2020;14:1103.
  42. Eicher JC, Audia S, Damy T. [Transthyretin cardiac amyloidosis]. Rev Med Interne. 2020;41(10):673-683.
  43. Guisier F, Dubos-Arvis C, Vinas F, Doubre H, Ricordel C, Ropert S, Janicot H, Bernardi M, Fournel P, Lamy R, Perol M, Dauba J, Gonzales G, Falchero L, Decroisette C, Assouline P, Chouaid C, Bylicki O. Efficacy and Safety of Anti-PD-1 Immunotherapy in Patients With Advanced NSCLC With BRAF, HER2, or MET Mutations or RET Translocation: GFPC 01-2018. J Thorac Oncol. 2020;15(4):628-636.
  44. Pallet N, Hamdane S, Garinet S, Blons H, Zaanan A, Paillaud E, Taieb J, Laprevote O, Loriot M-A, Narjoz C. A comprehensive population-based study comparing the phenotype and genotype in a pretherapeutic screen of dihydropyrimidine dehydrogenase deficiency. Br J Cancer. 2020;123(5):811-818.
  45. Colaneri M, Seminari E, Piralla A, Zuccaro V, Di Filippo A, Baldanti F, Bruno R, Mondelli MU. Lack of SARS-CoV-2 RNA environmental contamination in a tertiary referral hospital for infectious diseases in Northern Italy. J Hosp Infect. 2020;105(3):474-6.
  46. Emsen B, Villafane G, David J-P, Evangelista E, Chalaye J, Lerman L, Authier F-J, Gracies J-M, Itti E. Clinical impact of dual-tracer FDOPA and FDG PET/CT for the evaluation of patients with parkinsonian syndromes. Medicine (Baltimore). 2020;99(45):e23060.
  47. Chouaid C. [Not Available]. Rev Malad Respir Actual. 2020;12(2):2S378-2S382.
  48. Mohty D, Pibarot P, Damy T. Aortic stenosis and amyloid heart disease: 'the 2A dangerous liaisons'. Eur Heart J. 2020;41(29):2815.
  49. Tacher V, Blain M, Hérin E, Vitellius M, Chiaradia M, Oubaya N, Derbel H, Kobeiter H. CBCT-Based Image Guidance for Percutaneous Access: Electromagnetic Navigation Versus 3D Image Fusion with Fluoroscopy Versus Combination of Both Technologies-A Phantom Study. Cardiovasc Intervent Radiol. 2020;43(3):495-504.
  50. Coquerelle S, Darlington M, Michel M, Durand M, Borget I, Baffert S, Marino P, Perrier L, Durand-Zaleski I. Impact of Next Generation Sequencing on Clinical Practice in Oncology in France: Better Genetic Profiles for Patients Improve Access to Experimental Treatments. Value Health. 2020;23(7):898-906.
  51. Dabi Y, Gosset M, Bastuji-Garin S, Mitri-Frangieh R, Bendifallah S, Darai E, Paniel BJean, Rouzier R, Haddad B, Touboul C. Associated Lichen Sclerosis Increases the Risk of Lymph Node Metastases of Vulvar Cancer. J Clin Med. 2020;9(1).
  52. Phan T, Yana J, Fabre J, Yana L, Renard V, Ferrat E. [At-risk drinking screening by general practitioners: A survey of patients in primary care]. Rev Epidemiol Sante Publique. 2020;68(4):215-225.
  53. Stehlé T, Karoui KEl, Sakka M, Ismail A, Matignon M, Grimbert P, Canoui-Poitrine F, Prié D, Audard V. Creatinine clearance after cimetidine administration in a new short procedure: comparison with plasma and renal clearances of iohexol. Clin Kidney J. 2020;13(4):587-596.
  54. Beghdadi N, Reitano E, Cochennec F, Desgranges P, Amiot A, Sobhani I, Mongardon N, Langeron O, Notarnicola M, Mulé S, Luciani A, Canoui-Poitrine F, Laurent A, Sommacale D, Brunetti F, Angelis NDe'. Predictors of mortality following emergency open colectomy for ischemic colitis: a single-center experience. World J Emerg Surg. 2020;15(1):40.
  55. N Saleh B, Voron T, de'Angelis N, Franco I, Canoui-Poitrine F, Mutter D, Brunetti F, Gagnière J, Memeo R, Pezet D, Monange B, Pereira B, Le Roy B. Intracorporeal versus extracorporeal anastomosis in laparoscopic right hemicolectomy: results from the CLIMHET study group. Tech Coloproctol. 2020;24(6):585-592.
  56. Angeli E, Chouahnia K, Canoui-Poitrine F, Duchemann B, Aparicio T, Paillaud E, Zelek L, Bousquet G, Pamoukdjian F. Development, validation and clinical impact of a prediction model for 6-month mortality in older cancer patients: the GRADE. Aging (Albany NY). 2020;12(5):4230-4246.
  57. Aparicio T, Canoui-Poitrine F, Caillet P, Francois E, Cudennec T, Carola E, Albrand G, Bouvier A-M, Petri C, Couturier B, Phelip J-M, Bengrine-Lefevre L, Paillaud E. Treatment guidelines of metastatic colorectal cancer in older patients from the French Society of Geriatric Oncology (SoFOG). Dig Liver Dis. 2020;52(5):493-505.
  58. Beinse G, Reitter D, Segaux L, Carvahlo-Verlinde M, Rousseau B, Tournigand C, Cudennec T, Laurent M, Boudou-Rouquette P, Paillaud E, Canoui-Poitrine F, Caillet P. Potential drug-drug interactions and risk of unplanned hospitalization in older patients with cancer: A survey of the prospective ELCAPA (ELderly CAncer PAtients) cohort. J Geriatr Oncol. 2020;11(4):586-592.
  59. Ingen-Housz-Oro S, Alves A, Colin A, Ouedraogo R, Layese R, Canoui-Poitrine F, Chosidow O, Mekontso-Dessap A, Wolkenstein P, de Prost N. Health-related quality of life and long-term sequelae in survivors of epidermal necrolysis: an observational study of 57 patients. Br J Dermatol. 2020;182(4):916-926.
  60. Etienne N, Karmochkine M, Slama L, Pavie J, Batisse D, Usubillaga R, Letembet V-A, Brazille P, Canouï E, Slama D, Joumaa H, Canoui-Poitrine F, Segaux L, Weiss L, Viard J-P, Salmon D. HIV infection and COVID-19: risk factors for severe disease. AIDS. 2020;34(12):1771-1774.
  61. Ceron DSalmon, Bartier S, Hautefort C, Nguyen Y, Nevoux J, Hamel A-L, Camhi Y, Canoui-Poitrine F, Verillaud B, Slama D, Haim-Boukobza S, Sourdeau E, Cantin D, Corré A, Bryn A, Etienne N, Rozenberg F, Layese R, Papon J-F, Béquignon E. Self-reported loss of smell without nasal obstruction to identify COVID-19. The multicenter Coranosmia cohort study. J Infect. 2020;81(4):614-620.
  62. de'Angelis N, Notarnicola M, Martínez-Pérez A, Memeo R, Charpy C, Urciuoli I, Maroso F, Sommacale D, Amiot A, Canoui-Poitrine F, Levesque E, Brunetti F. Robotic Versus Laparoscopic Partial Mesorectal Excision for Cancer of the High Rectum: A Single-Center Study with Propensity Score Matching Analysis. World J Surg. 2020;44(11):3923-3935.
  63. Hue S, Beldi-Ferchiou A, Bendib I, Surenaud M, Fourati S, Frapard T, Rivoal S, Razazi K, Carteaux G, Delfau-Larue M-H, Mekontso-Dessap A, Audureau E, de Prost N. Uncontrolled Innate and Impaired Adaptive Immune Responses in Patients with COVID-19 Acute Respiratory Distress Syndrome. Am J Respir Crit Care Med. 2020;202(11):1509-1519.
  64. Zarski J-P, David-Tchouda S, Trocme C, Margier J, Vilotitch A, Hilleret M-N, Cagnot C, Boursier V, Ziol M, Sutton A, Layese R, Audureau E, Roudot-Thoraval F, Nahon P. Non-invasive fibrosis tests to predict complications in compensated post-hepatitis C cirrhosis. Clin Res Hepatol Gastroenterol. 2020;44(4):524-531.
  65. Roumenina LT, Chadebech P, Bodivit G, Vieira-Martins P, Grunenwald A, Boudhabhay I, Poillerat V, Pakdaman S, Kiger L, Jouard A, Audureau E, Pirenne F, Galactéros F, Frémeaux-Bacchi V, Bartolucci P. Complement activation in sickle cell disease: Dependence on cell density, hemolysis and modulation by hydroxyurea therapy. Am J Hematol. 2020;95(5):456-464.
  66. Raffetin A, Melica G, Audureau E, Habibi A, Decousser JW, Fourati S, Razazi K, Lepeule R, Guillaud C, Khellaf M, Bartolucci P, Gallien S. Molecular testing for respiratory pathogens in sickle cell disease adult patients presenting with febrile acute chest syndrome. Med Mal Infect. 2020;50(1):49-56.
  67. Caeymaex L, Lebeaux C, Roze JChristophe, Danan C, Reynaud A, Jung C, Audureau E. Study on preventing adverse events in neonates (SEPREVEN): A stepped-wedge randomised controlled trial to reduce adverse event rates in the NICU. Medicine (Baltimore). 2020;99(31):e20912.
  68. Bataille P, Amiot A, Claudepierre P, Paris N, Neuraz A, Lerner I, Garcelon N, Rance B, Grisel O, Moreau T, Bernaux M, Audureau E, Sbidian E. Letter: severe COVID-19 infection and biologic therapies-a cohort study of 7 808 patients in France. Aliment Pharmacol Ther. 2020;52(7):1245-1248.
  69. Heidet M, Da Cunha T, Brami E, Mermet É, Dru M, Simonnard B, Lecarpentier E, Chollet-Xémard C, Bergeron C, Khalid M, Grunau B, Marty J, Audureau E. EMS Access Constraints And Response Time Delays For Deprived Critically Ill Patients Near Paris, France. Health Aff (Millwood). 2020;39(7):1175-1184.
  70. Hebert N, Rakotoson MGeorgine, Bodivit G, Audureau E, Bencheikh L, Kiger L, Oubaya N, Pakdaman S, Sakka M, Di Liberto G, Chadebech P, Vingert B, Pirenne F, Galactéros F, Cambot M, Bartolucci P. Individual red blood cell fetal hemoglobin quantification allows to determine protective thresholds in sickle cell disease. Am J Hematol. 2020;95(11):1235-1245.
  71. Rougier E, Mar W, V Valle D, Morel B, Irtan S, Audureau E, Coulomb-L'Hermine A, H le Pointe D, Blondiaux E. Added value of MRI for the diagnosis of adnexal torsion in children and adolescents after inconclusive ultrasound examination. Diagn Interv Imaging. 2020;101(11):747-756.
  72. Audureau E, Carrat F, Layese R, Cagnot C, Asselah T, Guyader D, Larrey D, De Lédinghen V, Ouzan D, Zoulim F, Roulot D, Tran A, Bronowicki J-P, Zarski J-P, Riachi G, Calès P, Péron J-M, Alric L, Bourlière M, Mathurin P, Blanc J-F, Abergel A, Chazouillères O, Mallat A, Grangé J-D, Attali P, d'Alteroche L, Wartelle C, Dao T, Thabut D, Pilette C, Silvain C, Christidis C, Nguyen-Khac E, Bernard-Chabert B, Zucman D, Di Martino V, Sutton A, Pol S, Nahon P. Personalized surveillance for hepatocellular carcinoma in cirrhosis - using machine learning adapted to HCV status. J Hepatol. 2020;73(6):1434-1445.
  73. Sifaoui I, Oliver L, Tacher V, Fiore A, Lepeule R, Moussafeur A, Huguet R, Teiger E, Audureau E, Derbel H, Luciani A, Kobeiter H, Lim P, Ternacle J, Deux J-F. Diagnostic Performance of Transesophageal Echocardiography and Cardiac Computed Tomography in Infective Endocarditis. J Am Soc Echocardiogr. 2020;33(12):1442-1453.
  74. Mahévas M, Tran V-T, Roumier M, Chabrol A, Paule R, Guillaud C, Fois E, Lepeule R, Szwebel T-A, Lescure F-X, Schlemmer F, Matignon M, Khellaf M, Crickx E, Terrier B, Morbieu C, Legendre P, Dang J, Schoindre Y, Pawlotsky J-M, Michel M, Perrodeau E, Carlier N, Roche N, de Lastours V, Ourghanlian C, Kerneis S, Ménager P, Mouthon L, Audureau E, Ravaud P, Godeau B, Gallien S, Costedoat-Chalumeau N. Clinical efficacy of hydroxychloroquine in patients with covid-19 pneumonia who require oxygen: observational comparative study using routine care data. BMJ. 2020;369:m1844.
  75. Delchier J-C, Bastuji-Garin S, Raymond J, Megraud F, Amiot A, Cambau E, Burucoa C. Efficacy of a tailored PCR-guided triple therapy in the treatment of Helicobacter pylori infection. Med Mal Infect. 2020;50(6):492-499.


  1. Valembois L, Audureau E, Takeda A, Jarzebowski W, Belmin J, Lafuente-Lafuente C. Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation. Cochrane Database Syst RevCochrane Database Syst RevCochrane Database Syst Rev. 2019;9:Cd005049.
  2. Neuzillet Y, Geiss R, Paillaud E, Mongiat-Artus P. [Optimizing the management of bladder cancer in older patients]. Prog Urol. 2019;29(14):849-864.
  3. Mongiat-Artus P, Paillaud E, Albrand G, Caillet P, Neuzillet Y. [Evaluation of the elderly patient with cancer]. Prog Urol. 2019;29(14):807-827.
  4. Mongiat-Artus P, Paillaud E, Albrand G, Neuzillet Y. [Onco-urology of the aging patient: Epidemiological and biological aspects]. Prog Urol. 2019;29(14):797-806.
  5. Mongiat-Artus P, Paillaud E, Caillet P, Albrand G, Neuzillet Y. [Geriatric specificities of localized renal cell carcinoma]. Prog Urol. 2019;29(14):865-873.
  6. Mongiat-Artus P, Paillaud E, Caillet P, Albrand G, Neuzillet Y. [Geriatric specificities of prostate cancer]. Prog Urol. 2019;29(14):828-839.
  7. Neuzillet Y, Albrand G, Caillet P, Paillaud E, Mongiat-Artus P. [Specificity of the management of metastatic renal cancer in the older patient]. Prog Urol. 2019;29(14):874-895.
  8. Neuzillet Y, Geiss R, Caillet P, Paillaud E, Mongiat-Artus P. [Epidemiological, pathological and prognostic characteristics of bladder cancer in elderly patients]. Prog Urol. 2019;29(14):840-848.
  9. Vayr F, Savall F, Bigay-Gamé L, Soulat J-M, Chouaid C, Hérin F. Lung cancer survivors and employment: A systematic review. Lung Cancer. 2019;131:31-39.
  10. Paillaud E, Cudennec T, Caillet P, Bellera C, Mathoulin-Pelissier S, Soubeyran P. [Clinical trials and elderly patients with cancer, the Geriatric Core Dataset (G-Code) tool]. Soins Gerontol. 2019;24(137):35-37.
  11. Pichon J, Chouaid C, Marc E, Voiriot G. [Respiratory isolation in suspected tuberculosis with negative direct sputum examination]. Rev Mal Respir. 2019;36(3):396-404.
  12. Berthelot E, Nouhaud C, Lafuente-Lafuente C, Assayag P, Hittinger L. [Heart failure in patients over 80 years old]. Presse Med. 2019;48(2):143-153.
  13. Villemain O, Correia M, Mousseaux E, Baranger J, Zarka S, Podetti I, Soulat G, Damy T, Hagège A, Tanter M, Pernot M, Messas E. Myocardial Stiffness Evaluation Using Noninvasive Shear Wave Imaging in Healthy and Hypertrophic Cardiomyopathic Adults. JACC Cardiovasc Imaging. 2019;12(7 Pt 1):1135-1145.
  14. Zores F, Iliou M-C, Gellen B, Kubas S, Berthelot E, Guillo P, Bauer F, Lamblin N, Bosser G, Damy T, Cohen-Solal A, Beauvais F. Physical activity for patients with heart failure: Position paper from the heart failure (GICC) and cardiac rehabilitation (GERS-P) Working Groups of the French Society of Cardiology. Arch Cardiovasc Dis. 2019;112(11):723-731.
  15. Zouari HG, S Tin NWing, Wahab A, Damy T, Lefaucheur J-P. Assessment of autonomic innervation of the foot in familial amyloid polyneuropathy. Eur J Neurol. 2019;26(1):94-e10.
  16. Mongiat-Artus P, Paillaud E, Albrand G, Neuzillet Y. [Conclusion]. Prog Urol. 2019;29(14):896-897.
  17. Solomon SD, Adams D, Kristen A, Grogan M, González-Duarte A, Maurer MS, Merlini G, Damy T, Slama MS, Brannagan TH, Dispenzieri A, Berk JL, Shah AM, Garg P, Vaishnaw A, Karsten V, Chen J, Gollob J, Vest J, Suhr O. Effects of Patisiran, an RNA Interference Therapeutic, on Cardiac Parameters in Patients With Hereditary Transthyretin-Mediated Amyloidosis. Circulation. 2019;139(4):431-443.
  18. Tison A, Quere G, Misery L, Funck-Brentano E, Danlos F-X, Routier E, Robert C, Loriot Y, Lambotte O, Bonniaud B, Scalbert C, Maanaoui S, Lesimple T, Martinez S, Marcq M, Chouaid C, Dubos C, Brunet-Possenti F, Stavris C, Chiche L, Beneton N, Mansard S, Guisier F, Doubre H, Skowron F, Aubin F, Zehou O, Roge C, Lambert M, Pham-Ledard A, Beylot-Barry M, Veillon R, Kramkimel N, Giacchero D, De Quatrebarbes J, Michel C, Auliac J-B, Gonzales G, Decroisette C, Le Garff G, Carpiuc I, Vallerand H, Nowak E, Cornec D, Kostine M. Safety and Efficacy of Immune Checkpoint Inhibitors in Patients With Cancer and Preexisting Autoimmune Disease: A Nationwide, Multicenter Cohort Study. Arthritis Rheumatol. 2019;71(12):2100-2111.
  19. Pradel S, Magne J, Jaccard A, Fadel BM, Boulogne C, Salemi VMaria Cury, Damy T, Aboyans V, Mohty D. Left ventricular assessment in patients with systemic light chain amyloidosis: a 3-dimensional speckle tracking transthoracic echocardiographic study. Int J Cardiovasc Imaging. 2019;35(5):845-854.
  20. Richard P, Ader F, Roux M, Donal E, Eicher J-C, Aoutil N, Huttin O, Selton-Suty C, Coisne D, Jondeau G, Damy T, Mansencal N, Casalta A-C, Michel N, Haentjens J, Faivre L, Lavoute C, Nguyen K, Tregouët D-A, Habib G, Charron P. Targeted panel sequencing in adult patients with left ventricular non-compaction reveals a large genetic heterogeneity. Clin Genet. 2019;95(3):356-367.
  21. Mirabel M, Damy T, Donal E, Huttin O, Labombarda F, Eicher J-C, Cervino C, Laurito M, Offredo L, Tafflet M, Jouven X, Giura G, Desnos M, Jeunemaître X, Empana J-P, Charron P, Habib G, Réant P, Hagège A. Influence of centre expertise on the diagnosis and management of hypertrophic cardiomyopathy: A study from the French register of hypertrophic cardiomyopathy (REMY). Int J Cardiol. 2019;275:107-113.
  22. Kissel M, Martel-Lafay I, Lequesne J, Faivre J-C, Le Péchoux C, Stefan D, Barraux V, Loiseau C, Grellard J-M, Danhier S, Lerouge D, Chouaid C, Gervais R, Thariat J. Stereotactic ablative radiotherapy and systemic treatments for extracerebral oligometastases, oligorecurrence, oligopersistence and oligoprogression from lung cancer. BMC Cancer. 2019;19(1):1237.
  23. Kwun J, Matignon M, Manook M, Guendouz S, Audard V, Kheav D, Poullot E, Gautreau C, Ezekian B, Bodez D, Damy T, Faivre L, Menouche D, Yoon J, Park J, Belhadj K, Chen D, Bilewski AM, Yi JS, Collins B, Stegall M, Farris AB, Knechtle S, Grimbert P. Daratumumab in Sensitized Kidney Transplantation: Potentials and Limitations of Experimental and Clinical Use. J Am Soc Nephrol. 2019;30(7):1206-1219.
  24. Galat A, Guellich A, Bodez D, Lipskaia L, Moutereau S, Bergoend E, Hue S, Ternacle J, Mohty D, Monin J-L, Derumeaux G, Radu C, Damy T. Causes and consequences of cardiac fibrosis in patients referred for surgical aortic valve replacement. ESC Heart Fail. 2019;6(4):649-657.
  25. Damy T, Kristen AV, Suhr OB, Maurer MS, Planté-Bordeneuve V, Yu C-R, Ong M-L, Coelho T, Rapezzi C. Transthyretin cardiac amyloidosis in continental Western Europe: an insight through the Transthyretin Amyloidosis Outcomes Survey (THAOS). Eur Heart J. 2019;43(5):391-400.
  26. Dang J, Abulizi M, Moktefi A, Karoui KEl, Deux J-F, Bodez D, Le Bras F, Belhadj K, Remy P, Issaurat P, Planté-Bordeneuve V, Molinier-Frenkel V, Fanen P, Guendouz S, Kharoubi M, Itti E, Damy T, Audard V. Renal Infarction and Its Consequences for Renal Function in Patients With Cardiac Amyloidosis. Mayo Clin Proc. 2019;94(6):961-975.
  27. Delva F, Laurent F, Paris C, Belacel M, Brochard P, Bylicki O, Chouaid C, Clin B, Dewitte J-D, Le Denmat V, Gehanno J-F, Lacourt A, Margery J, Verdun-Esquer C, Mathoulin-Pelissier S, Pairon J-C. LUCSO-1-French pilot study of LUng Cancer Screening with low-dose computed tomography in a smokers population exposed to Occupational lung carcinogens: study protocol. BMJ Open. 2019;9(3):e025026.
  28. Descourt R, Perol M, Rousseau-Bussac G, Planchard D, Mennecier B, Wislez M, Cortot A, Guisier F, Galland L, Do P, Schott R, Dansin E, Arrondeau J, Auliac J-B, Chouaid C. Brigatinib in patients with ALK-positive advanced non-small-cell lung cancer pretreated with sequential ALK inhibitors: A multicentric real-world study (BRIGALK study). Lung Cancer. 2019;136:109-114.
  29. Cholet C, Damy T, Legou F, Kobeiter H, Rahmouni A, Deux J-F. Quantification of Myocardial Enhancement on Cine-MRI: Diagnostic Value in Cardiac Amyloidosis. Acad Radiol. 2019;26(6):e98-e107.
  30. Conceição I, Damy T, Romero M, Galán L, Attarian S, Luigetti M, Sadeh M, Sarafov S, Tournev I, Ueda M. Early diagnosis of ATTR amyloidosis through targeted follow-up of identified carriers of TTR gene mutations. Amyloid. 2019;26(1):3-9.
  31. Dalon F, Devouassoux G, Belhassen M, Nachbaur G, Da Silva CCorreia, Sail L, Jacoud F, Chouaid C, Van Ganse E. Impact of Therapy Persistence on Exacerbations and Resource Use in Patients Who Initiated COPD Therapy. Int J Chron Obstruct Pulmon Dis. 2019;14:2905-2915.
  32. Bourdin A, Fabry-Vendrand C, Ostinelli J, Ait-Yahia M, Darnal E, Bouée S, Laurendeau C, Bureau I, Gourmelen J, Chouaid C. The Burden of Severe Asthma in France: A Case-Control Study Using a Medical Claims Database. J Allergy Clin Immunol Pract. 2019;7(5):1477-1487.
  33. Auliac J-B, Do P, Bayle S, Doubre H, Vinas F, Letreut J, Falchero L, Hauss PAlexandre, Thomas P, Chouaid C. Non-Small Cell Lung Cancer Patients Harboring HER2 Mutations: Clinical Characteristics and Management in a Real-Life Setting. Cohort HER2 EXPLORE GFPC 02-14. Adv Ther. 2019;36(8):2161-2166.
  34. Auliac JBernard, Perol M, Planchard D, Monnet I, Wislez M, Doubre H, Guisier F, Pichon E, Greillier L, Mastroianni B, Decroisette C, Schott R, Le Moulec S, Arrondeau J, Cortot AB, Gérinière L, Renault A, Daniel C, Falchero L, Chouaid C. Real-life efficacy of osimertinib in pretreated patients with advanced non-small cell lung cancer harboring EGFR T790M mutation. Lung Cancer. 2019;127:96-102.
  35. Auliac J-B, Saboundji K, André M, Madelaine J, Quere G, Masson P, Vergnenègre A, Lamy R, Raymond S, Chiappa A-M, Hauss P-A, Fournel P, Corre R, Chouaid C. Real-Life Efficacy of Osimertinib in Pretreated Octogenarian Patients with T790M-Mutated Advanced Non-small Cell Lung Cancer. Target Oncol. 2019;14(3):307-314.
  36. Boully C, Vidal J-S, Guibert E, Ghazali FNisrin, Pesce A, Beauplet B, Roger J-D, Carrière I, Timbely B, Idiri H, Constensoux J-P, Durocher A-M, Dubail D, Fargier M, Jeandel C, Berrut G, Hanon O. National survey on the management of heart failure in individuals over 80 years of age in French geriatric care units. BMC Geriatr. 2019;19(1):204.
  37. Ternacle J, Krapf L, Mohty D, Magne J, Nguyen A, Galat A, Gallet R, Teiger E, Côté N, Clavel M-A, Tournoux F, Pibarot P, Damy T. Aortic Stenosis and Cardiac Amyloidosis: JACC Review Topic of the Week. J Am Coll Cardiol. 2019;74(21):2638-2651.
  38. Witteles RM, Bokhari S, Damy T, Elliott PM, Falk RH, Fine NM, Gospodinova M, Obici L, Rapezzi C, García-Pavía P. Screening for Transthyretin Amyloid Cardiomyopathy in Everyday Practice. JACC Heart Fail. 2019;7(8):709-716.
  39. Hagège A, Réant P, Habib G, Damy T, Barone-Rochette G, Soulat G, Donal E, Germain DP. Fabry disease in cardiology practice: Literature review and expert point of view. Arch Cardiovasc Dis. 2019;112(4):278-287.
  40. Magny E, Donadio C, Maronnat F, Nghiem D, Berthelot E, Belmin J, Lafuente-Lafuente C. [Hypotensions in the elderly: Clinical and therapeutic features]. Presse Med. 2019;48(2):134-142.
  41. Maurer MS, Bokhari S, Damy T, Dorbala S, Drachman BM, Fontana M, Grogan M, Kristen AV, Lousada I, Nativi-Nicolau J, Quarta CCristina, Rapezzi C, Ruberg FL, Witteles R, Merlini G. Expert Consensus Recommendations for the Suspicion and Diagnosis of Transthyretin Cardiac Amyloidosis. Circ Heart Fail. 2019;12(9):e006075.
  42. Bylicki O, Didier M, Rivière F, Margery J, Grassin F, Chouaid C. Lung cancer and end-of-life care: a systematic review and thematic synthesis of aggressive inpatient care. BMJ Support Palliat Care. 2019;9(4):413-424.
  43. Couderc A-L, Boulahssass R, Nouguerède E, Gobin N, Guerin O, Villani P, Barlesi F, Paillaud E. Functional status in a geriatric oncology setting: A review. J Geriatr Oncol. 2019;10(6):884-894.
  44. Bonnefoy M, Gilbert T, Bruyère O, Paillaud E, Raynaud-Simon A, Guerin O, Jeandel C, Le Sourd B, Haine M, Ferry M, Rolland Y, Berrut G. [Protein supplementation to prevent loss in muscle mass and strength in frail older patients: a review]. Geriatr Psychol Neuropsychiatr Vieil. 2019;17(2):137-143.
  45. Brain E, Caillet P, de Glas N, Biganzoli L, Cheng K, Dal Lago L, Wildiers H. HER2-targeted treatment for older patients with breast cancer: An expert position paper from the International Society of Geriatric Oncology. J Geriatr Oncol. 2019;10(6):1003-1013.
  46. Flécher E, Guihaire J, Pozzi M, Ouattara A, Baudry G, Berthelot E, Beauvais F, Radu C, Dorent R, Sebbag L, Galli E, Roubille F, Damy T, Verhoye JPhilippe, Leprince P, Obadia J-F, Lebreton G. Extracorporeal membrane oxygenation support in acute circulatory failure: A plea for regulation and better organization. Arch Cardiovasc Dis. 2019;112(6-7):441-449.
  47. Bylicki O, Barazzutti H, Paleiron N, Margery J, Assié J-B, Chouaid C. First-Line Treatment of Non-Small-Cell Lung Cancer (NSCLC) with Immune Checkpoint Inhibitors. BioDrugs. 2019;33(2):159-171.
  48. Guyard A, Charpy C, Théou-Anton N, Cremades A, Grassin F, Bourgogne A, Leroy K, Pujals A, Copie-Bergman C, Chouaid C, Mansuet-Lupo A. Isolated 5' Signals Are an Atypical Pattern To Be Considered as Positive for ALK Rearrangement: A Brief Report of Three Cases and Review of the Literature. Transl Oncol. 2019;12(5):784-787.
  49. Costantini A, Fallet V, Corny J, Friard S, Chouaid C, Duchemann B, Giroux-Leprieur E, Taillade L, Doucet L, Brosseau S, Wislez M, Tredaniel J, Cadranel J. Nivolumab-refractory patients with advanced non-small-cell lung cancer. Lung Cancer. 2019;130:128-134.
  50. Ekman S, Griesinger F, Baas P, Chao D, Chouaid C, O'Donnell JC, Penrod JR, Daumont M, Lacoin L, McKenney A, Khovratovich M, Munro REj, Durand-Zaleski I, Johnsen SPaaske. I-O Optimise: a novel multinational real-world research platform in thoracic malignancies. Future Oncol. 2019;15(14):1551-1563.
  51. Chouaid C, Germain N, de Pouvourville G, Aballéa S, Korchagina D, Baldwin M, Le Lay K, Luciani L, Toumi M, Devillier P. Patient preference for chronic obstructive pulmonary disease (COPD) treatment inhalers: a discrete choice experiment in France. Curr Med Res Opin. 2019;35(5):785-792.
  52. Chouaid C, Salaün M, Gounant V, Febvre M, Vergnon J-M, Jouniaux V, Fournier C, Lachkar S, Hermant C, Raspaud C, Quantin X, Quiot J-J, Molard A, Dayen C, Marquette C-H, Lena H, Zalcman G, Thiberville L. Clinical efficacy and cost-effectiveness of endobronchial ultrasound-guided transbronchial needle aspiration for preoperative staging of non-small-cell lung cancer: Results of a French prospective multicenter trial (EVIEPEB). PLoS One. 2019;14(1):e0208992.
  53. Mongiat-Artus P, Paillaud E, Albrand G, Neuzillet Y. [Introduction]. Prog Urol. 2019;29(14):795-796.
  54. Badois N, Bauër P, Chéron M, Hoffmann C, Nicodème M, Choussy O, Lesnik M, Poitrine FCanoui, Fromantin I. Acellular fish skin matrix on thin-skin graft donor sites: a preliminary study. J Wound Care. 2019;28(9):624-628.
  55. Canouï E, Zarrouk V, Canoui-Poitrine F, Desmoulin U, Leflon V, Allaham W, de Lastours V, Guigui P, Fantin B. Surgery is safe and effective when indicated in the acute phase of hematogenous pyogenic vertebral osteomyelitis. Infect Dis (Lond). 2019;51(4):268-276.
  56. Pamoukdjian F, Aparicio T, Canoui-Poitrine F, Duchemann B, Lévy V, Wind P, Ganne N, Sebbane G, Zelek L, Paillaud E. Obesity survival paradox in cancer patients: Results from the Physical Frailty in older adult cancer patients (PF-EC) study. Clin Nutr. 2019;38(6):2806-2812.
  57. Leibler C, Matignon M, Moktefi A, Samson C, Zarour A, Malard S, Boutin E, Pilon C, Salomon L, Natella P-A, Durrbach A, Robert T, Canoui-Poitrine F, Grimbert P. Belatacept in renal transplant recipient with mild immunologic risk factor: A pilot prospective study (BELACOR). Am J Transplant. 2019;19(3):894-906.
  58. Vaux J, Lecarpentier E, Heidet M, Oubaya N, Hubert H, Baert V, Segal N, Mansouri N, Gueugniaud P-Y, Bertrand C, Canoui-Poitrine F. Management and outcomes of cardiac arrests at nursing homes: A French nationwide cohort study. Resuscitation. 2019;140:86-92.
  59. Hervochon R, Teissier N, Blondeau J-R, Remus N, Bassinet L, Canoui-Poitrine F, Van Den Abbeele T, Prulière-Escabasse V. Computed Tomography Description of the Uncinate Process Angulation in Patients With Cystic Fibrosis and Comparison With Primary Ciliary Dyskinesia, Nasal Polyposis, and Controls. Ear Nose Throat J. 2019;98(2):89-93.
  60. Sobhani I, Bergsten E, Couffin S, Amiot A, Nebbad B, Barau C, de'Angelis N, Rabot S, Canoui-Poitrine F, Mestivier D, Pédron T, Khazaie K, Sansonetti PJ. Colorectal cancer-associated microbiota contributes to oncogenic epigenetic signatures. Proc Natl Acad Sci U S A. 2019;116(48):24285-24295.
  61. Bartier S, Bodez D, Kharoubi M, Guellich A, Canoui-Poitrine F, Chatelin V, Coste A, Damy T, Béquignon E. Association between hearing loss and hereditary ATTR amyloidosis. Amyloid. 2019;26(4):234-242.
  62. Deshayes S, Khellaf M, Zarour A, Layese R, Fain O, Terriou L, Viallard J-F, Cheze S, Graveleau J, Slama B, Audia S, Cliquennois M, Ebbo M, Le Guenno G, Salles G, Bonmati C, Teillet F, Galicier L, Lambotte O, Hot A, Lefrère F, Mahévas M, Canoui-Poitrine F, Michel M, Godeau B. Long-term safety and efficacy of rituximab in 248 adults with immune thrombocytopenia: Results at 5 years from the French prospective registry ITP-ritux. Am J Hematol. 2019;94(12):1314-1324.
  63. Bartier S, Bodez D, Kharoubi M, Canoui-Poitrine F, Chatelin V, Henrion C, Coste A, Damy T, Béquignon E. Pharyngo-laryngeal involvement in systemic amyloidosis with cardiac involvement: a prospective observational study. Amyloid. 2019;26(4):216-224.
  64. Heidet M, Canoui-Poitrine F, Revaux F, Perennou T, Bertin M, Binetruy C, Palazzi J, Tapiero E, Nguyen M, Reuter P-G, Lecarpentier E, Vaux J, Marty J. Factors affecting medical file documentation during telephone triage at an emergency call centre: a cross-sectional study of out-of-hours home visits by general practitioners in France. BMC Health Serv Res. 2019;19(1):531.
  65. Valembois L, Audureau E, Takeda A, Jarzebowski W, Belmin J, Lafuente-Lafuente C. Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation. Cochrane Database Syst RevCochrane Database Syst RevCochrane Database Syst Rev. 2019;9:CD005049.
  66. Lalevée S, Audureau E, Riou A, Colin A, Anquetin M, Barau C, Valeyrie-Allanore L, Delfau-Larue M-H, Chosidow O, Wolkenstein P, Ingen-Housz-Oro S, Hue S. Acute generalized exanthematous pustulosis and epidermal necrolysis differ in innate cytokine patterns. Clin Exp Allergy. 2019;49(9):1258-1261.
  67. Thabut D, Bureau C, Layese R, Bourcier V, Hammouche M, Cagnot C, Marcellin P, Guyader D, Pol S, Larrey D, De Lédinghen V, Ouzan D, Zoulim F, Roulot D, Tran A, Bronowicki J-P, Zarski J-P, Goria O, Calès P, Péron J-M, Alric L, Bourlière M, Mathurin P, Blanc J-F, Abergel A, Serfaty L, Mallat A, Grangé J-D, Attali P, Bacq Y, Wartelle-Bladou C, Dao T, Pilette C, Silvain C, Christidis C, Capron D, Bernard-Chabert B, Hillaire S, Di Martino V, Sutton A, Audureau E, Roudot-Thoraval F, Nahon P. Validation of Baveno VI Criteria for Screening and Surveillance of Esophageal Varices in Patients With Compensated Cirrhosis and a Sustained Response to Antiviral Therapy. Gastroenterology. 2019;156(4):997-1009.e5.
  68. Gracies J-M, Pradines M, Ghédira M, Loche C-M, Mardale V, Hennegrave C, Gault-Colas C, Audureau E, Hutin E, Baude M, Bayle N. Guided Self-rehabilitation Contract vs conventional therapy in chronic stroke-induced hemiparesis: NEURORESTORE, a multicenter randomized controlled trial. BMC Neurol. 2019;19(1):39.
  69. Audureau E, Davis B, Besson MHélène, Saba J, Ladner J. Willingness to pay for medical treatments in chronic diseases: a multicountry survey of patients and physicians. J Comp Eff Res. 2019;8(5):357-369.
  70. Audureau E, Besson MHélène, Nofal A, Jayasundera R, Saba J, Ladner J. Ability to pay for medication: a clustering analysis of 1404 patients with the Patient Financial Eligibility Tool. J Comp Eff Res. 2019;8(12):969-977.
  71. Ahmed-Yahia S, Decousser J-W, Flouzat-Lachaniette CHenri, Dervin G, Roubineau F, Audureau E, Hourdille A, Royer G, Eymard F, Chevalier X. Is the discopathy associated with Modic changes an infectious process? Results from a prospective monocenter study. PLoS One. 2019;14(8):e0221030.
  72. Blondiaux E, Autret G, Dhombres F, Gonzales M, Audureau E, Clément O, Jouannic J-M, Houyel L. Evaluation of septal insertion of atrioventricular valves in fetuses by postmortem 4.7 Tesla cardiac MRI: A feasibility study. Diagn Interv Imaging. 2019;100(2):109-116.
  73. Attias P, Melica G, Boutboul D, De Castro N, Audard V, Stehlé T, Gaube G, Fourati S, Botterel F, Fihman V, Audureau E, Grimbert P, Matignon M. Epidemiology, Risk Factors, and Outcomes of Opportunistic Infections after Kidney Allograft Transplantation in the Era of Modern Immunosuppression: A Monocentric Cohort Study. J Clin Med. 2019;8(5).
  74. Costentin CE, Layese R, Roudot-Thoraval F, Audureau E, Nahon P. Reply. Gastroenterology. 2019;156(1):289-290.
  75. Gouraud C, Paillaud E, Martinez-Tapia C, Segaux L, Reinald N, Laurent M, Corsin L, Hoertel N, Gisselbrecht M, Mercadier E, Boudou-Rouquette P, Chahwakilian A, Bastuji-Garin S, Limosin F, Lemogne C, Canoui-Poitrine F. Depressive Symptom Profiles and Survival in Older Patients with Cancer: Latent Class Analysis of the ELCAPA Cohort Study. Oncologist. 2019;24(7):e458-e466.
  76. Canoui-Poitrine F, Lièvre A, Dayde F, Lopez-Trabada-Ataz D, Baumgaertner I, Dubreuil O, Brunetti F, Coriat R, Maley K, Pernot S, Tournigand C, Hagege M, Aparicio T, Paillaud E, Bastuji-Garin S. Inclusion of Older Patients with Cancer in Clinical Trials: The SAGE Prospective Multicenter Cohort Survey. Oncologist. 2019;24(12):e1351-e1359.
  77. Allaire M, Rekik S, Layese R, Mumana A, Guyot E, Nkontchou G, Bourcier V, Grando V, Ziol M, Nahon P, Ganne-Carrié N, Sutter O, Audureau E, Seror O, Nault J-C. Virologic control and severity of liver disease determine survival after radiofrequency ablation of hepatocellular carcinoma on cirrhosis. Dig Liver Dis. 2019;51(1):86-94.
  78. Bouillanne O, Melchior J-C, Faure C, Paul M, Canoui-Poitrine F, Boirie Y, Chevenne D, Forasassi C, Guery E, Herbaud S, Le Corvoisier P, Neveux N, Nivet-Antoine V, Astier A, Raynaud-Simon A, Walrand S, Cynober L, Aussel C. Impact of 3-week citrulline supplementation on postprandial protein metabolism in malnourished older patients: The Ciproage randomized controlled trial. Clin Nutr. 2019;38(2):564-574.
  79. Gelu-Simeon M, Lewin M, Ostos M, Bayan T, Delgado MBeso, Teicher E, Layese R, Roudot-Thoraval F, Fontaine H, Sobesky R, Salmon-Céron D, Samuel D, Seror O, Nahon P, Meyer L, Duclos-Vallée J-C. Prognostic factors of survival in HIV/HCV co-infected patients with hepatocellular carcinoma: The CARCINOVIC Cohort. Liver Int. 2019;39(1):136-146.
  80. Petrucciani N, Brunetti F, de'Angelis N. Urinary Tract Infection and Vaginal Purulent Flow in a Patient With Recurrent Sigmoiditis. Gastroenterology. 2019;156(1):e5-e7.
  81. Brichler S, Nahon P, Zoulim F, Layese R, Bourcier V, Audureau E, Sutton A, Letouze E, Cagnot C, Marcellin P, Guyader D, Roulot D, Pol S, De Lédinghen V, Zarski J-P, Calès P, Tran A, Péron J-M, Mallat A, Riachi G, Grangé J-D, Blanc J-F, Bacq Y, Ouzan D, Bronowicki J-P, Mathurin P, Larrey D, Alric L, Attali P, Serfaty L, Pilette C, Bourlière M, Thabut D, Silvain C, Wartelle C, Zucman D, Christidis C, Roudot-Thoraval F, Ganne-Carrié N. Non-virological factors are drivers of hepatocellular carcinoma in virosuppressed hepatitis B cirrhosis: Results of ANRS CO12 CirVir cohort. J Viral Hepat. 2019;26(3):384-396.
  82. Contou D, Canoui-Poitrine F, Coudroy R, Préau S, Cour M, Barbier F, Terzi N, Schnell G, Galbois A, Zafrani L, Zuber B, Ehrmann S, Gelisse E, Colling D, Schmidt M, Jaber S, Conia A, Sonneville R, Colin G, Guérin L, Roux D, Jochmans S, Kentish-Barnes N, Audureau E, Layese R, Alves A, Ouedraogo R, Brun-Buisson C, Dessap AMekontso, de Prost N. Long-term Quality of Life in Adult Patients Surviving Purpura Fulminans: An Exposed-Unexposed Multicenter Cohort Study. Clin Infect Dis. 2019;69(2):332-340.
  83. Pamoukdjian F, Liuu E, Caillet P, Herbaud S, Gisselbrecht M, Poisson J, Boudou-Rouquette P, Zelek L, Paillaud E. How to Optimize Cancer Treatment in Older Patients: An Overview of Available Geriatric Tools. Am J Clin Oncol. 2019;42(2):109-116.
  84. Zehou O, Ferkal S, Brugières P, Barbarot S, Bastuji-Garin S, Combemale P, Valeyrie-Allanore L, Sbidian E, Wolkenstein P. Absence of Efficacy of Everolimus in Neurofibromatosis 1-Related Plexiform Neurofibromas: Results from a Phase 2a Trial. J Invest Dermatol. 2019;139(3):718-720.
  85. Belkacemi Y, Colson-Durand L, Fayolle-Campana M, Pons P, Rialland A, Bastuji-Garin S, Hoang QNguyen, Lerouge D, Jaffré F, Bollet M, Azria D. A Wake-Up Call for Routine Morbidity and Mortality Review Meeting Procedures as Part of a Quality Governance Programs in Radiation Therapy Departments: Results of the PROUST Survey. Pract Radiat Oncol. 2019;9(2):108-114.
  86. Thuleau A, Gilbert C, Bauër P, Alran S, Fourchotte V, Guillot E, Vincent-Salomon A, Kerihuel J-C, Dugay J, Semetey V, Kriegel I, Fromantin I. A New Transcutaneous Method for Breast Cancer Detection with Dogs. Oncology. 2019;96(2):110-113.


  1. Mohty D, Petitalot V, Magne J, Fadel BM, Boulogne C, Rouabhia D, Hamel CEl, Lavergne D, Damy T, Aboyans V, Jaccard A. Author's reply. J Cardiol. 2018;72(4):368.
  2. Van Der Gucht A, Cottereau A-S, Abulizi M, Guellich A, Blanc-Durand P, Israël J-M, Galat A, Planté-Bordeneuve V, Dubois-Randé J-L, Bodez D, Rosso J, Damy T, Itti E. Apical sparing pattern of left ventricular myocardial Tc-HMDP uptake in patients with transthyretin cardiac amyloidosis. J Nucl Cardiol. 2018;25(6):2072-2079.
  3. Maurer MS, Schwartz JH, Gundapaneni B, Elliott PM, Merlini G, Waddington-Cruz M, Kristen AV, Grogan M, Witteles R, Damy T, Drachman BM, Shah SJ, Hanna M, Judge DP, Barsdorf AI, Huber P, Patterson TA, Riley S, Schumacher J, Stewart M, Sultan MB, Rapezzi C. Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy. N Engl J Med. 2018;379(11):1007-1016.
  4. Mohty D, Petitalot V, Magne J, Fadel BM, Boulogne C, Rouabhia D, Hamel CEl, Lavergne D, Damy T, Aboyans V, Jaccard A. Left atrial function in patients with light chain amyloidosis: A transthoracic 3D speckle tracking imaging study. J Cardiol. 2018;71(4):419-427.
  5. Lefaucheur J-P, Zouari HG, Gorram F, Nordine T, Damy T, Planté-Bordeneuve V. The value of electrochemical skin conductance measurement using Sudoscan® in the assessment of patients with familial amyloid polyneuropathy. Clin Neurophysiol. 2018;129(8):1565-1569.
  6. Gillmore JD, Damy T, Fontana M, Hutchinson M, Lachmann HJ, Martinez-Naharro A, Quarta CC, Rezk T, Whelan CJ, Gonzalez-Lopez E, Lane T, Gilbertson JA, Rowczenio D, Petrie A, Hawkins PN. A new staging system for cardiac transthyretin amyloidosis. Eur Heart J. 2018;39(30):2799-2806.
  7. d'Humières T, Fard D, Damy T, Roubille F, Galat A, Doan H-L, Oliver L, Dubois-Randé J-L, Squara P, Lim P, Ternacle J. Outcome of patients with cardiac amyloidosis admitted to an intensive care unit for acute heart failure. Arch Cardiovasc Dis. 2018;111(10):582-590.
  8. Carment L, Abdellatif A, Lafuente-Lafuente C, Pariel S, Maier MA, Belmin J, Lindberg PG. Manual Dexterity and Aging: A Pilot Study Disentangling Sensorimotor From Cognitive Decline. Front Neurol. 2018;9:910.
  9. Chevance V, Damy T, Tacher V, Legou F, Ridouani F, Luciani A, Kobeiter H, Rahmouni A, Deux J-F. Myocardial iodine concentration measurement using dual-energy computed tomography for the diagnosis of cardiac amyloidosis: a pilot study. Eur Radiol. 2018;28(2):816-823.
  10. Cantrelle C, Dorent R, Legeai C, Damy T, Bastien O, Tuppin P. Hospitalisation and life support in the year before and during heart transplantation: a French national study. Open Heart. 2018;5(2):e000913.
  11. Abulizi M, Cottereau A-S, Guellich A, Vandeventer S, Galat A, Van Der Gucht A, Planté-Bordeneuve V, Dubois-Randé J-L, Bodez D, Rosso J, Damy T, Itti E. Early-phase myocardial uptake intensity of Tc-HMDP vs Tc-DPD in patients with hereditary transthyretin-related cardiac amyloidosis. J Nucl Cardiol. 2018;25(1):217-222.
  12. Pamoukdjian F, Tine S, Aber M, Ferreira A, Sebbane G, Paillaud E. [Not Available]. Soins Gerontol. 2018;23(130):45-46.
  13. McDonagh T, Damy T, Doehner W, Lam CSP, Sindone A, van der Meer P, Cohen-Solal A, Kindermann I, Manito N, Pfister O, Pohjantähti-Maaroos H, Taylor J, Comin-Colet J. Screening, diagnosis and treatment of iron deficiency in chronic heart failure: putting the 2016 European Society of Cardiology heart failure guidelines into clinical practice. Eur J Heart Fail. 2018;20(12):1664-1672.
  14. Berthelot E, Bauer F, Eicher J-C, Flécher E, Gellen B, Guihaire J, Guijarro D, Roul G, Salvat M, Tribouilloy C, Zores F, Lamblin N, De Groote P, Damy T. Pulmonary hypertension in chronic heart failure: definitions, advances, and unanswered issues. ESC Heart Fail. 2018;5(5):755-763.
  15. Devillers L, Sicsic J, Delbarre A, Le Bel J, Ferrat E, Lary OSaint. General Practitioner trainers prescribe fewer antibiotics in primary care: Evidence from France. PLoS One. 2018;13(1):e0190522.
  16. Audureau E, Roux F, D Danic L, Bagot M, Cantagrel A, Dernis E, Gouyette N, Hilliquin P, Jullien D, Lioté F, Passeron T, Richard MA, Claudepierre P. Psoriatic arthritis screening by the dermatologist: development and first validation of the 'PURE-4 scale'. J Eur Acad Dermatol Venereol. 2018;32(11):1950-1953.
  17. Bastard J-P, Fellahi S, Audureau E, Layese R, Roudot-Thoraval F, Cagnot C, Mahuas-Bourcier V, Sutton A, Ziol M, Capeau J, Nahon P. Elevated adiponectin and sTNFRII serum levels can predict progression to hepatocellular carcinoma in patients with compensated HCV1 cirrhosis. Eur Cytokine Netw. 2018;29(3):112-120.
  18. Winter A, Féray C, Audureau E, Azoulay D, Antoine C, Daurès J-P, Landais P. Author Correction: A Donor Quality Index for liver transplantation: development, internal and external validation. Sci Rep. 2018;8(1):15109.
  19. Aparicio T, Bouché O, Taieb J, Maillard E, Kirscher S, Etienne P-L, Faroux R, F Akouz K, F Hajbi E, Locher C, Rinaldi Y, Lecomte T, Lavau-Denes S, Baconnier M, Oden-Gangloff A, Genet D, Paillaud E, Retornaz F, Francois E, Bedenne L. Bevacizumab+chemotherapy versus chemotherapy alone in elderly patients with untreated metastatic colorectal cancer: a randomized phase II trial-PRODIGE 20 study results. Ann Oncol. 2018;29(1):133-138.
  20. Petrucciani N, Debs T, Nigri G, Giannini G, Sborlini E, Kassir R, Ben Amor I, Iannelli A, Valabrega S, D'Angelo F, Gugenheim J, Ramacciato G. Pancreatectomy combined with multivisceral resection for pancreatic malignancies: is it justified? Results of a systematic review. HPB (Oxford). 2018;20(1):3-10.
  21. de'Angelis N, Abdalla S, Bianchi G, Memeo R, Charpy C, Petrucciani N, Sobhani I, Brunetti F. Robotic Versus Laparoscopic Colorectal Cancer Surgery in Elderly Patients: A Propensity Score Match Analysis. J Laparoendosc Adv Surg Tech A. 2018;28(11):1334-1345.
  22. Nigri G, Petrucciani N, Debs T, Mangogna LMaria, Crovetto A, Moschetta G, Persechino R, Aurello P, Ramacciato G. Treatment options for PNET liver metastases: a systematic review. World J Surg Oncol. 2018;16(1):142.
  23. Nigri G, Petrucciani N, Pinna ADaniele, Ravaioli M, Jovine E, Minni F, Grazi GLuca, Chirletti P, Balzano G, Ferla F, De Carlis L, Tisone G, Napoli N, Boggi U, Ramacciato G. Evolution of pancreatectomy with en bloc venous resection for pancreatic cancer in Italy. Retrospective cohort study on 425 cases in 10 pancreatic referral units. Int J Surg. 2018;55:103-109.
  24. Aparicio T, Bouché O, Francois E, Retornaz F, Barbier E, Taieb J, Kirscher S, Etienne P-L, Faroux R, F Akouz K, F Hajbi E, Locher C, Rinaldi Y, Lecomte T, Lavau-Denes S, Baconnier M, Oden-Gangloff A, Genet D, Bedenne L, Paillaud E. Geriatric analysis from PRODIGE 20 randomized phase II trial evaluating bevacizumab + chemotherapy versus chemotherapy alone in older patients with untreated metastatic colorectal cancer. Eur J Cancer. 2018;97:16-24.
  25. Fancellu A, Petrucciani N, Melis M, Porcu A, Feo CF, Zorcolo L, Nigri G. Usefulness of Infra-hepatic Inferior Vena Cava Clamping During Liver Resection: a Meta-analysis of Randomized Controlled Trials. J Gastrointest Surg. 2018;22(5):941-951.
  26. Petrucciani N, Martínez-Pérez A, Bianchi G, Memeo R, Brunetti F, Angelis NDe'. The use of laparoscopy for locally advanced rectal cancer. Minerva Chir. 2018;73(1):77-92.
  27. Ramacciato G, Petrucciani N, Nigri G. Open vs Minimally Invasive Approach in Pancreatic Surgery: Where Are We?. J Am Coll Surg. 2018;226(2):203-204.
  28. Vergnenègre A, Chouaid C. Review of economic analyses of treatment for non-small-cell lung cancer (NSCLC). Expert Rev Pharmacoecon Outcomes Res. 2018;18(5):519-528.
  29. Bylicki O, Paleiron N, Rousseau-Bussac G, Chouaid C. New PDL1 inhibitors for non-small cell lung cancer: focus on pembrolizumab. Onco Targets Ther. 2018;11:4051-4064.
  30. Saboundji K, Auliac J-B, Perol M, François G, Janicot H, Marcq M, Dubos-Arvis C, Renault A, Guisier F, Odier L, Gervais R, Chouaid C. Efficacy of Osimertinib in EGFR-Mutated Non-Small Cell Lung Cancer with Leptomeningeal Metastases Pretreated with EGFR-Tyrosine Kinase Inhibitors. Target Oncol. 2018;13(4):501-507.
  31. Naccache J-M, Gibiot Q, Monnet I, Antoine M, Wislez M, Chouaid C, Cadranel J. Lung cancer and interstitial lung disease: a literature review. J Thorac Dis. 2018;10(6):3829-3844.
  32. Garassino MChiara, Cho B-C, Kim J-H, Mazières J, Vansteenkiste J, Lena H, Jaime JCorral, Gray JE, Powderly J, Chouaid C, Bidoli P, Wheatley-Price P, Park K, Soo RA, Huang Y, Wadsworth C, Dennis PA, Rizvi NA. Durvalumab as third-line or later treatment for advanced non-small-cell lung cancer (ATLANTIC): an open-label, single-arm, phase 2 study. Lancet Oncol. 2018;19(4):521-536.
  33. Picchi H, Mateus C, Chouaid C, Besse B, Marabelle A, Michot JM, Champiat S, Voisin AL, Lambotte O. Infectious complications associated with the use of immune checkpoint inhibitors in oncology: reactivation of tuberculosis after anti PD-1 treatment. Clin Microbiol Infect. 2018;24(3):216-218.
  34. Gauvain C, Vauléon E, Chouaid C, Le Rhun E, Jabot L, Scherpereel A, Vinas F, Cortot ABenjamin, Monnet I. Intracerebral efficacy and tolerance of nivolumab in non-small-cell lung cancer patients with brain metastases. Lung Cancer. 2018;116:62-66.
  35. Babey H, Quere G, Descourt R, Le Calloch R, Lanfranco L, Nousbaum J-B, Cornec D, Tison A, Chouaid C. Immune-checkpoint inhibitors to treat cancers in specific immunocompromised populations: a critical review. Expert Rev Anticancer Ther. 2018;18(10):981-989.
  36. la Martire G, Robin C, Oubaya N, Lepeule R, Beckerich F, Leclerc M, Barhoumi W, Toma A, Pautas C, Maury S, Akrout W, Cordonnier-Jourdin C, Fihman V, Venditti M, Cordonnier C. De-escalation and discontinuation strategies in high-risk neutropenic patients: an interrupted time series analyses of antimicrobial consumption and impact on outcome. Eur J Clin Microbiol Infect Dis. 2018;37(10):1931-1940.
  37. Gauthier M, Canoui-Poitrine F, Guery E, Desvaux D, Hue S, Canaud G, Stehlé T, Lang P, Kofman T, Grimbert P, Matignon M. Anticardiolipin antibodies and 12-month graft function in kidney transplant recipients: a prognosis cohort survey. Nephrol Dial Transplant. 2018;33(4):709-716.
  38. Serris A, Amoura Z, Canoui-Poitrine F, Terrier B, Hachulla E, Costedoat-Chalumeau N, Papo T, Lambotte O, Saadoun D, Hié M, Blanche P, Lioger B, Gottenberg J-E, Godeau B, Michel M. Efficacy and safety of rituximab for systemic lupus erythematosus-associated immune cytopenias: A multicenter retrospective cohort study of 71 adults. Am J Hematol. 2018;93(3):424-429.
  39. Lemogne C, Turinici M, Panjo H, Ngo C, Canoui-Poitrine F, Chauvet-Gelinier J-C, Limosin F, Consoli SM, Goldberg M, Zins M, Ringa V. Personality and breast cancer screening in women of the GAZEL cohort study. Cancer Med. 2018;7(2):515-524.
  40. Frasca M, Soubeyran P, Bellera C, Rainfray M, Leffondre K, Mathoulin-Pélissier S. Alterations in comprehensive geriatric assessment decrease survival of elderly patients with cancer. Eur J Cancer. 2018;90:10-18.
  41. Contou D, Sonneville R, Canoui-Poitrine F, Colin G, Coudroy R, Pène F, Tadié J-M, Cour M, Béduneau G, Marchalot A, Guérin L, Jochmans S, Ehrmann S, Terzi N, Préau S, Barbier F, Schnell G, Roux D, Leroy O, Pichereau C, Gelisse E, Zafrani L, Layese R, Brun-Buisson C, Dessap AMekontso, de Prost N. Clinical spectrum and short-term outcome of adult patients with purpura fulminans: a French multicenter retrospective cohort study. Intensive Care Med. 2018;44(9):1502-1511.
  42. Hanon O, Vidal J-S, Lehmann S, Bombois S, Allinquant B, Tréluyer J-M, Gelé P, Delmaire C, Blanc F, Mangin J-F, Buée L, Touchon J, Hugon J, Vellas B, Galbrun E, Benetos A, Berrut G, Paillaud E, Wallon D, Castelnovo G, Volpe-Gillot L, Paccalin M, Robert P-H, Godefroy O, Dantoine T, Camus V, Belmin J, Vandel P, Novella J-L, Duron E, Rigaud A-S, Schraen-Maschke S, Gabelle A. Plasma amyloid levels within the Alzheimer's process and correlations with central biomarkers. Alzheimers Dement. 2018;14(7):858-868.
  43. Hentati H, Salloum C, Caillet P, Lahat E, Disabato M, Levesque E, Compagnon P, Lim C, Azoulay D. Risk Factors for Mortality and Morbidity in Elderly Patients Presenting with Digestive Surgical Emergencies. World J Surg. 2018;42(7):1988-1996.
  44. Sobhani I, Itti E, Luciani A, Baumgaertner I, Layese R, André T, Ducreux M, Gornet J-M, Goujon G, Aparicio T, Taieb J, Bachet J-B, Hemery F, Retbi A, Mons M, Flicoteaux R, Rhein B, Baron S, Cherrak I, Rufat P, Le Corvoisier P, de'Angelis N, Natella P-A, Maoulida H, Tournigand C, I Zaleski D, Bastuji-Garin S. Colorectal cancer (CRC) monitoring by 6-monthly 18FDG-PET/CT: an open-label multicentre randomised trial. Ann Oncol. 2018;29(4):931-937.
  45. Brenaut E, Bastuji-Garin S. [Notions of epidemiology of value in dermatology]. Ann Dermatol Venereol. 2018;145(2):129-140.
  46. Audureau E, Simon-Deckers A, Franco-Montoya M-L, Annangi B, Kermanizadeh A, Boczkowski J, Lanone S. Substantial modification of the gene expression profile following exposure of macrophages to welding-related nanoparticles. Sci Rep. 2018;8(1):8554.
  47. Bocahut N, Audureau E, Poignard A, Delambre J, Queinnec S, Lachaniette C-HFlouzat, Allain J. Incidence and impact of implant subsidence after stand-alone lateral lumbar interbody fusion. Orthop Traumatol Surg Res. 2018;104(3):405-410.
  48. Felip E, Barlesi F, Besse B, Chu Q, Gandhi L, Kim S-W, Carcereny E, Sequist LV, Brunsvig P, Chouaid C, Smit EF, Groen HJM, Kim D-W, Park K, Avsar E, Szpakowski S, Akimov M, Garon EB. Phase 2 Study of the HSP-90 Inhibitor AUY922 in Previously Treated and Molecularly Defined Patients with Advanced Non-Small Cell Lung Cancer. J Thorac Oncol. 2018;13(4):576-584.
  49. Cacoub P, Nahon P, Layese R, Blaise L, Desbois AClaire, Bourcier V, Cagnot C, Marcellin P, Guyader D, Pol S, Larrey D, De Lédinghen V, Ouzan D, Zoulim F, Roulot D, Tran A, Bronowicki J-P, Zarski J-P, Riachi G, Calès P, Péron J-M, Alric L, Bourlière M, Mathurin P, Blanc J-F, Abergel A, Serfaty L, Mallat A, Grangé J-D, Attali P, Bacq Y, Wartelle C, Dao T, Thabut D, Pilette C, Silvain C, Christidis C, Capron D, Thiefin G, Zucman D, Di Martino V, Bagnis CIsnard, Ziol M, Sutton A, Letouze E, Roudot-Thoraval F, Audureau E. Prognostic value of viral eradication for major adverse cardiovascular events in hepatitis C cirrhotic patients. Am Heart J. 2018;198:4-17.
  50. Allaire M, Nahon P, Layese R, Bourcier V, Cagnot C, Marcellin P, Guyader D, Pol S, Larrey D, De Lédinghen V, Ouzan D, Zoulim F, Roulot D, Tran A, Bronowicki J-P, Zarski J-P, Riachi G, Calès P, Péron J-M, Alric L, Bourlière M, Mathurin P, Blanc J-F, Abergel A, Serfaty L, Mallat A, Grangé J-D, Attali P, Bacq Y, Wartelle C, Dao T, Thabut D, Pilette C, Silvain C, Christidis C, Nguyen-Khac E, Bernard-Chabert B, Zucman D, Di Martino V, Sutton A, Letouze E, Audureau E, Roudot-Thoraval F. Extrahepatic cancers are the leading cause of death in patients achieving hepatitis B virus control or hepatitis C virus eradication. Hepatology. 2018;68(4):1245-1259.
  51. Teiger E, Thambo J-B, Defaye P, Hermida J-S, Abbey S, Klug D, Juliard J-M, Pasquie J-L, Rioufol G, Lepillier A, Elbaz M, Horvilleur J, Brenot P, Pierre B, Le Corvoisier P. Percutaneous Left Atrial Appendage Closure Is a Reasonable Option for Patients With Atrial Fibrillation at High Risk for Cerebrovascular Events. Circ Cardiovasc Interv. 2018;11(3):e005841.
  52. Nahon P, Layese R, Bourcier V, Cagnot C, Marcellin P, Guyader D, Pol S, Larrey D, De Lédinghen V, Ouzan D, Zoulim F, Roulot D, Tran A, Bronowicki J-P, Zarski J-P, Riachi G, Calès P, Péron J-M, Alric L, Bourlière M, Mathurin P, Blanc J-F, Abergel A, Serfaty L, Mallat A, Grangé J-D, Attali P, Bacq Y, Wartelle C, Dao T, Thabut D, Pilette C, Silvain C, Christidis C, Nguyen-Khac E, Bernard-Chabert B, Zucman D, Di Martino V, Sutton A, Roudot-Thoraval F, Audureau E. Incidence of Hepatocellular Carcinoma After Direct Antiviral Therapy for HCV in Patients With Cirrhosis Included in Surveillance Programs. Gastroenterology. 2018;155(5):1436-1450.e6.
  53. Blondiaux E, Chougar L, Gelot A, Valence S, Audureau E, le Pointe HDucou, Jouannic J-M, Dhombres F, Garel C. Developmental patterns of fetal fat and corresponding signal on T1-weighted magnetic resonance imaging. Pediatr Radiol. 2018;48(3):317-324.
  54. Schlemmer F, Boyer L, Soumagne T, Ridoux A, Chouaid C, Maitre B, Lanone S, Adnot S, Audureau E, Boczkowski J. Beclin1 circulating levels and accelerated aging markers in COPD. Cell Death Dis. 2018;9(2):156.
  55. Audureau E, Chivet A, Ursu R, Corns R, Metellus P, Noel G, Zouaoui S, Guyotat J, Le Reste P-J, Faillot T, Litre F, Desse N, Petit A, Emery E, Lechapt-Zalcman E, Peltier J, Duntze J, Dezamis E, Voirin J, Menei P, Caire F, Hieu PDam, Barat J-L, Langlois O, Vignes J-R, Fabbro-Peray P, Riondel A, Sorbets E, Zanello M, Roux A, Carpentier A, Bauchet L, Pallud J. Prognostic factors for survival in adult patients with recurrent glioblastoma: a decision-tree-based model. J Neurooncol. 2018;136(3):565-576.
  56. Bassez G, Audureau E, Hogrel J-Y, Arrouasse R, Baghdoyan S, Bhugaloo H, Gourlay-Chu M-L, Le Corvoisier P, Peschanski M. Improved mobility with metformin in patients with myotonic dystrophy type 1: a randomized controlled trial. Brain. 2018;141(10):2855-2865.
  57. Ridouani F, Damy T, Tacher V, Derbel H, Legou F, Sifaoui I, Audureau E, Bodez D, Rahmouni A, Deux J-F. Myocardial native T2 measurement to differentiate light-chain and transthyretin cardiac amyloidosis and assess prognosis. J Cardiovasc Magn Reson. 2018;20(1):58.
  58. Costentin CE, Layese R, Bourcier V, Cagnot C, Marcellin P, Guyader D, Pol S, Larrey D, De Lédinghen V, Ouzan D, Zoulim F, Roulot D, Tran A, Bronowicki J-P, Zarski J-P, Riachi G, Calès P, Péron J-M, Alric L, Bourlière M, Mathurin P, Blanc J-F, Abergel A, Serfaty L, Mallat A, Grangé J-D, Attali P, Bacq Y, Wartelle C, Dao T, Thabut D, Pilette C, Silvain C, Christidis C, Nguyen-Khac E, Bernard-Chabert B, Zucman D, Di Martino V, Sutton A, Letouze E, Imbeaud S, Zucman-Rossi J, Audureau E, Roudot-Thoraval F, Nahon P. Compliance With Hepatocellular Carcinoma Surveillance Guidelines Associated With Increased Lead-Time Adjusted Survival of Patients With Compensated Viral Cirrhosis: A Multi-Center Cohort Study. Gastroenterology. 2018;155(2):431-442.e10.
  59. Winter A, Féray C, Audureau E, Azoulay D, Antoine C, Daurès J-P, Landais P. A Donor Quality Index for liver transplantation: development, internal and external validation. Sci Rep. 2018;8(1):9871.
  60. Boyer L, Bastuji-Garin S, Chouaid C, Housset B, Le Corvoisier P, Derumeaux G, Boczkowski J, Maitre B, Adnot S, Audureau E. Are Systemic Manifestations Ascribable to COPD in Smokers? A Structural Equation Modeling Approach. Sci Rep. 2018;8(1):8569.
  61. Wendum D, Layese R, Ganne-Carrié N, Bourcier V, Merabtene F, Cagnot C, Sauce E, Barget N, Bedossa P, Terris B, Selves J, Bioulac-Sage P, Sturm N, Sattonnet C, Nahon P, Roudot-Thoraval F, Ziol M. Influence of Progenitor-Derived Regeneration Markers on Hepatitis C Virus-Related Cirrhosis Outcome (ANRS CO12 CirVir Cohort). Hepatology. 2018;68(4):1534-1548.
  62. Corre R, Gervais R, Guisier F, Tassy L, Vinas F, Lamy R, Fraboulet G, Greillier L, Doubre H, Descourt R, Chouaid C, Auliac J-B. Octogenarians with EGFR-mutated non-small cell lung cancer treated by tyrosine-kinase inhibitor: a multicentric real-world study assessing tolerance and efficacy (OCTOMUT study). Oncotarget. 2018;9(9):8253-8262.
  63. Polivka L, Oubaya N, Bachelez H, Paul C, Richard MA, Beylot-Barry M, Schmutz JL, Beneton N, Mahé E, Viguier M, Chosidow O, Canoui-Poitrine F, Sbidian E. Trends in hospitalization rates for psoriasis flares since the introduction of biologics: a time series in France between 2005 and 2015. J Eur Acad Dermatol Venereol. 2018;32(11):1920-1929.
  64. Chouaid C, Assié JBaptiste, Andujar P, Blein C, Tournier C, Vainchtock A, Scherpereel A, Monnet I, Pairon JClaude. Determinants of malignant pleural mesothelioma survival and burden of disease in France: a national cohort analysis. Cancer Med. 2018;7(4):1102-1109.
  65. Cadranel J, Cortot AB, Lena H, Mennecier B, Do P, Dansin E, Mazières J, Chouaid C, Perol M, Barlesi F, Robinet G, Friard S, Thiberville L, Audigier-Valette C, Vergnenègre A, Westeel V, Slimane K, Buturuga A, Moro-Sibilot D, Besse B. Real-life experience of ceritinib in crizotinib-pretreated advanced non-small cell lung cancer patients. ERJ Open Res. 2018;4(1).
  66. de'Angelis N, Petrucciani N, Giannandrea G, Brunetti F. The protocol of low-impact laparoscopic cholecystectomy: the combination of mini-laparoscopy and low-pressure pneumoperitoneum. Updates Surg. 2018;70(4):553-556.
  67. Gellen B, Messonnier LA, Galactéros F, Audureau E, Merlet AN, Rupp T, Peyrot S, Martin C, Féasson L, Bartolucci P. Moderate-intensity endurance-exercise training in patients with sickle-cell disease without severe chronic complications (EXDRE): an open-label randomised controlled trial. Lancet Haematol. 2018;5(11):e554-e562.
  68. Petrucciani N, de'Angelis N, Brunetti F. Robotic Toupet fundoplication following Heller myotomy for achalasia (with video). J Visc Surg. 2018;155(5):427-428.
  69. Auliac JB, Bayle S, Vergnenegre A, Le Caer H, Falchero L, Gervais R, Doubre H, Vinas F, Marin B, Chouaid C. Patients with non-small-cell lung cancer harbouring a mutation: a multicentre study exploring clinical characteristics, management, and outcomes in a real-life setting: EXPLORE GFPC 02-14. Curr Oncol. 2018;25(5):e398-e402.
  70. Le Corvoisier P, Gallet R, Lesault P-F, Audureau E, Paul M, Ternacle J, Ghostine S, Champagne S, Arrouasse R, Bitari D, Mouillet G, Dubois-Randé J-L, Berdeaux A, Ghaleh B, Deux J-F, Teiger E. Intra-coronary morphine versus placebo in the treatment of acute ST-segment elevation myocardial infarction: the MIAMI randomized controlled trial. BMC Cardiovasc Disord. 2018;18(1):193.
  71. Scherpereel A, Durand-Zaleski I, Cotté F-E, Fernandes J, Debieuvre D, Blein C, Gaudin A-F, Tournier C, Vainchtock A, Chauvin P, Souquet P-J, Westeel V, Chouaid C. Access to innovative drugs for metastatic lung cancer treatment in a French nationwide cohort: the TERRITOIRE study. BMC Cancer. 2018;18(1):1013.
  72. Lesueur P, Escande A, Thariat J, Vauléon E, Monnet I, Cortot A, Lerouge D, Danhier S, Do P, Dubos-Arvis C, Chouaid C, Gervais R. Safety of combined PD-1 pathway inhibition and radiation therapy for non-small-cell lung cancer: A multicentric retrospective study from the GFPC. Cancer Med. 2018;7(11):5505-5513.
  73. Bigay-Gamé L, Bota S, Greillier L, Monnet I, Madroszyk A, Corre R, Mastroianni B, Falchero L, Mazières J, Colineaux H, Lepage B, Chouaid C. Characteristics of Lung Cancer in Patients Younger than 40 Years: A Prospective Multicenter Analysis in France. Oncology. 2018;95(6):337-343.
  74. Meyer G, Besse B, Doubre H, Charles-Nelson A, Aquilanti S, Izadifar A, Azarian R, Monnet I, Lamour C, Descourt R, Oliviero G, Taillade L, Chouaid C, Giraud F, Falcoz P-E, Revel M-P, Westeel V, Dixmier A, Trédaniel J, Dehette S, Decroisette C, Prevost A, Pichon E, Fabre E, Soria J-C, Friard S, Stern J-B, Jabot L, Dennewald G, Pavy G, Petitpretz P, Tourani J-M, Alifano M, Chatellier G, Girard P. Anti-tumour effect of low molecular weight heparin in localised lung cancer: a phase III clinical trial. Eur Respir J. 2018;52(4).
  75. Franco I, de'Angelis N, Canoui-Poitrine F, Le Roy B, Courtot L, Voron T, Aprodu R, Salamé E, Saleh NBou, Berger A, Ouaïssi M, Altomare DFrancesco, Pezet D, Mutter D, Brunetti F, Memeo R. Feasibility and Safety of Laparoscopic Right Colectomy in Oldest-Old Patients with Colon Cancer: Results of the CLIMHET Study Group. J Laparoendosc Adv Surg Tech A. 2018;28(11):1326-1333.
  76. Lesueur P, Martel-Laffay I, Escande A, Kissel M, Locher C, Gervais R, Schott R, Vergnenègre A, Chouaid C. Oral vinorelbine-based concomitant chemoradiotherapy in unresectable stage III non-small cell lung cancer: a systematic review. Expert Rev Anticancer Ther. 2018;18(11):1159-1165.
  77. Paillaud E, Soubeyran P, Caillet P, Cudennec T, Brain E, Terret C, Etchepare F, Mourey L, Aparicio T, Pamoukdjian F, Audisio RA, Rostoft S, Hurria A, Bellera C, Mathoulin-Pélissier S. Multidisciplinary development of the Geriatric Core Dataset for clinical research in older patients with cancer: A French initiative with international survey. Eur J Cancer. 2018;103:61-68.
  78. Chouaid C, Danson S, Andreas S, Siakpere O, Benjamin L, Ehness R, Dramard-Goasdoue M-H, Barth J, Hoffmann H, Potter V, Barlesi F, Price M, Chirila C, Hollis K, Sweeney C, Wolowacz S, Kaye JA, Kontoudis I. Adjuvant treatment patterns and outcomes in patients with stage IB-IIIA non-small cell lung cancer in France, Germany, and the United Kingdom based on the LuCaBIS burden of illness study. Lung Cancer. 2018;124:310-316.
  79. Andreas S, Chouaid C, Danson S, Siakpere O, Benjamin L, Ehness R, Dramard-Goasdoue M-H, Barth J, Hoffmann H, Potter V, Barlesi F, Chirila C, Hollis K, Sweeney C, Price M, Wolowacz S, Kaye JA, Kontoudis I. Economic burden of resected (stage IB-IIIA) non-small cell lung cancer in France, Germany and the United Kingdom: A retrospective observational study (LuCaBIS). Lung Cancer. 2018;124:298-309.
  80. Bush SH, Lawlor PG, Ryan K, Centeno C, Lucchesi M, Kanji S, Siddiqi N, Morandi A, Davis DHJ, Laurent M, Schofield N, Barallat E, Ripamonti CI. Delirium in adult cancer patients: ESMO Clinical Practice Guidelines. Ann Oncol. 2018;29(Suppl 4):iv143-iv165.
  81. Costantini A, Corny J, Fallet V, Renet S, Friard S, Chouaid C, Duchemann B, Giroux-Leprieur E, Taillade L, Doucet L, Nguenang M, Jouveshomme S, Wislez M, Trédaniel J, Cadranel J. Efficacy of next treatment received after nivolumab progression in patients with advanced nonsmall cell lung cancer. ERJ Open Res. 2018;4(2).
  82. Hersant B, SidAhmed-Mezi M, Belkacemi Y, Darmon F, Bastuji-Garin S, Werkoff G, Bosc R, Niddam J, Hermeziu O, La Padula S, Meningaud JPaul. Efficacy of injecting platelet concentrate combined with hyaluronic acid for the treatment of vulvovaginal atrophy in postmenopausal women with history of breast cancer: a phase 2 pilot study. Menopause. 2018;25(10):1124-1130.
  83. Remy P, Audard V, Natella PAndré, Pelle G, Dussol B, Leray-Moragues H, Vigneau C, Bouachi K, Dantal J, Vrigneaud L, Karras A, Pourcine F, Gatault P, Grimbert P, Sahlia NAit, Moktefi A, Daugas E, Rigothier C, Bastuji-Garin S, Sahali D. An open-label randomized controlled trial of low-dose corticosteroid plus enteric-coated mycophenolate sodium versus standard corticosteroid treatment for minimal change nephrotic syndrome in adults (MSN Study). Kidney Int. 2018;94(6):1217-1226.
  84. Thuleau A, Dugay J, Dacremont C, Jemmali Z, Elard J, De Ricke Y, Cassoux N, Watson S, Escande M-C, Fromantin I. Volatile Organic Compounds of Malignant Breast Cancer Wounds: Identification and Odors. Wounds. 2018;30(11):337–344.
  85. Kofman T, Pourcine F, Canoui-Poitrine F, Kamar N, Malvezzi P, François H, Boutin E, Audard V, Lang P, Martinez F, Legendre C, Matignon M, Grimbert P. Safety of renal transplantation in patients with bipolar or psychotic disorders: a retrospective study. Transpl Int. 2018;31(4):377-385.
  86. Rwabihama J-P, Audureau E, Laurent M, Rakotoarisoa L, Jegou M, Saddedine S, Krypciak S, Herbaud S, Benzengli H, Segaux L, Guery E, Ambime G, Rabus M-T, Perilliat J-G, David J-P, Paillaud E. Prophylaxis of Venous Thromboembolism in Geriatric Settings: A Cluster-Randomized Multicomponent Interventional Trial. J Am Med Dir Assoc. 2018;19(6):497-503.
  87. Fonteyne V, Ost P, Bellmunt J, Droz JPierre, Mongiat-Artus P, Inman B, Paillaud E, Saad F, Ploussard G. Curative Treatment for Muscle Invasive Bladder Cancer in Elderly Patients: A Systematic Review. Eur Urol. 2018;73(1):40-50.
  88. Villafane G, Thiriez C, Audureau E, Straczek C, Kerschen P, Cormier-Dequaire F, Van Der Gucht A, Gurruchaga J-M, Quéré-Carne M, Evangelista E, Paul M, Defer G, Damier P, Remy P, Itti E, Fénelon G. High-dose transdermal nicotine in Parkinson's disease patients: a randomized, open-label, blinded-endpoint evaluation phase 2 study. Eur J Neurol. 2018;25(1):120-127.
  89. Pamoukdjian F, Bouillet T, Lévy V, Soussan M, Zelek L, Paillaud E. Prevalence and predictive value of pre-therapeutic sarcopenia in cancer patients: A systematic review. Clin Nutr. 2018;37(4):1101-1113.


  1. Debs T, Petrucciani N, Kassir R, Chassang M, Havet J, Piche T, Ben Amor I, Gugenheim J. Double Perforation of Marginal Ulcers after One Anastomosis Gastric Bypass with a Biliary Peritonitis. Obes Surg. 2017;27(11):2993-2995.
  2. Petrucciani N, Debs T, Nigri G, D'Angelo F, Gugenheim J, Ramacciato G. Borderline resectable pancreatic cancer: an evolving concept. Ann Oncol. 2017;28(9):2315.
  3. Debs T, Petrucciani N, Gugenheim J. Why Would a Patient Complain of Dysphagia and Heartburn After Multiple Bariatric Surgeries?. Gastroenterology. 2017;153(3):653-654.
  4. Aurello P, Petrucciani N', Sirimarco D, Mangogna LMaria, Nigri G, Valabrega S, D'Angelo F, Ramacciato G. Esophagectomy with Esophagocoloplasty for Malignancies: Indications, Technique (with Video), and Results. Systematic Review of the Literature. J Gastrointest Surg. 2017;21(9):1557-1561.
  5. Kassir R, Debs T, Petrucciani N, Tiffet O, Ben Amor I, Gugenheim J. Predictive Value of C-Reactive Protein for Complications Post-Laparoscopic Roux-en-Y Gastric Bypass. Obes Surg. 2017;27(9):2460-2461.
  6. Kassir R, Lointier P, Tiffet O, Debs T, Petrucciani N, Kassir R, Ben Amor I, Gugenheim J. Revision bariatric surgery: What technical choices should be taken depending on the first intervention?. Int J Surg. 2017;44:7-8.
  7. Petrucciani N, Debs T, Kassir R, Ben Amor I, Gugenheim J. Gastric Bypass and Synchronous Cholecystectomy: a Matter of Numbers?. Obes Surg. 2017;27(8):2174-2176.
  8. Petrucciani N, Debs T, Ciampi D, Massalou D, Kassir R, Ben Amor I, Gugenheim J. Rare Cause of Small Bowel Ischemia During Pregnancy After Roux-en-Y Gastric Bypass. Obes Surg. 2017;27(7):1879-1881.
  9. Aurello P, Petrucciani N, Antolino L, Giulitti D, D'Angelo F, Ramacciato G. Follow-up after curative resection for gastric cancer: Is it time to tailor it?. World J Gastroenterol. 2017;23(19):3379-3387.
  10. Debs T, Petrucciani N, Kassir R, Vanbiervliet G, Ben Amor I, Staccini AMyx, Sejor E, Gugenheim J. Migration of an Endoscopic Double Pigtail Drain into the Abdominal Wall Placed as a Treatment of a Fistula Post Revisional Bariatric Surgery. Obes Surg. 2017;27(5):1335-1337.
  11. Ben Amor I, Petrucciani N, Kassir R, Munifi AAl, Piche T, Debs T, Gugenheim J. Laparoscopic Conversion of One Anastomosis Gastric Bypass to a Standard Roux-en-Y Gastric Bypass. Obes Surg. 2017;27(5):1398.
  12. Debs T, Petrucciani N, Kassir R, Ouvrier D, Frin AClaire, Ben Amor I, Gugenheim J. Chylous leak after pancreatic resection: A grading system was needed. Surgery. 2017;162(6):1345.
  13. Ramacciato G, Nigri G, Petrucciani N', Pinna ADaniele, Ravaioli M, Jovine E, Minni F, Grazi GLuca, Chirletti P, Tisone G, Ferla F, Napoli N', Boggi U. Prognostic role of nodal ratio, LODDS, pN in patients with pancreatic cancer with venous involvement. BMC Surg. 2017;17(1):109.
  14. Le Caer H, Borget I, Corre R, Locher C, Raynaud C, Decroisette C, Bérard H, Audigier-Valette C, Dujon C, Auliac JBernard, Crequit J, Monnet I, Vergnenègre A, Chouaid C. Prognostic role of a comprehensive geriatric assessment on the management of elderly patients with advanced non-small cell lung cancer (NSCLC): a pooled analysis of two prospective phase II trials by the GFPC Group. J Thorac Dis. 2017;9(10):3747-3754.
  15. Paris C, Do P, Mastroianni B, Dixmier A, Dumont P, Pichon E, Chouaid C, Coudert B, Foucher P, Fraboulet S, Locatelli-Sanchez M, Baize N, Dansin E, Moreau L, Vincent M, Missy P, Morin F, Moro-Sibilot D, Couraud S. Association between lung cancer somatic mutations and occupational exposure in never-smokers. Eur Respir J. 2017;50(4).
  16. Tordrup D, Chouaid C, Cuijpers P, Dab W, van Dongen JMaria, Espin J, Jönsson B, Léonard C, McDaid D, McKee M, Miguel JPereira, Patel A, Reginster J-Y, Ricciardi W, van Molken MRutten-, Rupel VPrevolnik, Sach T, Sassi F, Waugh N, Bertollini R. PRIORITIES FOR HEALTH ECONOMIC METHODOLOGICAL RESEARCH: RESULTS OF AN EXPERT CONSULTATION. Int J Technol Assess Health Care. 2017;33(6):609-619.
  17. Pignata M, Chouaid C, Le Lay K, Luciani L, McConnachie C, Gordon J, Roze S. Evaluating the cost-effectiveness of afatinib after platinum-based therapy for the treatment of squamous non-small-cell lung cancer in France. Clinicoecon Outcomes Res. 2017;9:655-668.
  18. Etienne H, Majewski M, Cochennec F, Segaux L, Becquemin J-P. Emergency Endovascular Interventions for Ruptured Descending Thoracic Aortic Aneurysm. Ann Vasc Surg. 2017;39:160-166.
  19. Azoulay D, Audureau E, Bhangui P, Belghiti J, Boillot O, Andreani P, Castaing D, Cherqui D, Irtan S, Calmus Y, Chazouillères O, Soubrane O, Luciani A, Féray C. Living or Brain-dead Donor Liver Transplantation for Hepatocellular Carcinoma: A Multicenter, Western, Intent-to-treat Cohort Study. Ann Surg. 2017;266(6):1035-1044.
  20. Caillet P, Liuu E, Simon ARaynaud, Bonnefoy M, Guerin O, Berrut G, Lesourd B, Jeandel C, Ferry M, Rolland Y, Paillaud E. Association between cachexia, chemotherapy and outcomes in older cancer patients: A systematic review. Clin Nutr. 2017;36(6):1473-1482.
  21. Blondiaux E, Pidial L, Autret G, Rahmi G, Balvay D, Audureau E, Wilhelm C, Guerin CL, Bruneval P, Silvestre J-S, Menasché P, Clément O. Bone marrow-derived mesenchymal stem cell-loaded fibrin patches act as a reservoir of paracrine factors in chronic myocardial infarction. J Tissue Eng Regen Med. 2017;11(12):3417-3427.
  22. Ernande L, Audureau E, Jellis CL, Bergerot C, Henegar C, Sawaki D, Czibik G, Volpi C, Canoui-Poitrine F, Thibault H, Ternacle J, Moulin P, Marwick TH, Derumeaux G. Clinical Implications of Echocardiographic Phenotypes of Patients With Diabetes Mellitus. J Am Coll Cardiol. 2017;70(14):1704-1716.
  23. Baize N, Monnet I, Greillier L, Quere G, Kerjouan M, Janicot H, Vergnenègre A, Auliac JBernard, Chouaid C. Second-line treatments of small-cell lung cancers. Expert Rev Anticancer Ther. 2017;17(11):1033-1043.
  24. Deux J-F, Audard V, Brugières P, Habibi A, Manea E-M, Guillaud-Danis C, Godeau B, Galactéros F, Stehlé T, Lang P, Grimbert P, Audureau E, Rahmouni A, Bartolucci P. Magnetic Resonance Imaging Assessment of Kidney Oxygenation and Perfusion During Sickle Cell Vaso-occlusive Crises. Am J Kidney Dis. 2017;69(1):51-59.
  25. Auliac J-B, Monnet I, Dubos-Arvis C, Chiappa AMarie, Baize N, Bota S, Vergnenègre A, Doubre H, Locher C, Bizieux A, Robinet G, Chouaid C. Non-Small-Cell Lung Cancer (NSCLC) Harboring ALK Translocations: Clinical Characteristics and Management in a Real-Life Setting: a French Retrospective Analysis (GFPC 02-14 Study). Target Oncol. 2017;12(6):833-838.
  26. Derbez B, de Pauw A, Stoppa-Lyonnet D, de Montgolfier S. Supporting disclosure of genetic information to family members: professional practice and timelines in cancer genetics. Fam Cancer. 2017;16(3):447-457.
  27. Audureau E, Hua C, de Prost N, Hemery F, Decousser JW, Bosc R, Lepeule R, Chosidow O, Sbidian E. Mortality of necrotizing fasciitis: relative influence of individual and hospital-level factors, a nationwide multilevel study, France, 2007-12. Br J Dermatol. 2017;177(6):1575-1582.
  28. Delva F, Margery J, Laurent F, Petitprez K, Pairon J-C. Medical follow-up of workers exposed to lung carcinogens: French evidence-based and pragmatic recommendations. BMC Public Health. 2017;17(1):191.
  29. Chouaid C, Luciani L, LeLay K, Do P, Bennouna J, Perol M, Moro-Sibilot D, Vergnenègre A, de Pouvourville G. Cost-Effectiveness Analysis of Afatinib versus Gefitinib for First-Line Treatment of Advanced EGFR-Mutated Advanced Non-Small Cell Lung Cancers. J Thorac Oncol. 2017;12(10):1496-1502.
  30. Chouaid C, Loirat D, Clay E, Millier A, Godard C, Fannan A, Lévy-Bachelot L, Angevin E. Cost analysis of adverse events associated with non-small cell lung cancer management in France. Clinicoecon Outcomes Res. 2017;9:443-449.
  31. Chouaid C, Falchero L, Schott R, Bonnetain F, Taguieva-Pioger N, Bennouna J. [Bevacizumab in combination with first-line treatment for metastatic non-small cell lung cancer in clinical practice. Results of the EOLE study]. Rev Mal Respir. 2017;34(1):36-43.
  32. Chouaid C, Debieuvre D, Durand-Zaleski I, Fernandes J, Scherpereel A, Westeel V, Blein C, Gaudin A-F, Ozan N, Leblanc S, Vainchtock A, Chauvin P, Cotté F-E, Souquet P-J. Survival inequalities in patients with lung cancer in France: A nationwide cohort study (the TERRITOIRE Study). PLoS One. 2017;12(8):e0182798.
  33. Cambau E, Durand-Zaleski I, Bretagne S, Brun-Buisson C, Cordonnier C, Duval X, Herwegh S, Pottecher J, Courcol R, Bastuji-Garin S. Performance and economic evaluation of the molecular detection of pathogens for patients with severe infections: the EVAMICA open-label, cluster-randomised, interventional crossover trial. Intensive Care Med. 2017;43(11):1613-1625.
  34. Caliez J, Monnet I, Pujals A, Rousseau-Bussac G, Jabot L, Boudjemaa A, Leroy K, Chouaid C. [Lung adenocarcinoma with concomitant EGFR mutation and ALK rearrangement]. Rev Mal Respir. 2017;34(5):576-580.
  35. Cadier B, Bulsei J, Nahon P, Seror O, Laurent A, Rosa I, Layese R, Costentin C, Cagnot C, Durand-Zaleski I, Chevreul K. Early detection and curative treatment of hepatocellular carcinoma: A cost-effectiveness analysis in France and in the United States. Hepatology. 2017;65(4):1237-1248.
  36. Jourjon R, Morel B, Irtan S, Audureau E, Coulomb-L'Herminé A, Larroquet M, le Pointe HDucou, Blondiaux E. Analysis of Clinical and Ultrasound Determinants of Adnexal Torsion in Children and Adolescents. J Pediatr Adolesc Gynecol. 2017;30(5):582-590.
  37. Bylicki O, Paleiron N, Margery J, Guisier F, Vergnenègre A, Robinet G, Auliac J-B, Gervais R, Chouaid C. Targeting the PD-1/PD-L1 Immune Checkpoint in EGFR-Mutated or ALK-Translocated Non-Small-Cell Lung Cancer. Target Oncol. 2017;12(5):563-569.
  38. Gross J, Oubaya N, Eymard F, Hourdille A, Chevalier X, Guignard S. Stressful life events as a trigger for rheumatoid arthritis onset within a year: a case-control study. Scand J Rheumatol. 2017;46(6):507-508.
  39. Boussageon R, Pouchain D, Renard V. Prevention of complications in type 2 diabetes: is drug glucose control evidence based?. Br J Gen Pract. 2017;67(655):85-87.
  40. Uzzan M, Kirchgesner J, Oubaya N, Amiot A, Gornet J-M, Seksik P, Nancey S, Cotte E, Allez M, Boschetti G, Laharie D, de Angelis N, Nachury M, Pelletier A-L, Abitbol V, Fumery M, Brouquet A, Buisson A, Altwegg R, Cosnes J, Panis Y, Treton X. Risk of Rectal Neoplasia after Colectomy and Ileorectal Anastomosis for Ulcerative Colitis. J Crohns Colitis. 2017;11(8):930-935.
  41. Paillaud E, Canoui-Poitrine F, Varnier G, Anfasi-Ebadi N, Guery E, Saint-Jean O, Gisselbrecht M, Aparicio T, Bastuji-Garin S, Laurent M, Caillet P. Preferences about information and decision-making among older patients with and without cancer. Age Ageing. 2017;46(4):665-671.
  42. Toumi M, Motrunich A, Millier A, Rémuzat C, Chouaid C, Falissard B, Aballéa S. Analysis of health economics assessment reports for pharmaceuticals in France - understanding the underlying philosophy of CEESP assessment. J Mark Access Health Policy. 2017;5(1):1344088.
  43. Oubaya N, Dramé M, Novella J-L, Quignard E, Cunin C, Jolly D, Mahmoudi R. Screening for frailty in community-dwelling elderly subjects: Predictive validity of the modified SEGA instrument. Arch Gerontol Geriatr. 2017;73:177-181.
  44. Touma J, Kashi M, Oubaya N, Cochennec F, Allaire E, Marzelle J, Becquemin J-P, Desgranges P. Results of Cryopreserved Arterial Allografts to Treat Infections of Peripheral Bypasses. Ann Vasc Surg. 2017;38:e2.
  45. Notarpaolo A, Layese R, Magistri P, Gambato M, Colledan M, Magini G, Miglioresi L, Vitale A, Vennarecci G, Ambrosio CD, Burra P, Di Benedetto F, Fagiuoli S, Colasanti M, Ettorre GMaria, Andreoli A, Cillo U, Laurent A, Katsahian S, Audureau E, Roudot-Thoraval F, Duvoux C. Validation of the AFP model as a predictor of HCC recurrence in patients with viral hepatitis-related cirrhosis who had received a liver transplant for HCC. J Hepatol. 2017;66(3):552-559.
  46. Ternacle J, Wan F, Sawaki D, Surenaud M, Pini M, Mercedes R, Ernande L, Audureau E, Dubois-Randé J-L, Adnot S, Hue S, Czibik G, Derumeaux G. Short-term high-fat diet compromises myocardial function: a radial strain rate imaging study. Eur Heart J Cardiovasc Imaging. 2017;18(11):1283-1291.
  47. Natella P-A, Le Corvoisier P, Paillaud E, Renaud B, Mahé I, Bergmann J-F, Perchet H, Mottier D, Montagne O, Bastuji-Garin S. Long-term mortality in older patients discharged after acute decompensated heart failure: a prospective cohort study. BMC Geriatr. 2017;17(1):34.
  48. Nahon P, Lescat M, Layese R, Bourcier V, Talmat N, Allam S, Marcellin P, Guyader D, Pol S, Larrey D, De Lédinghen V, Ouzan D, Zoulim F, Roulot D, Tran A, Bronowicki J-P, Zarski J-P, Goria O, Calès P, Péron J-M, Alric L, Bourlière M, Mathurin P, Blanc J-F, Abergel A, Serfaty L, Mallat A, Grangé J-D, Attali P, Bacq Y, Wartelle C, Dao T, Benhamou Y, Pilette C, Silvain C, Christidis C, Capron D, Bernard-Chabert B, Hillaire S, Di Martino V, Trinchet J-C, Moreau R, Roudot-Thoraval F. Bacterial infection in compensated viral cirrhosis impairs 5-year survival (ANRS CO12 CirVir prospective cohort). Gut. 2017;66(2):330-341.
  49. Stücker I, Martin D, Neri M, Laurent-Puig P, Blons H, Antoine M, Guiochon-Mantel A, Brailly-Tabard S, Canonico M, Wislez M, Trédaniel J. Women Epidemiology Lung Cancer (WELCA) study: reproductive, hormonal, occupational risk factors and biobank. BMC Public Health. 2017;17(1):324.
  50. Nahon P, Bourcier V, Layese R, Audureau E, Cagnot C, Marcellin P, Guyader D, Fontaine H, Larrey D, De Lédinghen V, Ouzan D, Zoulim F, Roulot D, Tran A, Bronowicki J-P, Zarski J-P, Leroy V, Riachi G, Calès P, Péron J-M, Alric L, Bourlière M, Mathurin P, Dharancy S, Blanc J-F, Abergel A, Serfaty L, Mallat A, Grangé J-D, Attali P, Bacq Y, Wartelle C, Dao T, Benhamou Y, Pilette C, Silvain C, Christidis C, Capron D, Bernard-Chabert B, Zucman D, Di Martino V, Thibaut V, Salmon D, Ziol M, Sutton A, Pol S, Roudot-Thoraval F. Eradication of Hepatitis C Virus Infection in Patients With Cirrhosis Reduces Risk of Liver and Non-Liver Complications. Gastroenterology. 2017;152(1):142-156.e2.
  51. Moktefi A, Parisot J, Desvaux D, Canoui-Poitrine F, Brocheriou I, Peltier J, Audard V, Kofman T, Suberbielle C, Lang P, Rondeau E, Grimbert P, Matignon M. C1q binding is not an independent risk factor for kidney allograft loss after an acute antibody-mediated rejection episode: a retrospective cohort study. Transpl Int. 2017;30(3):277-287.